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Résumé en français  
Introduction 
A chaque division cellulaire, les cellules sœurs reçoivent une quantité de matériel 
génétique identique. Une seule erreur produit des cellules avec plus ou moins de 
chromosomes, situation qualifiée d’aneuploïde. Dans le cancer, l’aneuploidie  est un 
évènement fréquent, indiquant qu’il y a un problème au niveau de la machinerie impliquée 
dans la ségrégation des chromosomes. Il semble maintenant que l’aneuploïde pourrait être une 
mutation chromosomique discrète qui contribuerait à la  transformation maligne de la cellule  
et à la  progression du cancer. 
Le point de contrôle du fuseau mitotique (‘spindle checkpoint’) est un mécanisme 
conservé, qui retarde l’entrée de la cellule en anaphase jusqu'à ce que tous les chromosomes 
soient alignés dans la plaque métaphasique. Des défauts dans cette voie de signalisation sont 
impliqués dans la génération d’aneuploïdie. L'analyse génétique de la levure S. cerevisiae a 
permis d’identifier les composants moléculaires du point de contrôle du fuseau mitotique. Des 
souches mutantes provenant de deux criblages , « bourgeonnement inhibé par le 
benzimidazole » (bub1, 2, 3) et « déficience dans l’arrêt mitotique » (mad1, 2, 3), semblent 
avoir un fonctionnement normal des microtubules et de la formation du fuseau, mais elles 
sortent de la mitose avant l’assemblage d’un fuseau fonctionel et meurent. Il semble donc que 
cette sensibilité ne soit pas due à un problème structurel mais plutôt  à un défaut dans la 
surveillance du mécanisme. Chez les vertébrés, tous ces composants ont été localisés aux  
kinétochores de la  prophase à la métaphase, montrant l'importance de ces sites comme signal 
"attente-anaphase". 
Mad1 et Mad2 sont deux composants essentiels du point de contrôle du fuseau 
mitotique qui interagissent fortement tout au long du cycle cellulaire. Mad2 a été impliqué 
dans la liaison et l’inhibition de APC/CCdc20, la ligase E3 responsable de l’ubiquitylation et du 
ciblage pour la dégradation de la proéine sécurine, un inhibiteur de l’anaphase. Mad1 pourrait 
être responsable du recrutement kinétochorien de Mad2 dans le Xénope, et selon plusieurs 
études, la localisation de ces deux protéines au  kinétochore joue un rôle important dans 
l’activation du point de contrôl du fuseau mitotique. Cependant, la façon dont  ces protéines 
se lient aux kinétochores n’est pas claire. 
But de la thèse 
Le but du mon travail pendant mon PhD dans le laboratoire du Dr. Erich Nigg a été de 
mieux comprendre les mécanismes moléculaires mis en jeu dans le contrôle du fuseau 
mitotique humain. J’ai  donc sous-cloné quelques-uns des gènes humains, connus pour leur 
implication dans le point de contrôle du fuseau mitotique (hMad1, hMad2, hBub1, hBub3), 
dans des systèmes de multi-clonages (Univector, Creator). Ceci  pour avoir un accès rapide à 
une multiplicité de systèmes d'expression (bactéries, levure, insectes, mammifères) avec 
différentes étiquettes (tag). J’ai ensuite utilisé différentes approches (traduction in vitro suivie 
par une immunoprécipitation ou le système double-hybride dans la levure), pour localiser le 
domaine d’interaction de Mad2 dans Mad1. J’ai également préparé des anticorps polyclonaux 
dirigés contre plusieurs composants du fuseau mitotique, outils nécessaires pour identifier et 
caractériser précisément ces composants par des études immuno-chimiques (immunoblots, 
immunofluorescence et immunoprécipitation). 
Afin de trouver de nouvelles interactions impliquées dans la cascade du contrôle du 
fuseau mitotique, j’ai utilisé le système double-hybride (Y2H) avec hMad1 type sauvage 
(hMad1wt) comme apât. J’ai ainsi identifié plusieurs  composants connus du kintétochore et 
je les ai caractérisés pour trouver leur domaine d’interaction dans Mad1 en utilisant Y2H. J’ai 
ensuite déterminé les fonctions potentielles et les interactions in vivo de ces protéines en 
utilisant  des ARNs double brins synthétiques (small-interfering-RNA/siRNA) dans des 
cellules humaines.   Ces études nous ont permis de proposer une  nouvelle vision du 
mécanisme du point de contrôle du fuseau mitotique. 
 
Résultats 
Criblage double-hybride utilisant hMad1wt comme appât 
 
 Afin de définir quelques-uns des composants moléculaires inconnus du contrôle 
mitotique, nous avons utilisé hMad1 pour cribler une banque d’ADNc  humains en utilisant le 
système double-hybride. Nous avons isolé 92 clones. Basés sur l'analyse de restriction, les 92 
clones ont été groupés en 39 familles, qui ont été séquencées à partir de l’extrémité 5’ en 
utilisant un primer en amont dans le vecteur. Les recherches d’homologies  ont été éxéctuées 
par BLAST (NCBI server) et ClustalW (EBI server). Nous avons ainsi identifié 26 protéines 
connues, 8 protéines inconnues et 2 clones hors phase (3 familles n’ont pas été identifiées).  
Après analyse de ces séquences par ordinateur, nous avons défini 19 candidats potentiels. 
Plusieurs protéines du kinétochore  ont été identifiées, telles que Mad2 et Mad1 elle-
même (suggérant que Mad1 peut dimériser,  démontré précedemment), Smc3 (la première 
région « coiled-coil », cc) et CENP-F (le fragment C-terminal, ct). En outre, un des clones 
positivement identifiés (Mi-34) codait pour  une protéine d’un poids moléculaire calculé de 85 
kDa , qui était identique à Hec1. Comme contrôles, pACT-Hec1, pACT-Smc3 et pACT-
CENP-F (des vecteurs exprimant Hec1, Smc3 (cc) et CENP-F (ct) étiquetés au N- terminal 
avec le domaine d’activation) ont été testés avec le système du double hybride et ont donné un 
résultat négatif lorsqu’ils ont été cotransformés avec le vecteur DBD vide. Ils ont également 
donné un résultat négatif cotransformés avec  DBD-GM130 (fragment c-terminal), une 
protéine « coiled-coil » de l’appareil de Golgi. Ce contrôle nous a permis d’exclure une 
interaction non spécifique avec une protéine « coiled-coil » sans rapport. (Mad1, Hec1, Smc3 
(cc) et CENP-F (ct) contiennent toutes des régions « coiled-coil » putatives). 
L’interaction potentielle Mad1-Hec1 était particulièrement intéressante, parce que 
Hec1 a également été localisé aux kinétochores. Des formes mutantes de l’homologue dans la 
levure, Ndc80, montrent des défauts dans la ségrégation des chromosomes. Similairement, 
l’inactivation d’Hec1 par micro injection d’anticorps spécifiques dans des cellules produisait 
une mitose aberrante, générant des noyaux fragmentés. Dans la levure, Ndc80p fait partie d'un 
complexe de protéines comprenant Spc24p, Spc25p et Nuf2p. Des mutants de Spc24 entrent 
en anaphase avec un léger retard seulement, malgré leur incapacité totale à séparer les 
chromosomes, indiquant un défaut dans le  point de contrôle du fuseau mitotique. En utilisant 
des anticorps anti-hMad1 et anti-hHec1, nous avons testé la localisation de ces  deux protéines 
pendant le cycle cellulaire. Nous avons constaté que Hec1 est retenu aux kinétochores 
pendant toute la phase mitotique, jusqu’à la  télophase. Par contre, hMad1 est relâché après 
l'alignement des chromosomes sur la plaque métaphasique. Ceci confirme la colocalisation de 
ces deux protéines pendant la prophase-prométaphase, l’étape du cycle cellulaire pendant  
laquelle le point de contrôle du fuseau mitotique est actif. 
Identification du domaine d’interaction de hMad1 
Afin d'identifier les régions de hMad1 nécessaires à la liaison de ces protéines, nous 
avons utilisé le système double-hybride employant un ensemble complet de constructions qui 
enjambent différents domaines de hMad1. Nous avons montré qu'une séquence (résidus 203 à 
378), présente proche d’un signal de localisation nucléaire (NLS) de la protéine, est nécessaire 
pour la liaison d’Hec1 à hMad1.  Smc3(cc) donnait des résultats identiques à Hec1, alors que  
CENP-F (ct)  interagissait uniquement  avec une construction de hMad1 dont un petit 
fragment C-terminal  manquait (delta C). Ceci  suggère que l’interaction avec hMad1 doit se 
produire à travers de multiples régions. Aucune des protéines examinées  n’interagissait avec 
la région de hMad1 nécessaire à la liaison de Mad2, indiquant que l'interaction Mad1-Mad2 
pourrait se produire simultanément avec d’autres interactions potentielles. 
La réduction d’Hec1 provoque le relâchement  de hMad1 des kinétochores 
pendant la mitose 
 
Pour tester in vivo l’interaction potentielle de Mad1-Hec1, nous avons utilisé  la 
technique des « small-interfering-RNA/siRNA ». Afin de réduire les niveaux d’Hec1, des 
cellules HeLa S3 ont été transfectées avec un duplex d’ARN (21nucléotides double 
brins homologue à la séquence d’Hec1. 42 heures plus tard,  les cellules ont été fixées, traitées 
et observées par immunofluorescence. L'efficacité de transfection dans ces expériences était 
d’environ 90%. La réduction (silencing) de cette protéine  a été confirmée après 42 heures de 
traitement avec l’ARN double brins synthétique d’ Hec1 (par immunofluorescence, et 
également par immunoblot), alors qu'aucune réduction des niveaux d’ Hec1 n’a été observée 
dans les contrôles (anticorps anti-mHec1). 
Lorsque les cellules déficientes en  Hec1 ont été examinées en utilisant un anticorps 
anti-hMad1, aucun signal n’a pu être détecté aux kinétochores des cellules mitotiques, alors 
que le signal était normal dans les cellules contrôles. Simultanément, nous avons utilisé l'anti-
CENP-B comme marqueur des kinétochores.  CENP-B est une protéine qui se lie à l’ ADN de 
l'hétérochromatine centromérique. Dans les cellules réduites en Hec1p elle restait localisée 
aux kinétochores. Pour vérifier si Hec1 - Mad1 étaient ou non dépendantes l’une de l’autre, 
nous avons également examiné la réduction de Mad1 en utilisant le siRNA.  La réduction de 
Mad1 provoquait la perte de Mad2 mais pas d’Hec1 des kinétochores, ce qui place Hec1 en 
amont de Mad1-Mad2. 
La réduction d’Hec1 affecte spécifiquement quelques composants du 
kinétochore alors que d’autres restent inchangés 
 
Afin de vérifier si cet effet était spécifique de  Mad1 ou était dû à des défauts dans la 
structure du kinétochore, nous avons examiné la localisation mitotique de différentes 
protéines du kinétochore dans des cellules traitées avec le siRNA d’Hec1.  Similairement  à 
Mad1, Mad2 ne pouvait pas être détecté aux kinétochores dans ces cellules.  Un autre 
composant du point de contrôle du fuseau mitotique, Bub1, une kinase identifiée dans un 
complexe formé de Mad1- Bub1 - Bub3, semblait être réduite au kinétochores, bien qu'un 
faible signal restait présent sur quelques kinétochores. 
CENP-F est un composant de la matrice nucléaire qui s’associe avec les kinétochores 
tard dans la phase G2 et est dégradé après la mitose. Il pourrait être impliqué dans les 
premières étapes de l’assemblage du kinétochore, et son interaction avec CENP-E a été 
démontrée.  Dans les cellules réduites en Hec1 la plupart des kinétochores était positifs  pour 
CENP-F, indiquant que la localisation de CENP-F aux kinétochores est indépendante d’Hec1. 
CENP-E est une protéine similaire à la kinésine, nécessaire à l'alignement des 
chromosomes sur la plaque métaphasique.  Il a été démontré qu’elle joue un rôle dans le point 
de contrôle du fuseau mitotique, car la micro injection d'anti-CENP-E empêche la transition 
de la métaphase d'une façon dépendante de BubR1, une protéine avec laquelle CENP-E 
interagit directement. Il est intéressant de noter que la localisation de CENP-E aux 
kinétochores (visualisé au moyen d’un anti-CENP-E monoclonal) n’était pas altérée après le 
traitement avec le siRNA d’Hec1.  Donc, Hec1 semble affecter la localisation de Mad1 et de 
Mad2 aux kinétochores, plus faiblement celle de Bub1, mais pas celle de CENP-E, tandis que 
les composants structuraux du kinétochore (CENP-B, CENP-F) semblent être capables de 
s’assembler dans ces conditions. 
Nous avons également examiné la localisation de la dynactine et d’EB1 dans des 
cellules traitées par le siRNA d’Hec1. Dans nos observations ces deux protéines était encore 
localisées aux fuseaux mitotiques et aux kinétochores, indiquant que la localisation correcte 
de ces deux protéines liant les microtubules ne dépend pas d’Hec1. Ce résultat suggère 
qu'elles se lient directement aux kinétochores ou que des microtubules sont encore attachés 
aux kinétochores, et que la dynactine et EB1 (qui lient à l’extrémités ‘plus’ des microtubules) 
sont donc amenés à cet endroit  par l’intermédiaire des microtubules. 
Hec1 est nécessaire pour éteindre le point de contrôle du fuseau mitotique 
Les cellules traitées par le siRNA Hec1 sont en arrêt mitotique 
 
De façon frappante, dans les cellules traitées avec le siRNA d’Hec1 nous avons 
observé un pourcentage élevé de cellules ressemblant à des cellules en prométaphase, avec 
des chromosomes condensés et un fuseau mitotique entièrement assemblés, contrairement aux 
cellules contrôles. La réduction d’Hec1 a été confirmée par immunofluorescence et 
immunoblot.  Ce résultat indique que la réduction d’ Hec1 conduit à un arrêt mitotique. 
Nous avons ensuite calculé le nombre de cellule en arrêt. Dans les cellules réduites en 
Hec1, nous avons observé une augmentation de l'index mitotique après 24h (environ 15%), 
qui atteint 40% après 42h de traitement.  De plus, dans un cycle cellulaire normal CENP-F est 
dégradé après la mitose d'une façon APC/CCdh1 dépendante, alors que les cellules réduites en 
Hec1 avait un marquage CENP-F aux kinétochores.  Ceci suggère que l'APC/C était inactif 
dans ces cellules et indique que le point de contrôle du fuseau mitotique était très 
probablement actif. 
Dans  les  cellules traitées avec le siRNA d’Hec1, 88,3% des cellules mitotique 
observées était à un stade ressemblant à la prométaphase, par rapport à 42% des cellules 
contrôles, suggérant que la congression des chromosomes était affaiblie  quand les niveaux 
d’Hec1 était bas. Nous nous sommes demandés s'il y avait un attachement des microtubules 
aux kinétochores dans les cellules réduites en Hec1, et nous avons donc effectué un traitement 
au calcium, connu pour déstabiliser les microtubules non attachés.  Après traitement, les 
microtubules étaient encore organisés dans les fuseaux, mais d’une façon légèrement 
anormale, indiquant que l'attachement des microtubules n’était pas complètement perdu, mais 
plutôt changé. 
L'arrêt mitotique observé est dépendant du  point de contrôle du fuseau mitotique  
Afin d’examiner si l'arrêt mitotique était dépendant du point de contrôle du fuseau 
mitotique, nous avons réduit simultanément Hec1 et Mad2, et nous avons constaté en effet 
que l’arrêt mitotique était supprimé. Par immunoblot nous avons confirmé que les niveaux 
d’Hec1 n’étaient pas affectés dans les cellules contrôles et qu’ils étaient réduits dans les 
cellules traitées soit avec le siRNA d’Hec1 soit avec les siRNAs d’Hec1 et de Mad2.  
Cependant, les niveaux de Mad2 étaient inchangés dans les cellules contrôles et dans les 
cellules traitées avec le siRNA d’Hec1, mais étaient réduits dans les  cellules traitées avec les 
siRNA d’Hec1 et de Mad2.  Lorsque nous les avons quantifiés, nous avons remarqué que le 
nombre de cellules possédant des chromosomes condensés étaient fortement réduit dans les 
cellules traitées avec les 2 duplexes par rapport aux cellules traitées uniquement avec le 
siRNA d’Hec1.  Nous avons également réalisé une expérience semblable en utilisant 
simultanément les siRNA d’Hec1 et de BubR1 : le nombre de cellules possédant des 
chromosomes condensés était également fortement réduit.  Ces résultats montrent que l'arrêt 
observé est dépendant du point de contrôle du fuseau mitotique.  Etonnamment, le double 
siRNA Hec1+Mad1 produisait un niveau élevé de mort cellulaire. 
Pour exclure la possibilité d’un effet non spécifique, nous avons utilisé laminA.  La 
transfection du siRNA de laminA seule n'a eu aucun effet sur la progression du cycle 
celullaire, contrairement à Hec1.  Comme indiqué précédemment, la transfection des siRNA 
d’Hec1+Mad2 supprimait complètement l’arrêt mitotique.  Cependant, quand nous avons 
transfecté les siRNA d’Hec1+laminA, les cellules étaient arrêtées en  mitose à un niveau 
similaire à celui observé avec Hec1 seul.  
CENP-E siRNA provoque aussi un arrêt dépendant du point de contrôle du 
fuseau mitotique, mais il n'affecte pas la localisation de Mad1 - Mad2  
Le phénotype observé pourrait s’expliquer si Hec1 était impliqué dans l’attachement  
des microtubules et dans la signalisation du contrôle du fuseau mitotique. En fait ce rôle a été 
décrit précédemment pour CENP-E.  Dans les  cellules mammifères, la réduction de ce 
moteur par des ARN « antisense » conduit à une activation importante du contrôle du fuseau 
mitotique, en dépit du nombre de microtubules apparemment normal et de la présence 
continue d'autres  moteurs   aux kinétochores.  Cette étude a montré que des kinétochores non 
attachés dans des cellules réduites en CENP-E gardaient des niveaux élevés de Mad2. 
Dans les cellules Hela S3 traitées par la siRNA de CENP-E, Hec1, Mad1 et Mad2 
étaient  normalement localisés aux kinétochores sur des chromosomes mal alignés, alors que 
des chromosomes déjà alignés sur la plaque métaphasique ne présentait aucun marquage 
Mad1 et Mad2 aux kinétochores (comme démontré précédemment).  Conformément aux 
résultats publiés, les figures mitotiques observées dans les cellules de siRNA-CENP-E étaient 
différentes de celles observées dans les cellules siRNA d’Hec1 : alors que la perte d’Hec1 
produisait une majorité de cellules à un stade ressemblant au stade prométaphasique, la perte 
de CENP-E produisait beaucoup de cellules dans lesquelles la plupart des chromosomes 
étaient capables d’atteindre la plaque métaphasique, même si quelques chromosomes étaient 
encore situés près des pôles du fuseau.  De même que  pour Hec1, la réduction de CENP-E 
produisait également une augmentation de l'index mitotique, bien que moins prononcée.  Cet 
arrêt était également dépendant du point de contrôle du fuseau mitotique, car il pouvait être 
supprimé par le double-RNAi, en utilisant le siRNA de Mad2 ou de BubR1 ensemble avec la 
réduction de CENP-E.  Nos résultats confirment donc que CENP-E n'est pas nécessaire  à la 
localisation d’Hec1-Mad1-Mad2 aux kinétochores, et suggèrent que cette kinésine fait partie 
d'une voie de signalisation indépendante du point de contrôle du fuseau mitotique. 
Discussion  
Hec1 est nécessaire pour le recruitment de Mad1-Mad2 au kinétochore  
Nos expériences de siRNA montrent clairement que la réduction d’Hec1 provoque une 
délocalisation de Mad1 et Mad2  des  kinétochores pendant la mitose, suggérant que Hec1 est 
nécessaire pour le recruitment de ces protéines du point de contrôle du fuseau mitotique aux 
kinétochores.  Cependant, la réduction de Mad1 par siRNA produisait la perte de Mad2 aux 
kinétochores mais pas celle d’Hec1, ce qui place Hec1 en amont de Mad1 - Mad2.  En accord 
avec des résultats en cours dans la  levure, Ndc80 est impliquée dans l'attachement des 
microtubules aux kinétochores, car les  formes mutantes de cette protéine ont des 
chromosomes complètement détachés du fuseau.  Ceci offre une  possibilité intéressante : 
Hec1 pourrait être  une molécule de connexion, connectant l'attachement des microtubules 
aux kinétochores avec la  signalisation du point de contrôle du fuseau mitotique. 
Chez les mammifères, un rôle similaire a été auparavant proposé pour CENP-E, une 
kinésine impliquée dans l'attachement des chromosomes. Cependent, la réduction de CENP-E 
n'affecte pas la localisation de Mad1 - Mad2, tandis qu’il a été démontré que CENP-E 
interagit avec BubR1. Nos données suggèrent qu'il y a deux complexes indépendants pour la 
signalisation du point de contrôle du fuseau, l’un impliquant Hec1/Mad1/Mad2 et l'autre 
CENP-F/CENP-E/BubRI, en accord avec les modèles précédents.  Il est possible que les deux 
voies de signalisation puissent détecter des événements distincts, comme proposé récemment.  
Alternativement, elles pourraient appartenir à des mécanismes redondants convergents, les 
deux inhibant APC/CCdc20. Ces mécanismes provoqueraient un retard dans l'entrée en 
anaphase, et augmenteraient la sécurité de ce processus crucial. 
Hec1 est nécessaire  pour éteindre le point de contrôle du fuseau  
La réduction d’Hec1 induit un arrêt mitotique et une panne dans la congression des 
chromosomes 
  
Dans la  levure, Ndc80 (l'homologue d’Hec1) fait partie d'un complexe impliquant  
Spc24, Spc25 et Nuf2.  Il est intéressant de noter que les mutants Ndc80 (qui ne montrent pas 
d’attachement aux microtubules) ne produisent aucun arrêt, alors que nuf2-61, un mutant 
produisant des attachements de microtubules métastables, induit un arrêt métaphasique.  Cette 
observation a été expliquée par le fait qu’en absence totale d’attachement des microtubules 
aux kinétochores, aucun signal du point de contrôle du fuseau mitotique n’est généré, alors 
que les attachements métastables activent le point de contrôle du fuseau mitotique.  Cette 
interprétation est en accord avec les résultats obtenus dans des cellules réduites en CENP-E, 
présentés ci-dessous. Cette interprétation est également en accord avec le fait que les 
mutations qui suppriment complètement la fonction des kinétochores dans la levure, 
détruisent le point de contrôle du fuseau mitotique. 
La réduction d’Hec1 produit un arrêt mitotique dans un stade ressemblant à la  
prométaphase, avec des chromosomes incapables de congresser sur  la plaque métaphasique, 
en dépit de la présence d'un fuseau entièrement assemblé.  Bien que nous n’ayons pas étudié 
l'attachement des microtubules par microscopie électronique dans des cellules réduites en 
Hec1, nos résultats après traitement des cellules par le calcium et localisation de la  dynactin 
/EB1, suggèrent  que l’attachement des microtubules n’est pas perdu, même si  la congression 
des chromosomes est sévèrement altérée, conduisant à l’arrêt mitotique. 
Cette divergence peut être expliquée si l’on prend en considération quelques 
différences entre les kinétochores de la levure S. cerevisiae et des vertébrés.  Dans la levure, 
les kinétochores sont attachés à un seul microtubule.  Cependant, bien que les kinétochores 
soeurs chez la  levure ne soient pas alignés à l'équateur du fuseau avant l'anaphase, ils 
montrent une motilité largement similaire à celle des kinétochores des vertébrés. Chez les 
vertébrés, la capacité des kinétochores soeurs de lier les microtubules est similaire et dépend 
de leur diamètre, qui, bien qu'il puisse varier entre les chromosomes d’un génome, correspond 
seulement faiblement  à la taille du chromosome.  Dans la plupart des organismes, les 
kinétochores s'étendent entre 0,1-0,5 µm de diamètre et lient 10-45 microtubules.  Cette 
différence dans le nombre des microtubules pourrait représenter une adaptation pour 
augmenter la sécurité et pour réduire le risque de perdre l'attachement des chromosomes et par 
conséquent la miségrégation des chromosomes.  Simultanément, l'évolution pourrait avoir 
introduit des mécanismes redondants pour l'attachement des microtubules, réduisant ainsi la 
possibilité de perdre l'attachement dû à une mutation dans une seule protéine.  En effet, nos 
données suggèrent qu'il y a deux voies parallèles impliquées dans l'attachement des 
microtubules et le point de contrôle du fuseau mitotique, l’une comprenant Hec1/Mad1/Mad2, 
et la deuxième CENP-F/CENP-E/BubR1.  Ni CENP-F ni CENP-E n'ont d’homologues dans 
la levure, et BubR1 est complètement différent de son homologue Mad3, qui ne possède pas 
de domaine kinase. 
Compte tenu de ces différences, il semble clair que dans la levure le microtubule est 
lié au kinétochore ou  ne l’est pas,  un état métastable étant peu probable (situation du tout ou 
rien) .  Dans ce modèle, si le complexe Ndc80 est l’élément principal établissant l’interaction 
microtubule-kinétochore, des mutations dans n'importe lequel des composants de ce complexe 
perturberont complètement l'interaction.  Cependant chez les vertébrés, la rupture d’une 
connexion dépendante d’Hec1 n'affecterait pas celle maintenue par CENP-E, et peut-être par 
d'autres, de telle façon que la connexion existerait encore, même si elle est perturbée ou 
affaiblie.  En effet, ceci a été observé quand CENP-E est réduit par injection d'anticorps : la 
liaison des microtubules avec les kinétochores est réduite de 23% sur les chromosomes 
alignés, et plus sévèrement sur les chromosomes non-alignés.  En accord avec cette idée, les 
auteurs de cette étude suggère que les mécanismes redondants permettent la liaison des 
microtubules avec les kinétochores et la surveillance par le point de contrôle du fuseau 
mitotique en absence de CENP-E aux  kinétochores. 
La localisation kinétochorienne de Mad1 et Mad2 n'est pas essentielle pour établir un arrêt 
mitotique  
 
Il est intéressant de noter que dans des cellules réduites en Hec1, un arrêt mitotique se 
produit même lorsque la plus grande partie  (si non la totalité) de Mad1 et Mad2 n’est pas 
localisée aux kinétochores. Nous avons observé un résultat similaire dans des cellules MS751, 
une lignée cellulaire possédant des niveaux  de Mad1 et Mad2  indétectables aux kinétochores 
mitotiques, qui montrent même un arrêt mitotique après  traitement avec du nocodazole ou du  
taxol.  Cette donnée étonnante défie la notion disant que des niveaux élevés de complexes 
Mad1/Mad2  au « steady-state » associés avec les kinétochores constituent un marqueur fiable 
pour l'activation du point de contrôle du fuseau mitotique.  Etant donné la demi-vie courte du 
complexe Mad1/Mad2 au kinétochore, il est possible que des niveaux bas indétectables des 
complexes Mad1/Mad2 associés avec les kinétochores soient suffisants pour la signalisation 
du point de contrôle du fuseau mitotique.  Alternativement, il est possible qu'un facteur dont 
l'association avec des kinétochores ne dépende pas d’Hec1 puisse communiquer avec des 
complexes Mad2 diffus pour signaler l'activation du point de contrôle du fuseau mitotique.  
Dans les cellules réduites en Hec1, cette activité pourrait être CENP-E/BubR1. 
En conclusion, nos données suggèrent que chez l’homme,  Hec1 est nécessaire au 
recruitement de Mad1 et Mad2 sur les  kinétochores pendant la mitose, à  la congression des 
chromosomes et à l’inactivation du point de contrôle du fuseau mitotique.  De plus, nos 
données in vivo montrent que l'activation de Mad2 aux kinétochores n’est pas nécessaire pour 
établir un arrêt mitotique, ce qui soulève des questions concernant les modèles courants de 
l'induction du point de contrôle du fuseau mitotique.  Même s’il est clair que d’autres 
molécules sont impliquées dans l'attachement des microtubules aux kinétochores et dans le 
point de contrôle du fuseau mitotique, nos données ont des implications importantes : elles 
démontrent l'existence de mécanismes moléculaires redondants pour la signalisation,  elles 
identifient de nouvelles  interactions et elles proposent de nouveaux mécanismes potentiels 
conduisant à l’inactivation du point de contrôle du fuseau mitotique. 
 
 
 
Introduction 
A fascinating problem is how cells maintain the right number of chromosomes after each 
division cycle. A single mistake leading to cells with more or less chromosomes than normal, 
a situation termed aneuploidy, can produce cell death or catastrophic phenotypic results. In 
humans, Down’s syndrome appears in children carrying one extra chromosome 21, as a result 
of one error in meiosis. In cancer cells, aneuploidy is relatively frequent, indicating some 
damage in the machinery involved in chromosome segregation. Three lines of evidence now 
suggest that aneuploidy could be a discrete chromosome mutation event that contributes to 
malignant transformation and progression process (Sen, 2000): 
 
1. Precise assay of chromosome aneuploidy in several primary tumors with in situ 
hybridization and comparative genomic hybridization techniques have shown that specific 
chromosome aneusomies correlate with distinct tumor phenotypes. 
2. Aneuploid tumor cell lines and in vitro transformed rodent cells have been reported to 
display an elevated rate of chromosome instability, indicating that aneuploidy is a 
dynamic chromosome mutation event associated with transformation of cells. 
3. A number of mitotic genes regulating chromosome segregation have been found mutated 
in human cancer cells, implicating such mutations in the induction of aneuploidy in 
tumors. Some of these genes also cause tumorigenic transformation of cells in vitro. 
 
Sister chromatids cohesion during mitosis 
 
When cells are ready to divide, because the cell size is big enough or because they 
receive the appropriate stimulus (Conlon and Raff, 1999), they duplicate most of their 
organelles during S (for synthesis) phase, so that at the end of the process each daughter cell 
will receive a complete set. All organisms must duplicate their DNA accurately before cell 
division, a process known as DNA replication. In order to ensure proper chromosome 
segregation, cells must coordinate centrosome duplication with DNA replication, and failure 
in this coordination will inevitably lead to the formation of monopolar or multipolar spindles, 
which will generally provoke abnormal segregation of chromosomes (Meraldi et al., 1999). 
At the end of S phase, each chromosome is composed of two identical structures, called sister 
chromatids. Both sister chromatids stay together throughout G2 and the first stages of mitosis, 
when chromosome condensation and orientation takes place.  
Genetic and biochemical studies in yeast and in Xenopus laevis egg extracts have 
identified a multisubunit complex that plays a critical role in sister chromatid cohesion (for 
review, see Hirano, 2000). This complex is known as the cohesin complex and in 
Saccharomyces cerevisiae it is formed by at least four subunits, Smc1p, Smc3p, Scc1p (or 
Mcd1p) and Scc3p. Both Smc1p and Smc3p belong to the structural maintenance of 
chromosomes (SMC) family, a highly conserved group of chromosomal ATPases, and form 
an heterodimer (Smc1p/Smc3p). Scc1p is the budding yeast homologue of Rad21 , first 
identified as a DNA repair protein in S.pombe. All four proteins are essential in yeast, and 
mutations in any of them lead to premature sister chromatid separation. In yeast, cohesin 
binds to preferential sites along the chromosome arms and is highly enriched around the 
centromeres, as demonstrated by a chromatin immunoprecipitation assay (Tanaka et al., 
2001). However, it is not yet known whether cohesin directly connects sister chromatids (as 
suggested by the proposed structure of the SMC subunits) or mediates cohesion indirectly 
(Goshima and Yanagida, 2001; He et al., 2000; Tanaka et al., 2001). It has been proposed that 
the SMC components of cohesin play a structural role in cohesion, so that the SMC 
heterodimer may function as a DNA cross-linker whose conformation is regulated by ATP 
(Hirano, 1999), whereas Scc1p and Scc3p might play a regulatory role, yet unknown (Hirano, 
2000). 
In budding yeast, Pds1p (or securin) regulates sister chromatid cohesion, by binding 
and inhibiting Esp1p. At the onset of anaphase, Pds1p is degraded by the anaphase promoting 
complex or cyclosome (APC/C), which releases Esp1p (separin or separase), an enzyme that 
cleaves Scc1p, releasing sister chromatid cohesion (Ciosk et al., 1998). Furthermore, it seems 
that the Polo/Cdc5 kinase phosphorylates serine residues adjacent to Scc1 cleavage sites and 
strongly enhances their cleavage (Alexandru et al., 2001). This may regulate sister chromatid 
separation independently of securin.  
Although this machinery seems to have been conserved through evolution (Leismann 
et al., 2000; Zur and Brandeis, 2001), it seems that in vertebrates the bulk of the cohesins are 
released early in prophase in an APC/C independent manner (Sumara et al., 2000).  
Therefore, in vertebrates it is not known how sister chromatid cohesion is maintained between 
prophase and the onset of anaphase. However, it has been shown that a very small amount of 
Scc1 remains associated with human centromeres until metaphase, and a similarly small 
amount is cleaved in anaphase, when it disappears from centromeres (Losada et al., 2000). 
Chromosome segregation 
 
To ensure that each daughter cell receives one chromatid from each chromosome, cells 
have developed a precise and complex machinery. During S phase, as stated before, the 
centrosome starts to duplicate. Just at the onset of mitosis, both new centrioles reach their 
complete length, centrosomes recruit additional material and their microtubule nucleation 
capacity increases. As mitosis progresses, both centrosomes separate to finally establish the 
mitotic spindle (Mayor et al., 1999). In this way, the spindle of a mitotic cell has two poles 
emanating microtubules. Microtubules are long protein filaments with two asymmetric ends, a 
relatively stable minus-end close to the centrosome, and a plus-end undergoing alternative 
phases of shrinking and growing, that scans the middle of the cell. Each chromatid has a 
special region, the centromere, on which a protein structure named the kinetochore is 
assembled. Kinetochores are structures able to stabilize microtubules. Therefore, if by chance 
a microtubule happens to encounter a kinetochore, it may be captured by the kinetochore, and 
then the chromosome becomes attached to the spindle. Partner kinetochores on each 
chromatid lie back-to-back, and because of that, most of the times each kinetochore of one 
chromosome captures microtubules from opposite poles (Nicklas, 1997).  
Kinetochores attached to microtubules are quite mobile during prometaphase, 
oscillating towards and away from the centrosome. This motion is tightly coupled to 
microtubule plus-end assembly and disassembly reactions at the kinetochore attachment site.. 
At one point all the chromosomes become aligned in the middle of the spindle midzone, 
organizing the metaphase plate, a process that is not yet properly understood (Schaar et al., 
1997; Skibbens et al., 1995; Skibbens et al., 1993; Waters et al., 1996; Wood et al., 1997). 
Only after all chromosomes are aligned at the metaphase plate the degradation machinery is 
activated and sister chromatid cohesion is released. As each sister chromatid is attached to 
each pole, both new daughter cells reorganized around the centrosomes will receive a 
complete set of genetic information. 
 
 Regulation of M-phase progression: protein phosphorylation and 
proteolysis 
 
Cell cycle progression requires the successive activation of different cyclin-dependent 
kinases (CDK), which are regulated by transient association with cyclin regulatory subunits, 
binding of inhibitory polypeptides and reversible phosphorylations. Many different protein 
kinases have been shown to play an important role in the regulation of the different transitions 
in the cell cycle (Nigg, 2001). A complex spatially and temporally coordinated 
phosphorylation cascade that activates the M-phase/maturation Promoting Factor (MPF) 
regulates the initiation of mitosis (see Ohi and Gould, 1999 for review). MPF is composed of 
the cyclin dependent kinase Cdc28 in budding yeast (Cdc2 in fission yeast or Cdk1 in higher 
eukaryotes) and a B-type cyclin regulatory subunit. As first demonstrated in 
Schizosaccharomyces pombe, MPF activation centers on the phosphorylation state of the 
Tyr15 residue of Cdc2 (Gould et al., 1990). MPF is kept inactive in interphase through Tyr15 
phosphorylation and, upon entry into mitosis, MPF is activated by dephosphorylation of this 
residue. The onset of mitosis is triggered by simultaneous activation of the Tyr15 phosphatase 
Cdc25 and inactivation of the Tyr15 kinase Wee1. It is thought that Cdc2 activation depends 
in part on a positive-feedback loop, as MPF is able to phosphorylate and thereby activate and 
repress the activity of Cdc25 and Wee1, respectively. 
Activated MPF drives cells from G2 into mitosis by phosphorylating numerous 
substrates, leading to nuclear envelope breakdown, chromosome condensation, centrosome 
separation, spindle assembly, Golgi fragmentation and activation of the chromosome 
segregation machinery. Inactivation of MPF (coupled to cyclin B degradation) facilitates 
spindle disassembly, chromosome decondensation, inactivation of the chromosome 
segregation machinery, cytokinesis and nuclear envelope reformation, creating in this way 
two distinct daughter cells around the segregated genetic material (Nigg, 2001). 
In yeast, anaphase onset (defined by sister chromatid separation) and exit from mitosis 
(indicated by MPF inactivation) are two key events that require the degradation of two types 
of proteins: (i) securin (Pds1p, with homologues in a number in organisms: Cut2 in S.pombe 
and PTTG in vertebrates) (Visintin et al., 1997) and (ii) mitotic cyclins (Schwab et al., 1997). 
In fact, yeast cells with a non-degradable form of Pds1 arrest in mitosis with high levels of 
MPF activity, indicating that Pds1p proteolysis is required both for sister chromatid 
separation and exit from mitosis (Cohen-Fix et al., 1996a). However, deletions that remove 
the cyclin destruction box cause cells to remain in mitosis (Glotzer et al., 1991) although 
sister chromatids can still separate, indicating that cyclin proteolysis normally follows Pds1p 
degradation. 
As indicated before, both Pds1p and cyclins are targeted for degradation by the 
APC/C. The APC/C is part of an ubiquitin-conjugating system (Murray, 1995). In general, 
ubiquitin-conjugating systems comprise one activating enzyme (E1) that transfer ubiquitin to 
ubiquitin-conjugating enzymes (E2) that in the presence of an ubiquitin-ligase (E3) covalently 
attach ubiquitin to a target protein which is thus targeted for destruction by the proteasome. 
The APC/C (anaphase promoting complex or cyclosome) is a mitotic-specific E3 composed 
of 8-12 subunits, most of them conserved (Peters, 1998; Morgan, 1999; Peters, 1998). 
However, despite this complexity, the APC/C needs one extra activating subunit to complete 
the enzyme and promote ubiquitination of target proteins. There are two related activating 
subunits identified so far in numerous organisms: in budding yeast, these are Cdc20 (Fizzy in 
Drosophila and Xenopus, p55Cdc/hCdc20 in humans, Slp1 in S.pombe) and Hct1/Cdh1 
(Fizzy-related, hCdh1 or Ste9/Srw1 in the corresponding organisms). In budding yeast and in 
humans it has been shown that both Cdc20 and Cdh1 bind to the APC/C, but unlike other 
APC/C subunits, they bind in a cell-cycle-regulated manner  (Kramer et al., 1998; Kallio et 
al., 1998). Mutations in these proteins abolish APC/C-dependent proteolysis (Schwab et al., 
1997; Visintin et al., 1997). The presence of two APC/C-activating subunits is very important 
for regulation of late mitosis. First, there is some evidence that Cdc20 and Cdh1 confer 
different substrate specificities on the APC/C, and second, Cdc20 and Cdh1 seem to be 
regulated by different mechanisms. 
Regulating APC/C activity through mitosis 
 
In budding yeast, it has been shown that Cdc20 is essential for degradation of Pds1 at 
the metaphase-to-anaphase transition, whereas Cdh1 is required for degradation of Clb2 later 
in telophase (Peters, 1998; Schwab et al., 1997; Visintin et al., 1997). The most striking 
difference between Cdc20 and Cdh1 is not their substrate specificity, but their regulation. 
Whereas APC/CCdc20 seems to be stimulated by mitotic CDK activity (Lahav-Baratz et al., 
1995), APC/CCdh1 is inhibited by this activity. In budding yeast, phosphorylation of Cdh1 by 
Cdk1 blocks the ability of Cdh1 to activate the APC/C, and overexpression of a non-
phosphorylatable form of Cdh1 causes premature cyclin destruction in vivo (Jaspersen et al., 
1999; Zachariae et al., 1998).  
In S.cerevisiae, the correct order of late mitotic events is at least in part achieved by 
mechanisms ensuring that Cdh1 is activated after Cdc20. This order of events seems to be 
based in the ability of Cdc20 to promote the destruction of proteins that inhibit Cdh1 
activation. In fact, Pds1 itself has been proposed to be an inhibitor of cyclin destruction: 
overexpression of a non-degradable form of Pds1 blocks not only sister chromatids separation 
but also prevents cyclin destruction and cytokinesis (Alexandru et al., 1999; Cohen-Fix et al., 
1996b). 
Consistent with these results, it has recently been shown that Pds1p has a dual role 
during mitosis (Cohen-Fix and Koshland, 1999; Tinker-Kulberg and Morgan, 1999). In 
addition to sequestering Esp1p, it has a novel activity as an inhibitor of mitotic cyclin 
destruction, apparently by preventing the activation of APC/CCdh1. In this way, there is a 
safety control ensuring that cells will not exit mitosis until Pds1p is destroyed and they have 
entered anaphase.  
However, it seems unlikely that the order of events in late mitosis is controlled simply by 
sequential changes in the activating subunit or substrate specificity of the APC/C. There are 
further levels of regulation that need to be taken into consideration: 
 
• A number of observations indicate that phosphorylation of APC/C is involved in its 
mitotic activation: Cdc20 and several APC/C subunits undergo CDK-dependent mitotic 
phosphorylation in a variety of cell types (Descombes and Nigg, 1998; Patra and Dunphy, 
1998; Kotani et al., 1998). It has been shown that phosphorylation of APC/C subunits is 
required to allow APC/C activation by Cdc20, whereas the phosphorylation of Cdh1 
prevents the activation of the APC/C by Cdh1 (Kramer et al., 2000). Both Plk1 (polo-like 
kinase 1) and cyclinB/Cdk1/p9 (MPF) have been implicated in APC/C phosphorylation 
(Kotani et al., 1998; Lahav-Baratz et al., 1995). In vertebrates, both of these kinases are 
activated early during entry into mitosis, at the same time or even slightly before the 
phosphatase Cdc25 is activated (Gautier et al., 1991, Kumagai and Dunphy, 1996). Cdc25 
is a specific tyrosine phosphatase that directly activates MPF Gautier et al., 1991. 
However, Vorlaufer and Peters results suggest that APC/C core phosphorylation occurs 
significantly after Cdc25 and Cdk1 activation, most likely in prometaphase or metaphase 
(Vorlaufer and Peters, 1998). Therefore, it has been proposed that either some other 
kinases have a role in APC/C phosphorylation in vivo or a lag phase mechanism might 
delay the ability of Plk1 and cyclin B/Cdk1/p9 to recognize APC/C subunits in vivo. 
• As previously observed in animal embryos (Sigrist et al., 1995; Minshull et al., 1990), in 
vertebrate somatic cells cyclin A is degraded both in prometaphase and in the presence of 
taxol (Clute and Pines, 1999; den Elzen and Pines, 2001). Cyclin A degradation seems to 
be dependent on Cdc20 (Geley et al., 2001), but at prometaphase and in the presence of 
taxol, APC/CCdc20 is believed to be in an inactive form, indicating that this inhibition is not 
complete: maybe there are different forms of APC/CCdc20 , some of which are not inhibited 
and can recognize cyclin A but not cyclin B1. 
• Subcellular localization could provide another dimension to APC/C-substrate targeting. In 
vertebrate cells, the localization of the different components seems to be well defined: 
- APC/C subunits are concentrated at the kinetochores, spindle poles and along the 
spindle itself. Tugendreich and colleagues have reported that the Ccd27 and Cdc16 
proteins colocalize to the centrosome at all stages of the mammalian cell cycle, and to 
the mitotic spindle (Tugendreich et al., 1995). According to Jorgensen and colleagues, 
the mammalian APC-alpha homolog, Tsg24, is a centromere-associated protein: there 
are two forms of this protein in mammalian cells, a soluble form associated with other 
components of the APC/C and a centromere-bound form. Both the Tsg24 protein and 
the Cdc27 protein, another APC/C component, were detected bound to isolated 
mitotic chromosomes (Jorgensen et al., 1998).  
- Cdc20 is found at the kinetochores throughout mitosis: immunofluorescence studies 
and expression of a p55CDC-GFP chimera showed that p55CDC is concentrated at 
the kinetochores in M phase cells from late prophase to telophase. According to this 
study, some p55CDC is also associated with the spindle microtubules and spindle 
poles, and some is diffuse in the cytoplasm. At anaphase, the concentration of 
p55CDC at the kinetochores gradually diminishes, and is gone by late telophase 
(Kallio et al., 1998). 
- Cyclin B destruction and CDK inactivation are initiated at the spindle poles. 
Measuring cyclin B1 degradation in real time, Clute and Pines showed that it begins 
as soon as the last chromosome aligns on the metaphase plate, just after the spindle-
assembly checkpoint is inactivated. At this point, cyclin B1 staining disappears from 
the spindle poles and from the chromosomes. Cyclin B1 destruction can subsequently 
be inactivated throughout metaphase if the spindle checkpoint is reimposed, and this 
correlates with the reappearance of cyclin B1 on the spindle poles and the 
chromosomes. These results provide a temporal and spatial link between the spindle-
assembly checkpoint and ubiquitin-mediated proteolysis (Clute and Pines, 1999;). 
Huang and Raff used cyclin B-green fluorescent protein (GFP) fusion protein in living 
Drosophila embryos in order to study how the localization and destruction of cyclin B 
is regulated in space and time. They show that the fusion protein accumulates at 
centrosomes in interphase, in the nucleus in prophase, on the mitotic spindle in 
prometaphase and on the microtubules that overlap in the middle of the spindle in 
metaphase. In cellularized embryos, toward the end of metaphase, the spindle-
associated cyclin B-GFP disappears from the spindle in a wave that starts at the 
spindle poles and spreads to the spindle equator. When the cyclin B-GFP on the 
spindle is almost undetectable, the chromosomes enter anaphase, and any remaining 
cytoplasmic cyclin B-GFP then disappears over the next few minutes (Huang and 
Raff, 1999). 
Checkpoints in the cell cycle 
 
Checkpoints are control mechanisms enforcing dependency in the cell cycle (Hartwell 
and Weinert, 1989). The events of the cell cycle of most organisms are ordered into dependent 
pathways in which the initiation of late events is dependent on the completion of early events. 
The existence of a control mechanism is suggested when chemicals, mutants or other 
conditions relieve a dependence relationship in the cell cycle: the second event in a given 
pathway happens even when the prerequisites havenot been properly satisfied. For example, 
mitosis is dependent on the completion of DNA synthesis in eukaryotes, but this dependency 
can be relieved by mutation, and mitosis may occur before completion of DNA synthesis. 
This suggests that the dependency is due to a control mechanism (a checkpoint in the cell 
cycle) and not an intrinsic feature of the events themselves. 
The best understood of these control checkpoints is the RAD9 system in yeast, which 
is responsible for making mitosis dependent on the completion of DNA replication, but other 
evidence supports the existence of different checkpoints along the cell cycle. One of these is 
the spindle assembly checkpoint, a surveillance mechanism at the metaphase-to-anaphase 
transition. Citing Michael Glotzer: “It is now apparent that both yeast and metazoans present 
some conserved components of a checkpoint machinery working at the metaphase-anaphase 
transition, indicating that this mechanism was in place before the species diverged. The 
common progenitor of yeast and metazoans had evolved a control mechanism to ensure that 
daughter cells will have the correct number of chromosomes. By acquiring an error-detection 
mechanism, this species had presented an adaptative advantage, being able to increase the 
efficiency of its chromosome transmission” (Glotzer, 1996). 
The spindle assembly checkpoint: some milestones 
   
It was an early observation that when a single chromosome lags on its way to the 
metaphase plate, anaphase onset is delayed until some minutes after the arrival of the 
chromosome to the metaphase plate (Zirkle, 1970). This and similar observations suggested 
that a control mechanism exists at this point. Based on the fact that the disruption of the 
spindle with drugs such as nocodazole and colchicine arrests cells in metaphase (reviewed by 
Rieder and Palazzo, 1992), the control mechanism was termed the spindle assembly 
checkpoint. This regulatory pathway has been the object of extensive study during recent 
years (see Skibbens and Hieter, 1998; Gardner and Burke, 2000 for review).  
 Genetic analysis has allowed to determine which defects activate the spindle 
checkpoint, leading to the conclusion that spindle depolymerization (Li and Murray, 1991; 
Hoyt et al., 1991), dicentric chromosomes (Neff and Burke, 1992), aberrantly segregating 
centromeres (Wells and Murray, 1996), defects in the spindle pole body in S. cerevisiae 
(Hardwick et al., 1996), disrupted kinetochore proteins (Wang and Burke, 1995), centromere 
DNA mutations (Spencer and Hieter, 1992) or defects in microtubule motors (Li and Murray, 
1991) can be detected by the checkpoint. A recent report  summarizes all of these 
observations (Hardwick et al., 1999). 
Based in his own observations, Zirkle (Zirkle, 1970) first proposed that “some (..) 
substance, necessary for the cell to proceed to anaphase, appears a few minutes after C (time 
of arrival of the last kinetochore at the metaphase plate), or that a drastic change in 
cytoplasmic conditions occurs at or shortly after C” suggesting that such a control function 
resides in unattached kinetochores (Zirkle, R.E. 1970 J.Cell Biol. 47 :235a). McIntosh 
extended this proposal, suggesting that stretch sensitive enzyme(s) located at the centromeres 
produce an inhibitor of anaphase onset when the two kinetochores are not under bipolar 
tension (McIntosh, 1991). It seems clear that the “wait anaphase” signal is produced primarily 
at or near the unattached kinetochore (Rieder et al., 1995). However, the primary event 
associated with kinetochore attachment that turns off the inhibitory signal relieving the 
metaphase arrest, could be either the acquisition of microtubules by the kinetochore (as 
proposed by Rieder et al., 1995), or the tension itself stabilizing the attachment of the 
microtubules to the kinetochore (Nicklas and Ward, 1994; Li and Nicklas, 1997). Subsequent 
studies in Ptk1 cells containing two independent spindles in a common cytoplasm showed that 
the inhibitor of the metaphase-to-anaphase transition is produced by unattached kinetochores 
and is not freely diffusible (Rieder et al., 1997). However, in the same study it was shown that 
once the metaphase-to-anaphase transition is initiated in one part of the cell, it spreads 
throughout the cell and it can override the “wait anaphase” signal associated with a spindle 
containing unattached kinetochores.  
Checkpoint proteins 
 
Genetic analysis developed in budding yeast allowed the identification of components 
of the spindle assembly checkpoint (Hoyt et al., 1991; Li and Murray, 1991). These two 
similar but subtly different screens identified six of the nine known components of the spindle 
checkpoint in yeast (Table 1). Hoyt and coworkers used high amounts of benomyl (70µg/ml, 
three times the amount of this microtubule depolymerizing drug required to inhibit growth) to 
disrupt spindles within cells. Some mutant strains that died in response to treatment were 
found not to have arrested (as wild type yeast did) but progressed through mitosis. Li and 
Murray used lower levels of benomyl (15µg/ml) which diminish, but did not abolish, spindle 
assembly. Some mutant strains exited mitosis before assembling a functional spindle and 
died. Mutant strains from both screens, budding uninhibited by benzimidazole (bub1, 2, 3) 
and mitotic arrest deficient (mad1, 2, 3) appeared to have normal microtubule function and 
spindle formation, suggesting that sensitivity was not due to a structural problem, but rather to 
a defect in a surveillance mechanism. Other proteins identified as part of this mechanism 
were: 
• Mps1p (monopolar spindle). This is an essential protein required for spindle pole 
duplication. Overexpression of Mps1p affects both spindle pole body integrity and 
checkpoint activity (Hardwick et al., 1996; Weiss and Winey, 1996).  
• Cdc55p is a regulatory subunit of protein phosphatase 2A (PP2A), and has been proposed 
as a putative checkpoint component: cdc55 mutant strain fail to arrest cell cycle 
progression in response to spindle perturbations (Minshull et al., 1996) and cdc55 
genetically interacts with a kinetochore mutation (Wang and Burke, 1997). 
• Cdc20 interacts with the spindle checkpoint components Mad1, Mad2 and Mad3 in yeast 
(Hwang et al., 1998). Mutant forms of cdc20 that no longer bind the Mad proteins cannot 
arrest upon checkpoint activation, showing that Cdc20 is probably the target of the 
checkpoint pathway.  
Considering all the components previously described, the transition from mitosis to 
interphase in budding yeast can been described as two interconnected pathways. In the current 
model there are two control steps: the metaphase-to-anaphase transition, controlled by the 
spindle assembly checkpoint, leading to Pds1p degradation and chromosome segregation; and 
the exit from mitosis, controlled by the mitotic exit network (MEN), that targets Clb2p for 
degradation (see figure 1). 
 
Homologues of budding yeast checkpoint proteins have been found in 
Schizosacharomyces pombe, Zea mays, Caenorhabditis elegans, Xenopus laevis, Drosophila 
melanogaster, Mus musculus and Homo sapiens (He et al., 1998; Bernard et al., 1998; Yu et 
al., 1999; Kitagawa and Rose, 1999; Chen et al., 1996; Chen et al., 1998; Basu et al., 1998; 
Basu et al., 1999; Taylor and McKeon, 1997; Li and Benezra, 1996; Pangilinan et al, 1997; 
Taylor et al., 1998). In fact, the first report on Mad2 as an inhibitor of the APC used hMad2, 
adding recombinant protein to Xenopus extracts (Li et al., 1997), which produced metaphase 
arrest and prevented cyclin ubiquitination. Later on, it was shown that Mad2 interacts with 
Cdc20 in fission yeast and humans (Kim et al., 1998; Fang et al., 1998; Kallio et al., 1998).  
Interestingly, two independent groups (Chen and Fang, 2001; Pfleger et al., 2001) have 
shown in human and Xenopus that a previously identified homologue of Mad2 (Cahill et al., 
1999), called either Mad2B or Mad2L2, interacts with Cdh1, inhibiting the APC/C, in a 
parallel manner to Mad2-APC/CCdc20. 
 
Table 1: checkpoint proteins 
S.cerevisiae S.pombe Vertebrates 
Localization   
in vertebrate  
cells 
Comments References 
MAD1 nk hMAD1 
xMAD1 
nuclear,  
kinetochores 
Phosphorylated upon checkpoint 
activation in yeast 
Phosphorylated by Mps1 in vitro 
Forms a stable complex with Mad2 
Interacts with scCdc20 and scBub1  
Phosphorylated by hBub1 in vitro, 
but no evidence in vivo 
Recruits Xmad2 to the kinetochores 
Associates with nuclear pores in 
interphase 
Hardwick and Murray, 
1995 
Hardwick et al., 1996 
Hwang et al., 1998 
Chen et al., 1998 
Chen et al., 1999 
Seeley et al., 1999 
Brady and Hardwick, 
2000 
Campbell et al., 2001 
This study 
MAD2 mad2 hMAD2 
xMAD2 
nuclear, 
kinetochores, 
cytoplasm 
Forms a complex with Mad1, and 
Cdc20 
Inhibits APC/C activity 
Inactivation by antibody 
microinjection induces premature 
anaphase 
Mad2-/- is embryonic lethal in mice. 
Mad2+/- in mice causes premature 
anaphase and chromosome 
instability. 
Associates with nuclear pores in 
interphase. 
Li et al., 1997 
Hwang et al., 1998 
Kim et al., 1998 
Fang et al., 1998 
Gorbsky et al., 1998 
Kallio et al., 1998 
Chen et al., 1999 
Dobles et al., 2000 
Howell et al., 2000 
Luo et al., 2000 
Michel et al, 2001 
Campbell et al., 2001 
Sudakin et al., 2001 
MAD3 nk hBUBR1 cytoplasmic, 
kinetochores 
Homologue to the Nterm of Bub1 
Kinase in humans 
Interacts with scCdc20 
Interacts with scBub3 and scMad2 
Interacts with hBub3 
hBubR1 associates with APC/C in 
mitosis 
hBubR1 inhibits APC/C in vitro 
more effectively than Mad2 
Roberts et al., 1994 
Hwang et al., 1998 
Taylor et al., 1998 
Jablonski et al., 1998 
Chan et al., 1999 
Hardwick et al., 2000 
Murray and Marks, 2001 
Tang et al., 2001 
Sudakin et al., 2001 
BUB1 bub1 hBUB1 
mBUB1 
cytoplasmic, 
kinetochores 
Kinase that phosphorylates scBub3, 
hMad1 but not hBub3 in vitro 
Roberts et al., 1994 
Taylor and McKeon, 1997 
S.cerevisiae S.pombe Vertebrates 
Localization   
in vertebrate  
cells 
Comments References 
Forms complex with Bub3 
Functions of scBub1 and scMps1 
interdependent 
Mutations in dmBub1 cause 
chromosome missegregation and 
apoptosis 
XBub1 is required for kinetochore 
localization of XMad1, XMad2, 
XBub3 and XCENP-E, 
independently of its kinase activity 
Farr and Hoyt, 1998 
Jablonski et al., 1998 
Taylor et al., 1998 
Seeley et al., 1999 Basu et 
al., 1999 
Sharp-Baker and Chen, 
2001  
Schwab et al., 2001 
BUB2 cdc16+ nk spindle poles Essential for cytokinesis in S.pombe 
and required to maintain cdc2 kinase 
activity 
Fankhauser et al., 1993 
Tavormina and Burke, 
1998 
Fraschini et al., 2001a 
Wang et al., 2000 
Lee et al., 2001 
Pereira et al., 2001 
Hu et al., 2001 
BUB3 nk hBUB3 
mBUB3 
nuclear,  
kinetochores 
Phosphorylated in yeast by Bub1 in 
vitro, but not in human 
Forms a complex with Bub1 
Bub3-/- are embryonic lethal in mice 
hBub3 and the mRNA export factor 
hRAE1 interact with GLEB-
containing proteins 
Forms a complex with BubR1/Cdc20 
and Mad2, which inhibits APC/C in 
HeLa cells 
Roberts et al., 1994 
Taylor et al., 1998 
Seeley et al., 1999 
Martinez-Exposito et al., 
1999 
Kalitsis et al., 2000 
Wang et al., 2001 
Sudakin et al., 2001 
Fraschini et al., 2001b 
MPS1 mph1+ hMPS1 
(hTTK) 
mESK2 
kinetochores Kinase that phosphorylates scMad1 
in vitro 
Essential for SPB duplication in 
budding yeast, but not in fission 
yeast or metazoa. 
Kinetochore associated kinase, 
activity required for checkpoint 
activation in Xenopus. Required for 
CENP-E at kinetochores. 
Lauze et al., 1995 
Hardwick et al., 1996 
He et al., 1998 
Farr and Hoyt, 1998 
Friedman et al., 2001 
Abrieu et al., 2001 
Castillo et al., 2002 
Stucke et al., 2002 
CDC55 nk nk? unknown Regulatory subunit of protein 
phosphatase 2 A 
target controversial 
Healy et al., 1991 
Minshull et al., 1996 
Wang and Burke, 1997 
CDC20 slp1+ p55CDC 
(hCDC20) 
enriched 
at kinetochores 
Binds to and activates the APC/C 
Binds to and is inhibited by Mad2 in 
Xenopus 
Binds to Mad1,2,3 in S.cerevisiae 
Binds to Mad2 in S.pombe and in 
humans 
Visintin et al., 1997 
Fang et al., 1998 
Hwang et al., 1998 
Kim et al., 1998 
Kallio et al., 1998 
Yudkovsky et al., 2000 
S.cerevisiae S.pombe Vertebrates 
Localization   
in vertebrate  
cells 
Comments References 
Binds to BubR1 in humans Fraschini et al., 2001b 
Hilioti et al., 2001  
Sironi et al., 2001 
Sudakin et al., 2001 Tang 
et al., 2001  
Luo et al., 2002 
 
In vertebrates, all these components have been localized at the kinetochores between 
prophase and metaphase, when the spindle checkpoint  is active and the APC/C is inhibited 
(see Fig.2).  
Other proteins potentially involved in the spindle checkpoint 
 
 A checkpoint should consist of three functional units: (i) a sensor, (ii) a signal-
transduction cascade and (iii) an effector (Wells, 1996). The previously described proteins 
could be considered as the main core of the spindle checkpoint, the central signal-transduction 
cascade that converges  onto Mad2-APCCdc20, the effector component of the checkpoint. 
Citing Andrew Murray (Murray, 1994) “...the signal transduction pathway that controls cell 
cycle checkpoints are modular transmission systems that can be connected to different 
monitoring systems, allowing different cell types to produce the same cell cycle delay in 
response to different lesions”. As was noted before, the spindle checkpoint is able to respond 
to a variety of signals: problems in the centromeric DNA, in kinetochore proteins, in motors, 
in spindle dynamics and in spindle poles. So far, it is unknown what are the sensor(s) 
responsible to detect those defects, and how these signals are transmitted to the effector. Even 
more, with the exception of Mad2, BubR1 and Cdc20, we do not know which are the 
molecular roles of the main components of the spindle checkpoint. 
 However, some proteins have been identified to date, either as direct interacting 
partners of the spindle checkpoint components, or due to the phenotype of the mutants. These 
proteins are listed in table 2. 
 
 
 
Table 2: checkpoint related proteins 
Name Organism(s) Comments References 
Name Organism(s) Comments References 
CENP-E human Kinesin-like protein, concentrated at the 
fibrous corona at the kinetochore by 
prometaphase 
Disruption of CENP-E functions at 
kinetochores prevents chromosome 
alignment and arrests cells in mitosis 
CENP-E interacts in the Two-hybrid with 
hBubR1 and CENP-F 
CENP-E forms a complex with hBubR1 in 
HeLa cells 
hBubR1 is required for mitotic arrest 
resulting from loss of CENP-E function 
Abrieu et al., 2000;  
Ashar et al., 2000;  
Chan et al., 1998;  
Chan et al., 1999;  
Cooke et al., 1997;  
McEwen et al., 2001;  
Sharp-Baker and Chen, 2001; 
Thrower et al., 1996;  
Topper et al., 2001;  
Yao et al., 2000;  
Yen et al., 1991 
CENP-F human 367kD nuclear matrix protein 
Associates with nascent kinetochores by 
late G2 
Proposed to participate in the early steps of 
kinetochore assembly 
Interacts with CENP-E in the yeast Two-
hybrid 
Interacts with Bub1 in the yeast Two-hybrid 
(Jablonski and Yen, unpublished results, 
see Jablonski et al, 1998) 
Ashar et al., 2000;  
Chan et al., 1998;  
de la et al., 2001;  
Liao et al., 1995 
Zw10 Drosophilids, C. 
elegans, Arabidopsis 
thaliana, Mus 
musculus, and human 
Localized at the kinetochores after NEB 
Cells lacking this protein at kinetochores 
fail to arrest in mitosis when exposed to 
microtubule inhibitors 
Mutations in dmZw10 abolish the ability of 
dynein to localize at kinetochores 
Antibodies against Zw10 or Rod leave 
Mad2 at unattached kinetochores, but 
checkpoint is off:  role in Mad2 release? 
Rate of poleward chromosome motion is 
attenuated in zw10 mutants 
Basto et al., 2000;  
Basu et al., 1998;  
Chan et al., 2000;  
Savoian et al., 2000;  
Scaerou et al., 2001;  
Starr et al., 1997;  
Starr et al., 1998;  
Williams et al., 1996 
 
ROD human, Drosophila Cells lacking this protein at kinetochores 
fail to arrest in mitosis when exposed to 
microtubule inhibitors 
Antibodies against Zw10 or Rod leave 
Mad2 at unattached kinetochores, but 
checkpoint is off 
Rate of poleward chromosome motion is 
attenuated in rod mutants 
Basu et al., 1998;  
Chan et al., 2000;  
Savoian et al., 2000 
Dynein-Dynactin 
complex 
human, Drosophila, 
yeast 
Localized at the kinetochores after NEB 
A screen for dynein synthetic lethals in 
Aspergillus nidulans identifies spindle 
assembly checkpoint genes and other genes 
involved in mitosis 
Mutations in dmZw10 abolish the ability of 
dynein to localize at kinetochores 
Kinetochore binding dependent on 
Berrueta et al., 1999; 
Howell et al., 2001;  
Starr et al., 1998;  
Tai et al., 2002 
Name Organism(s) Comments References 
microtubule attachment 
Clip-170 human, yeast Coiled-coil protein associated with 
microtubule plus-end 
CLIP-170 transiently associates with 
prometaphase chromosome kinetochores 
and codistributes with dynein and dynactin 
at kinetochores 
Overexpression of the Cterm domain 
produces a delay in prometaphase 
Dujardin et al., 1998;  
Perez et al., 1999 
INCENP human, mouse, 
Drosophila 
INCENP1-405 interferes with both 
prometaphase chromosome alignment and 
the completion of cytokinesis 
Required for DmAuroraB localization in 
mitosis and functions as a histone H3 
kinase 
dmINCENP RNAi: inhibits the ability of 
cells to achieve a normal metaphase 
chromosome alignment 
Mackay et al., 1998;  
Tanaka et al., 2002 
Uren et al., 2000;  
Wheatley et al., 2001 
AuroraB human, budding yeast 
(Ipl1) Drosophila, 
C.elegans 
ceAuroraB RNAi: required for histone H3 
phosphorylation and sister chromatid 
separation 
AuroraB RNAi in Drosophila: abnormal 
segregation resulting from lagging 
chromatids and extensive chromatin 
bridging at anaphase, similar to the 
phenotype of barren (condensin) mutants 
AuroraB phosphorylates CENP-A. 
Ipl1p is required to maintain the spindle 
checkpoint that is induced by 
overexpression of the protein kinase Mps1.  
Biggins and Murray, 2001;  
Giet and Prigent, 1999;  
Giet and Glover, 2001;  
Hsu et al., 2000;  
Kaitna et al., 2000;  
MacCallum et al., 2002; 
Speliotes et al., 2000;  
Tanaka et al., 2002;  
Zeitlin et al., 2001 
Survivin human colocalizes with AuroraB and INCENP Li et al., 1998;  
Speliotes et al., 2000;  
Uren et al., 2000;  
Wheatley et al., 2001 
Histone H3 human, Drosophila, 
C.elegans 
H3 phosphorylation required for proper 
chromosome condensation and segregation 
both in mitosis and meiosis 
Phosphorylated by AuroraB, INCENP 
required 
Human condensin proteins hCAP-E, hCAP-
C and hCAP-D2 colocalize with 
phosphorylated histone H3 in early 
prophase 
Crosio et al., 2002;  
Giet and Glover, 2001;  
Hsu et al., 2000;  
Sauve et al., 1999;  
Schmiesing et al., 2000;  
Van Hooser et al., 1998;  
Wei et al., 1999 
Ndc10 yeast Structural component of the kinetochore in 
yeast 
Involved in chromosome segregation 
Temperature-sensitive ndc10 mutants 
complete nuclear division at restrictive 
temperature, but chromosomes segregate 
Fraschini et al., 2001;  
Gardner et al., 2001;  
Tavormina and Burke, 1998; 
Uren et al., 2000;  
Yoon and Carbon, 1999 
Name Organism(s) Comments References 
assymmetrically 
Ndc80 complex human, budding and 
fission yeast 
Associated with the centromere, both in 
yeast and human (HEC, highly expressed in 
cancer; also called Hec1) 
Disruption of function produces failure in 
chromosome segregation (yeast and 
human). 
Interaction with hSmc1 (cohesin) 
Chen et al., 1997;  
He et al., 2001;  
Janke et al., 2001;  
Wigge et al., 1998;  
Wigge and Kilmartin, 2001 
p90RSK
Xenopus 
Protein kinase p90RSK , a constitutively 
active target of MAPK, is sufficient to 
activate Bub1 in vivo and in vitro 
Schwab et al., 2001 
Adenomatous 
Polyposis Coli  
(APC) 
human Cells carrying a truncated form of APC are 
defective for chromosome segregation and 
mutations in this gene cause chromosomal 
instability 
APC localizes to the end of MTs embebbed 
in kinetochores 
Forms a complex wit Bub1 and Bub3. 
High-affinity substrate for Bub  
kinases in vitro. 
Kaplan et al., 2001 
Fodde et al., 2001 
NEB: nuclear envelope breakdown; MTs: microtubules 
 
According to the information available to date, the spindle checkpoint in vertebrates 
seems to be more complex (see figure 3 and Shah and Cleveland, 2000 for review) than it is in 
budding yeast. In vertebrates, new components have arisen (like CENP-E, for example) and 
some known components have different functions or even different structures (the more 
striking example being Mad3/BubR1). The spindle checkpoint itself seems to have acquired 
more relevance through evolution, since in mammals both Mad2 and Bub3 deletions are 
embryonic lethal (Kalitsis et al., 2000, Dobles et al., 2000).  Furthermore, the vertebrate 
spindle checkpoint components are necessary in every cell division, whereas in yeast none of 
the mad/bub proteins are essential although corresponding mutations do cause high 
chromosome loss or slow growth phenotypes.  
Identifying the physiologically relevant Cdc20 binding partner 
 
 Even if it seems clear that kinetochores are the signal generators for the diffusible 
“wait anaphase” mechanism that arrests cells in mitosis until the last chromosome arrives to 
the metaphase plate, there are a number of questions still unresolved. Mad2 seems to be part 
of this mechanism, and the current model proposes that it needs to be activated (Mad2*) at the 
kinetochores to be able to bind to Cdc20 and inhibit the APC/C. The nature of this activation 
is currently unknown (see Shah and Cleveland, 2000 for review).  
Arguing against Mad2 as the sole inhibitor of Cdc20, there are several reports 
indicating that Mad2 is not the only protein able to bind to and inhibit Cdc20 either in yeast or 
in vertebrates, since it has been shown that Mad3/BubR1 is also able to do so (Chan et al., 
1999; Hardwick et al., 2000; Tang et al., 2001; Sudakin et al., 2001).  
According to Tang and colleagues, hBubR1 is able to inhibit Cdc20 in a Mad2-
independent manner, and they observe that BubR1 kinase activity is not required for Cdc20 
inhibition. However, if BubR1 and Mad2 inhibit the APC/C independently, it is intriguing 
that loss of either one abrogates spindle checkpoint arrest in vivo, as indicated by Gillett and 
Sorger, 2001. To reconcile these data, three possibilities have been proposed: 
• Mad2 might act as a diffusible Cdc20 inhibitor, whereas BubR1 may act as a local 
inhibitor at kinetochores. 
• BubR1 might recruit Cdc20 to kinetochores and facilitate its association with Mad2. 
• Mad2 and BubR1 might block APC/CCdc20 activation as part of separate signaling 
systems, Mad2 detecting lack of microtubule attachment and BubR1 lack of tension, as 
has been proposed by Skoufias et al., 2001. Consistent with this model, BubR1 interacts 
with CENP-E, a kinesin-like motor localized at kinetochores whose interaction with 
microtubules could alter BubR1 activity in response to changes in kinetochore tension 
(Chan et al., 1999). Indeed, it was first proposed that Mad2 localization depends on 
microtubule attachment, and not tension (Waters et al., 1998). However, on Ptk2 cells 
treated with monastrol (a small molecule which inhibits the mitotic kinesin Eg5, 
producing monopolar spindles), of the chromosomes that have syntelic orientation (both 
kinetochores oriented towards the same pole) and have both kinetochores attached to 
microtubules (64%), 84% have at least one kinetochore positive for Mad2. This argues 
that Mad2 localization at kinetochores cannot be sensitive only to microtubule attachment 
(Kapoor et al., 2000). 
However, a recent publication about hBubR1 and its function as a Cdc20 inhibitor 
(Sudakin et al., 2001) has introduced an important change in our understanding of the spindle 
checkpoint. According to this study, the physiologically relevant inhibitor of the APC/C is a 
complex, the MCC (mitotic checkpoint complex) that is composed of hBubR1, hBub3, Cdc20 
and hMad2. Yet less than 5% of total hMad2 comigrated with the MCC and the APC/C, 
whereas the vast majority of it was found as monomers. It is interesting to note that the 
equivalent complex was previously described in yeast (Hardwick et al., 2000). Surprisingly, 
Sudakin and colleagues found that the MCC is active in interphase. Their results suggest that 
the ability of the MCC to bind the APC/C is not specified by the state of the MCC, but a 
regulated property of the APC/C. Mitotic APC/C is able to bind the MCC, but interphase 
APC/C is not. They also showed that APC/C inhibition in vitro could be enhanced by adding 
chromosomes purified from cells arrested in mitosis. Similarly, Tang et al., 2001 reported 
differences in the ability of the APC/C to bind hBubR1, suggesting that APC/C mitotic 
modification could be relevant for its inhibition.  
As indicated previously, the APC/C is phosphorylated specifically during mitosis 
(Descombes and Nigg, 1998; Patra and Dunphy, 1998; Kotani et al., 1998), which could 
explain those differences. Accordingly, Sudakin and colleagues have shown that hBubR1 
binds preferentially to APC/C containing hyperphosphorylated Cdc27, suggesting that mitotic 
phosphorylation of the APC/C might specify its inhibition by the MCC.  
The centrosome: a role in the spindle checkpoint? 
  
Another interesting question remaining open is how the “ready-to-go” signal is released. 
In a normal mitosis, chromosomes are quite mobile, and oscillate  back and forth between 
both centrosomes. Each chromosome of the complete set acquires the full set of kinetochore 
microtubules and stops at the metaphase plate (that is, becomes aligned) at a different time 
point. When one chromosome becomes aligned, the Mad2 signal at the kinetochores 
decreases by 100-fold and becomes undetectable (Hoffman et al., 2001). If different 
chromosomes acquire full sets of kinetochore microtubules at different time points, that 
means that each one is releasing the signal “ready-to-go” in the same way, and yet sister 
chromatid cohesion is not released until the last chromosome is aligned at the metaphase 
plate. Even if one chromosome is lagging, and takes longer to be aligned, the cell will 
maintain the “wait anaphase” signal until it arrives to the metaphase plate. In this situation, we 
will have most of the chromosomes signaling “ready-to-go” and yet the “wait anaphase” 
signal is able to inhibit progression to anaphase. One possible explanation for this would be to 
consider that each chromosome not yet aligned is sending an inhibitory signal to the 
centrosome, through the kinetochore microtubules. As far as there is at least one chromosome 
not yet aligned, the centrosome will be receiving this inhibitory signal, and the cell will wait 
(see figure 4). In support of this hypothesis, studying mitosis in PtK1 cells containing two 
independent spindles in a common cytoplasm, Rieder et al., 1997 showed that the inhibitory 
activity associated with an unattached kinetochore is functionally limited to the vicinity of the 
spindle containing the unattached kinetochore. About the nature of this inhibitory signal, it is 
interesting to note that Mad2 itself has been detected along spindle fibers and at spindle poles 
during prometaphase and early metaphase in living Ptk1 cells (Howell et al., 2000). Similarly, 
Mad1 has been detected along spindle microtubules (Campbell et al., 2001), and the Dynein-
Zw10-Rod complex has been shown to move on the kinetochore fiber towards the spindle 
pole when chromosomes are under tension (Williams et al., 1996; Scaerou et al., 1999). How 
this signaling pathway works and which is the exact role of the centrosomes in this pathway 
(if any) is a matter of future investigation. 
Aneuploidy and defects in the spindle checkpoint 
  
As indicated at the beginning of this introduction, aneuploidy is a common event in cancer, 
and several lines of evidence indicate that it could contribute to malignant transformation. If 
the spindle assembly checkpoint is the surveillance mechanism responsible to ensure that 
chromosomes have been properly aligned before progression to anaphase, it seems reasonable 
to speculate that aneuploidy could correlate with inactivation of the checkpoint machinery. In 
accordance with this idea, in 1998 one report identified dominantly acting Bub1 mutations in 
some colorectal tumor cell lines (Cahill et al., 1998). Further investigation has shown that, 
indeed, about 50% of the cancer cell lines checked have a defective spindle checkpoint when 
tested using drugs that disrupt the spindle machinery (see table 3), although in some cases an 
early arrest could be detected (Scolnick and Halazonetis, 2000). 
 
Table 3: Reports on defects in the spindle checkpoint in cancer cell lines 
Reference Report Sample Comments 
Cahill et al., 1998 Nature 392:300-4 4 MIN and 6 CIN 
colorectal cancer cell lines 
MIN: normal checkpoint 
resp.,  
CIN: no arrest in 
nocodazole or colcemid 
Takahashi et al., 1999 Oncogene 18(30): 
4295-33 
9 lung cancer cell lines 44% showed impaired 
mitotic checkpoint 
Scolnick and 
Halazonetis, 2000 
Nature 406: 430-5 8 cancer cell lines (mutated 
or wt Chfr) 
4 cell lines showed low 
mitotic index after noco 
(all wt Chfr) 
Reference Report Sample Comments 
Matsuura et al., 2000 Am J of Human Gen 
67(2): 483-6 
skin fibroblast cells from 2 
unrelated male infants with 
chrom. instability disorder 
(with tumors) 
both cases showed 
premature chromatid 
separation, mosaic 
variegated aneuploidy and 
absence of mitotic block 
after colcemid treatment 
Wang et al., 2000 Carcinogenesis 21(12): 
2293-7 
5 nasopharyngeal 
carcinoma cell lines 
40% showed defective 
mitotic checkpoint 
Weitzel and Vandre, 
2000 
Cell & Tissue Res 
300(1): 57-65 
2 lung adenocarcinoma cell 
lines 
1 cell line showed normal 
mitotic arrest after drug 
treatment, the other didn't 
 
 Despite of this high frequency, there are a number of reports in which the incidence of 
mutations in the spindle checkpoint genes has been analyzed in a variety of cancer cell lines, 
and the results suggest that these genes are either not mutated or in low frequency (table 4). Is 
worth noting, however, that in two different reports (Percy et al., 2000; Wang et al., 2000), a 
significant reduction in the expression levels of Mad2 was detected, which is consistent with 
the finding that Mad2 haplo-insufficiency in mouse produces premature anaphase and 
chromosome instability (Michel et al., 2001). One possible explanation for this low rate of 
mutation in the spindle checkpoint genes could be related to the fact that these proteins seem 
to be essential in mammals (Kalitsis et al., 2000; Dobles et al., 2000), probably because cells 
lacking these components show widespread chromosome missegregation and apoptosis. 
 
Table 4: Reports on mutations in the spindle checkpoint genes in cancer cell lines  
Reference Report Sample Genes Comments 
Cahill et al., 
1998 
Nature 392: 300-4 19 CIN colorectal 
cancer cell lines 
Bub1 1 mutation creating a 
frameshift, 
1 missense mutation   
Imai et al., 
1999 
Jpn J Cancer  
Res 90(8): 837-40 
32 sporadic digestive 
 tract cancer 
Mad2,  
Bub1 
no mutation observed in 
Mad2, one missense mutation 
in Bub1 
Yamaguchi 
et al., 1999 
Cancer Lett 139 
(2): 183-7 
31 head and neck  
squamous cell carcinoma 
(HNSCC) and lung  
cancer cell lines 
Bub1 expression in all cell lines 
and 1 silent mutation found 
Reference Report Sample Genes Comments 
Takahashi et 
al., 1999 
Oncogene 18(30): 
4295-33 
21 lung cancer cell lines,  
25 primary lung cancer 
 cases 
Mad2,  
p55CDC
no mutations found, but silent 
polymorphisms 
Nomoto et 
al., 1999 
Oncogene 18(50): 
7180-3 
49 lung cancer specimens Mad1 1 somatic, non-conservative  
missense mutation 
Sato et al., 
2000 
Jpn J Cancer Res 
 91(5): 504-9 
50 small cell lung cancers, 
51 non-small cell lung  
cancers, 4 mesothelioma 
cell line 
Bub1, 
BubR1 
no rearrangemens or deletions 
found, 1 point mutation in 
Bub1, no difference in expr. 
levels 
Ohshima et 
al., 2000 
Cancer Lett 158(2): 
141-50 
10 adult T-cell leukemia/ 
lymphoma (ATLL),  
8 B-cell lymphomas 
Bub1, 
BubR1 
ATLL: 4 cases of 
mutation/deletion in Bub1 or 
BubR1; B-cell  
lymphomas: 1 in BubR1 
Gemma et 
al., 2000 
Genes, Chromosomes 
 & Cancer 29(3): 
213-8 
30 lung cancer cell lines,  
30 primary lung cancer 
 tumors 
Bub1 3 different nucleotide 
substitutions 
found in some primary tumors 
and cancer cell lines (low 
freq) 
Jaffrey et 
al., 2000 
Cancer Res 60(16): 
4349-52 
32 colorectal cancer (CRC), 
20 non-small cell lung 
cancer (NSCLC) 
Bub1 mutations and polymorphisms 
rare (<1%) in the CRC or 
NSCLC, 
but allelic instability in CRC 
Percy et al., 
2000 
Genes, Chromosomes 
& Cancer 29(4): 
356-62 
21 aneuploid breast cancer 
cell lines, 5 immortalized  
normal mammary epithelial 
cell lines 
Mad2 3 cancer lines with significant 
differences in expression, 1 
cell  
line with a truncated form 
Myrie et al., 
2000 
Cancer Lett 152(2):  
193-9 
19 aneuploid breast cancer 
cell lines 
Bub1,  
Bub1b 
no mutations found, but 9 
seq  
variations; variable 
expression level 
Wang et al., 
2000 
Carcinogenesis 21 
(12): 2293-7 
5 nasopharyngeal carcinoma
cell lines 
Mad2 aberrantly reduced 
expression  
of Mad2 in 2 cell lines 
Weitzel and 
Vandre, 
2000 
Cell & Tissue Res 
300(1): 57-65 
2 lung adenocarcinoma 
cell lines 
Mad1,  
Bub1 
1 cell line didn't arrest after 
drug  
treatment, but both showed  
normal levels of both 
proteins 
Reference Report Sample Genes Comments 
Mimori et 
al., 2001 
Oncology Reports  
8(1): 39-42 
59 multiple carcinoma  
cell lines 
Bub1 no mutation found with 
amino acid  
change 
Haruki et 
al., 2001 
Cancer Lett 162(2): 
201-205 
44 lung cancer cases Bub1, 
BubR1, 
Bub3 
no frequent mutations found 
Olesen et 
al., 2001 
Carcinogenesis 22 
(5): 813-815 
6 aneuploid bladder cancer 
cell lines 
15 human bladder tumors 
Bub1, 
Bub1b 
Bub3 
TTK 
both mutational inactivation 
and loss 
of one allele are relatively 
uncommon 
 
However, if in cancer cell lines the spindle checkpoint is not responding to drugs 
affecting microtubule dynamics, but the genes currently tested are either not mutated or in low 
frequency: 
• either there is a mutation in one of the components of the defect-sensing machinery 
(therefore specific to the type of defect) 
• or there is a mutation in the signal transduction pathway after the known components are 
activated 
- restricted to the kinetochore of one specific chromosome 
- in the general pathway (no defect would be sensed) 
All this data implies that it is necessary to understand the whole checkpoint pathway, by 
identifying the different components, the interacting partners and the respective functions for 
each one. 
Goals of the project 
 
The aim of the present thesis has been to develop a better understanding of the 
mechanism of action of the spindle assembly checkpoint. The work can be structured in two 
parts: the first part describes the characterization of hMad1 at the kinetochore and its possible 
role in the spindle checkpoint. The second part describes the results of a two-hybrid screen in 
yeast, using hMad1wt as bait, and the characterization of some of the potential interactors 
identified in the screen. 
 
Materials and methods 
Plasmid constructions 
 
In order to have access to a high number of tags for expression in different systems, all 
genes used were cloned both in the Univector plasmid-fusion system (Liu et al., 1998) and in 
a modified version of the Creator system (Clontech). Both systems use Cre-lox site-specific 
recombination to catalyze plasmid fusion between the plasmid containing the gene of interest 
and host vectors containing regulatory information. All the tags used were amino-terminal to 
the gene of interest.  
Vectors for expression in bacteria (GST-tagged of His6-tagged), for expression in Sf9 
cells after baculovirus infection (His6-tagged) and for in vitro translations (myc3-tagged and 
the HA3-tagged vectors for mammalian expression) are from the Univector system (vectors 
pHB2-GST, pHB3-His6, pHI100-His6, pHM200-MYC3 and pHM200-HA3 respectively, a 
kind gift of Stephen Elledge). The entry vector used in most cases for this system was 
pUNI10 (unless specified), and every gene cloned was introduced to be in frame with the loxP 
site. 
For the Creator system, the corresponding entry vector (pDNR1 or pDNR3) was 
modified, removing the open reading frame encoding the chloramphenicol resistance gene 
(CmR), the second loxP site and the sucrose gene from B.subtilis (SacB). pDNR1 was excised 
using BspMI and SacI, the sticky ends of the 2.2 kb fragment were filled using Klenow 
endonuclease (New England Biolabs) and religated. For pDNR3, the same strategy was used, 
but taking SpeI instead of SacI. The resulting donor vectors (pDNR1s, pDNR3s) have only 
one loxP site, in front of the multiple cloning site, and therefore they are equivalent to 
pUNI10. DBD-tagged constructs for the two-hybrid system were produced using pLP-
GBKT7 Acceptor Vector in most cases (unless specified). This vector has a T7 promoter and 
a myc-tag after the DBD gene, both in frame with the loxP site, and it was used for some in 
vitro translation experiments. For mammalian expression of GFP-tagged proteins, pLP-
EGFP-C1 Acceptor Vector was used. 
A list of all the constructs generated is incorporated at the end of this work. 
hMad1 gene 
hMad1 was obtained from Dr. K.T.Jeang in pACT2 (Jin et al., 1998). It was excised 
BamHI/EcoRI and introduced in pBS-SK-. PCR was performed to introduce a NdeI site at the 
start codon and a BamHI site after the stop codon, and the gene was recloned in pBS-SK- 
(SM014). The complete coding sequence was excised using NdeI/BamHI and introduced into 
pUNI10 (SM009). The gene was completely sequenced and verified to be correct (accession 
number AF123318) and in frame with the loxP site. From this construct, the coding sequence 
was excised NdeI/BamHI and introduced in pDNR1s. For the two-hybrid screen, hMad1 was 
excised by NdeI/BamHI from SM009, the ends were blunted using Klenow endonuclease and 
the gene was cloned into the SmaI site in pGBDΟ-C3 (this vector was generated by P.I. 
Duncan, replacing the ampicillin resistance gene in pGBDU-C3 (James et al., 1996) by a 
streptomycin resistance gene) generating SM064. 
 
hMad1 fragments were produced using SM014 as template as follows: 
 
• ∆C-Mad1: from aa1 to aa686. This mutant was generated using the Transformer Site-
Directed Mutagenesis Kit (Clontech), using one primer whose 15 first nucleotides expand 
from aa682 to aa686 and the last 15 nucleotides expand from the stop codon towards the 
3’ end of the original sequence.  
• N-Mad1: from aa1 to aa480. This mutant and the following were generated by PCR. In 
this case, the 3’ oligo inserted a stop codon in position 481, followed by a BamHI site. 
• N2-Mad1: from aa1 to aaa202. The 3’ oligo inserted a stop codon in position 203, 
followed by a BamHI site. 
• I2-Mad1: from aa379 to aa565. The 5´oligo inserted a NdeI site including a start codon in 
position 378. The 3’ oligo inserted a stop codon in position 566, followed by a BamHI 
site. 
• I1-Mad1: from aa475 to aa565. The 5´oligo inserted a NdeI site including a start codon in 
position 474. The 3’ oligo inserted a stop codon in position 566, followed by a BamHI 
site. 
• C0-Mad1: from aa379 to aa718. The 5´oligo inserted a NdeI site including a start codon in 
position 378. 
• C1-Mad1: from aa475 to aa718. The 5´oligo inserted a NdeI site including a start codon in 
position 475. 
• C2-Mad1: from aa558 to aa718. The 5´oligo inserted a NdeI site including a start codon in 
position 557. 
• C3-Mad1: from aa628 to aa718. The 5´oligo inserted a NdeI site including a start codon in 
position 627. 
 
All the fragments were excised using NdeI/BamHI, introduced into pUNI10, completely 
sequenced and then introduced into pDNR1s, also by NdeI/BamHI.  
To generate the mutants K503R and L514K, mutations were generated using pDNR1s-
Mad1 as template (SM009) by the Quickchange site-directed mutagenesis method (12 to 18 
PCR cycles with Pfu turbo polymerase, using two complementary oligos, 33 bases long with 
the codon to be altered in the middle, and ending with one or more G/C bases; addition of 
DpnI to the PCR reaction and 1h incubation at 37ºC, to specifically digest methylated DNA; 
10 µl of the resulting reaction are used to transform 100ul of chemically competent XL1Blue, 
which are then plated on the appropriate selection and eventually processed to isolate the 
DNA). Coding sequences were then verified by sequencing. 
hMad2 gene 
 hMad2 was obtained from Dr. K.T.Jeang in pGAD-GH (Jin, Spencer and Jeang, 
1998). By PCR, a NcoI site was introduced including the start codon of the gene. The coding 
sequence was introduced by NcoI/BamHI into pUNI10 (SM010) and sequenced. From the 
pGAD-GH construct, the gene was excised by EcoRI/ApaI and cloned into pDNR1s 
(SM097). 
hBub1 gene 
 hBub1 was obtained in pBI-GFP from B.Vogelstein (Cahill et al., 1998). The 
complete coding sequence was excised by NotI/SalI and cloned into pBS-SK- (SM001). PCR 
was performed to introduce a BamHI site and a NdeI site at the start codon and the gene was 
recloned by BamHI/SalI into pBS-SK- (SM012). The coding sequence was excised by 
Nde1/BamHI and introduced into pUNI10. The gene was completely sequenced and three 
mutations were found: K54M, Q139R and D486G. The mutations were corrected sequentially 
by the Quickchange site-directed mutagenesis method (see Mad1 mutants generation for 
description). The first reaction introduced a BspHI site together with the M to K change, and 
the clones obtained were selected by BspHI digestion. The second reaction introduced a PstI 
site together with the R to Q change, and the clones obtained were selected by PstI digestion. 
The G to D change was selected by sequencing five clones in the mutated region. The hBub1 
coding sequence in the final construct (SM180) was completely sequenced. 
hBub3 gene 
 An EST coding for hBub3 was obtained from ATCC (human H2MBK93, 
EST179627). It was excised by EcoRI/XhoI, cloned into pBS-SK- (SM065) and completely 
sequenced. PCR was performed to introduce an EcoRI site and a NdeI site at the start codon 
and the gene was recloned by EcoRI/XhoI into pBS-SK- (SM067). The coding sequence was 
completely sequenced and excised by NdeI/SacI to be introduced into pUNI10 (SM075). 
hNdc80/Hec1 gene 
 The complete coding sequence for Hec1 in pACT (SM119) was obtained from an 
activation domain-tagged human cDNA library (Durfee et al., 1993) after a two-hybrid screen 
using hMad1wt as a bait (see below for details). The coding sequence was completely 
sequenced, excised by XhoI and introduced into pDNR3s (SM084). To get into the Univector 
system, the XhoI/XhoI fragment from SM119 was treated with Klenow endonuclease, to fill-
in the ends, and cloned in a modified version of pUNI10 (VH127, in which a linker fragment 
has been introduced at the EcoRI site, prepared by M.vanHouwe) cut by HpaI (SM135). 
 To obtain the MBP-tagged version for expression in bacteria, PCR was performed 
using SM119 as template, to introduce a NdeI site before the start codon and a HindIII site 
after the stop codon.  The PCR fragment was cut by NdeI, blunted using Klenow 
endonuclease and cut by HindIII. This fragment was then introduced into pMALc2x (New 
England Biolabs), cut by XmnI/HindIII (SM194). 
 Fragments of Hec1 were produced from SM084 by PCR as follows: 
• N-Hec1: from aa1 to aa99. The 5’oligo introduces a NdeI site including the start codon of 
the gene, and the 3’ oligo introduces a stop codon in position 100, followed by a SmaI 
site. 
• K-Hec1: from aa235 to aa409. The 5’ oligo introduces a NdeI site in position 233-234, 
and the 3’ oligo introduces a stop codon in position 410, followed by a SmaI site. 
• C-Hec1: from aa542 to aa642. The 5’ oligo introduces a NdeI site in position 540-541, 
and the 3’ oligo introduces a SmaI site after the stop codon of the gene. 
All PCR fragments were cut by NdeI/SmaI and introduced into pUNI10 cut by NdeI/HpaI 
(SM184, 185, 186). The coding sequences were completely sequenced. 
Antibody production 
hMad1 
 Polyclonal peptide-antibodies against hMad1 were generated by immunizing rabbits 
(Eurogentec Bel, Parc Scientific du Sart-Tilman, Ougrée, Belgium) with the following 
peptides coupled to ovalbumin (rabbits 139/140 were immunized with a mixture of peptides 
1+2 and rabbits 141/142 were immunized with a mixture of peptides 3+4): 
• EP991001: aa18-31+C 
• EP991002: aa416-430+C 
• EP991003: C+aa551-564 
• EP991004: C+aa704-718 
Sera from rabbits 139/140 were tested positive against GST-hMad1 expressed in bacteria 
and myc3-hMad1 in vitro translated or expressed in human cells as compared to preimmune 
sera.  
Serum from rabbit 139 was split in two samples, and affinity-purified on EP991001 or 
EP991002 coupled to Thiopropyl Sepharose 6B (Amersham Pharmacia). After two rounds of 
purification on the same peptide, each sample was passed over the other peptide. Purified 
antibody was eluted from the column after each round, and dialyzed/concentrated in PBS 
using Centricon Plus-20 columns (Millipore).  
hBub1 
 Immunizing four rabbits (Eurogentec Bel, Parc Scientific Du Sart-Tilman, Ougrée, 
Belgium) with the following peptides coupled to ovalbumin generated polyclonal peptide-
antibodies against hBub1 (each rabbit was immunized with one peptide): 
• EP990273: aa16-30+C; this peptide shows some conservation with hBubR1  
• EP990274: aa407-421 
• EP990275: aa482-495+C 
• EP990276: aa653-666+C 
All sera were tested positive against His6-hBub1 expressed in Sf9 cells after baculovirus 
infection and myc3-hBub1 expressed in human cells or in vitro translated, as compared to 
preimmune sera. 
hNdc80/Hec1 
 To generate polyclonal antibodies against Hec1, three GST-tagged constructs 
(Hec1wt, K-Hec1 and C-Hec1) were produced in bacteria. The insoluble pellet after 
extraction with RIPA buffer was acetone precipitated, resuspended in PBS and used for 
immunizing rabbits, two rabbits per construct (Biogenes, Berlin, Germany). Rabbits were 
preselected not to show any reactivity at the expected size for Hec1 (85kD). All sera were 
tested positive against MBP-Hec1 expressed in bacteria. 
In vitro interaction assays 
 Proteins were synthesized from plasmid templates in coupled transcription/translation 
reactions (T7 TnT, Promega), in the presence of a mixture of  35S labeled methionine plus 
cysteine (Promix; Amersham). 20 µl reactions were supplemented with various DNAs 
encoding myc3-hMad1 (wild type or mutants) and HA3-hMad2. Translation reactions were 
performed for 1h at 30ºC and then the ones whose interaction was under study were mixed 
and incubated for 30min more at 30ºC. Reactions were halted by addition of TNES buffer (50 
mM Tris pH 7.5, 100 mM NaCl, 2 mM EDTA, 1% NP-40). Soluble products were incubated 
for 1h with protein G Sepharose beads (Amersham Pharmacia) at 4ºC. Precleared 
supernatants were then incubated for 1h at 4ºC with primary antibody (monoclonal anti-myc; 
9E10) and then protein G Sepharose beads were added for another hour at 4ºC. Beads were 
then washed sequentially in binding buffer (TNES), TNES supplemented with 2M NaCl and 
TNE buffer. Samples were resolved by SDS-PAGE and electrophoretically transferred to 
nitrocellulose membranes (Schleicher & Schuell). Labeled translation products were 
visualized by autoradiography and then membranes were processed for immunoblotting using 
monoclonal anti-HA antibody (12CA5). 
Cell culture and transfections 
 Human cells were grown at 37ºC in a 5% CO2 atmosphere in Dulbecco’s modified 
Eagle’s medium (DMEM; Gibco) supplemented with 10% heat-inactivated serum, penicillin-
streptomycin (100 mg/ml) and non-essential aminoacids (50 U/ml). In case of LNCaP cell 
line (a prostate cancer cell line with a mutation in Mad1; Tsukasaki et al., 2001), RPMI-1640 
was used instead of DMEM, supplemented as indicated before. For transient transfection 
studies, HeLa cells were seeded onto HCl-treated glass coverslips at a density of 1x105 cells 
per 35 mm dish and transfected with a constant total amount of 0.4 µg of plasmid using 
Effectene reagent according to the manufacturer’s instructions (Qiagen) in 2ml DMEM 
freshly added, and then incubated at 37ºC in a 5% CO2 atmosphere. After 12-14h incubation 
with the reagent, medium was removed, cells washed three times with PBS and fresh medium 
added. The cells were fixed 48h after addition of the Effectene Reagent plus DNA solution. 
Hec1 was expressed GFP-tagged. hBub1 and hMad1 were expressed myc3-tagged. The three 
proteins were under the control of a CMV promoter. As a control, pLP-EGFP-C1 Acceptor 
Vector (empty) was used. 
 To obtain mitotically arrested cells, nocodazole (200 ng/ml) or taxol (10 µM) was 
added at the indicated time point in each case. To study whether or not cells had gone through 
S phase, BrdU (20 µM) was added 8h before cells were fixed. 
siRNA experiments 
 
 The following oligos were used for silencing of the different genes (only the sense 
oligo is indicated): 
• hMad1:   CCA GCG GCU CAA GGA GGU U dT dT (the siRNA sequence targeting 
hMad1 (AF123318) was from position 1843-1865 relative to the start codon) 
• hMad2:   GAG UCG GGA CCA CAG UUU A dT dT (HSU65410: position 503-525) 
• Hec1:   GUU CAA AAG CUG GAU GAU C dT dT (NM_006101.1: position 1517-1539)  
• hBubR1:   GGA GAU CCU CUA CAA AGG G dT dT (XM_031603.1: position 1124-
1146) 
• CENP-E:   ACU CUU ACU GCU CUC CAG U dT dT (NM_001813: position 944-966)  
• lamin A:   CUG GAC UUC CAG AAG AAC A dT dT (NM_005572: position 608-630) 
The 21-nucleotide RNA oligos were purchased from Dharmacon Research, Inc. 
Annealing of the siRNAs and transfections using oligofectamine (Life Technologies) were 
performed as described (Elbashir et al., 2001). Cells were fixed 42h after transfection reagent 
was added onto cells. 
Cell extracts and immunoblots 
 
 To prepare whole cell extracts, cells were washed once in PBS and lysed in Laemmli 
buffer. For immunoblotting, equal amounts of protein (assayed first by Coomassie staining) 
were resolved by SDS-PAGE and electrophoretically transferred to nitrocellulose membranes 
(Schleicher & Schuell). Membranes were stained with Ponceau S, fixed with 5% acetic acid, 
blocked in 5% non fat dry milk in PBS+Tween20 0.1% (PBSTM) overnight at 4ºC and 
incubated with polyclonal affinity purified primary hMad1 antibody (1 µg/µl), crude 
antiserum against hMad2 (BAbCO, 1:500), polyclonal anti-mHec1 (1:500; a kind gift from J. 
Kilmartin) or monoclonal  anti-α-tubulin (Sigma Aldrich, 1:2000) in PBSTM for 1h at RT. 
After three washes in PBST, membranes were incubated with horsheradish peroxidase (HRP) 
conjugated goat anti-rabbit antibodies or goat anti-mouse antibodies respectively (Amersham, 
1:3000) in PBSTM for 1h at RT. After three washes with PBST, bound conjugated antibodies 
were detected with the ECL detection system. 
Immunofluorescence microscopy 
 
Cells were seeded onto HCl-treated glass coverslips and simultaneously fixed and 
permeabilized in 20 mM Pipes pH 6.8, 4% formaldehyde, 0.2% TritonX-100, 10 mM EGTA, 
1 mM MgCl2 for 10 min at RT. For labeling of microtubules or microtubule-associated 
proteins (EB1, dynactin) cells were fixed for 5 min in methanol at  –20ºC. For calcium 
treatment, samples were treated as described (Kapoor et al., 2000). After washing in PBS, 
cells were incubated for 30 min at RT in blocking solution (PBS-Tween20 0.05%, 3% BSA: 
PBSTB). Primary antibodies used in this study were: polyclonal affinity purified anti-hMad1 
antibody (1 µg/µl), polyclonal anti-XMad2 (1:1000; a kind gift of T.Mayer), crude serum 
against hBub1 (1:500), polyclonal anti-mHec1 (1:500; a kind gift of J. Kilmartin), crude 
serum against hHec1 (1:1000), polyclonal anti-CENP-F (Abcam, product ab5; 1:1000), 
monoclonal anti-CENP-B (1:1000; a kind gift of W.Earnshaw), monoclonal anti-CENP-E 
(1:500; a kind gift of D.Brown), monoclonal anti-EB1 (BD Transduction Laboratories, 
1:100), monoclonal anti-dynactin (BD Transduction Laboratories, 1:150), monoclonal  anti-α-
tubulin (Sigma Aldrich, 1:2000) and monoclonal anti-BrdU (Amersham; undiluted).  
All antibody incubations were performed in PBSTB for 1h at 37ºC in a humidified 
chamber. After three washes in PBST 0.2%, coverslips were incubated with Texas Red-
conjugated or AlexaFluor488-conjugated secondary antibodies (either goat anti-rabbit or anti-
mouse) and DAPI (2 µg/ml) for 1h in PBSTB at 37ºC in a humidified chamber. After three 
washes in PBST 0.2% and one in water, coverslips were mounted either in 90% glycerol plus 
DABCO (25 µg/ml) in PBS or in Mowiol. Immunofluorescence microscopy was performed 
using a Zeiss Axioplan-II microscope and 40x or 63x oil immersion objectives. Photographs 
were taken using a Micromax (Princeton Instruments) CCD camera and Metaview (Universal 
Imaging Corp.) software. Images were processed using Adobe Photoshop (Adobe Systems, 
Mountain View, CA) software. 
Two-Hybrid system 
 
All media and protocols used are described in The Gietz Lab Yeast Transformation 
Page  (http://www.umanitoba.ca/faculties/medicine/units/biochem/gietz/). 
Library screening 
 Prior to performing the screen, yeast strain PJ69-4A (James et al., 1996) was 
cotransformed either with pGBDO-hMad1 (SM064) + pGAD-C3 or with pGBDO-hMad1 + 
pACT-hMad2 using herring sperm DNA as carrier (see Two-hybrid Interactions for 
description). Both transformation mixtures were plated on SC-LW / SC-LWA and incubated 
at 30ºC. As expected, on the selective plates (SC-LWA) there was no growth in the first plate 
(Mad1), whereas colonies were observed in the second plate (Mad1+Mad2), indicating that 
pGBDO-hMad1 was not self-activating and it was able to interact with a known interactor.  
To perform the screen, PJ69-4A was transformed to Trp prototrophy with pGBDO-
hMad1 (SM064) using a Trafo Scale 10x. Transformed cells were plated in SC-W and 
allowed to grow at 30ºC. Some colonies were then plated in SC-LW to discard any potential 
contamination with pACT plasmid before transformation with the library. Some colonies 
from the SC-W plate were then grown in 25 ml SC-W and transformed with 1 µg of DNA 
library (prepared from human peripheral lymphocytes using pACT; Durfee et al., 1993) using 
ss-DNA as carrier. The transformation mixture (1,4x105 transformants) was then plated on 
10x15cm petri dishes containing SC media lacking leucine, tryptophan and adenine (SC-
LWA) and incubated at 30ºC. After 5 days, 68 colonies were found, and 6 days later 30 extra 
colonies appeared. All colonies were replated in SC-LH+20mM 3-AT (Sigma Aldrich), SC-
LH+50mM 3-AT and SC-LH+80mM 3-AT. 
Recovery of plasmids from yeast 
 Total DNA of yeast was prepared as follows: a loopful of yeast was scraped into 
Solution I (1.2M D-Sorbitol, 1mM EDTA, 20mM Tris pH 8, 25µg/ml RNase A), lyticase 
added and the mixture incubated at 37ºC for 15min. Then  one volume of Solution II (0.2M 
NaOH, 1% SDS) was added, mixed and half a volume of Solution III (3M KAc pH 5.7) was 
added, mixed and spun. Isopropanol was then added to the supernatant (90% of the volume), 
and the mixture was spun. The pellet was washed with 70% ethanol, dried and resuspended in 
water. This DNA was used to transform E.coli DH5α using an Electro Cell Manipulator 600 
(BTX Inc.) according to the manufacturer’s instructions. Transformations were plated in 
media containing ampicillin. During this process, 6 colonies were lost, as they were not able 
to regrow. 
Clone processing 
 From colonies growing on Amp plates, plasmid DNA was prepared and digested by 
XhoI+HaeIII. Clones were then grouped according to the digestion pattern.  The 92 clones 
were therefore grouped in 39 families, which were sequenced from the 5’ end using an 
upstream primer in the vector. Sequences were analyzed using Sci Ed Central (Scientific and 
Educational Software). Homology searches were performed using BLAST (NCBI server) and 
ClustalW (EBI server). 
Two-hybrid interactions 
 To test the interaction between two putative partners and to map the interaction 
domain between two tested partners, the pDBD construct and the pACT construct were 
cotransformed in PJ69-4A as follows: an aliquot of an overnight yeast culture was spun, and 
the pellet resuspended with carrier DNA (herring sperm DNA; Merck). Then 1 µg of each 
plasmid and ONE STEP solution (0.2 M LiAc 40% PEG 3350 and 0.1M DTT freshly added) 
were incorporated, vortexed and incubated for 30min at 45ºC. The mixture was spun, 
resuspended in water, plated on non-selective plates (SC-L) and grown at 30ºC. From these 
plates, five colonies where selected, replated on selective plates (SC-LWAH) and grown at 
30ºC to test for interaction. Medium used in plates to test interactions was about 1.5x richer 
than the medium used for screening (which was more stringent, to reduce the frequency of 
false positives) to allow better growth. However, the selection used was stronger (also 
histidine was removed from the drop-out mix). 
 
 
Part I: hMad1 in the spindle assembly checkpoint. 
Introduction 
Mad1 protein in budding yeast (scMad1) 
 
 Mad1 was first identified in budding yeast  from mutants that failed to delay cell 
division in response to microtubule polymerization (Li and Murray, 1991). It was cloned by 
Hardwick and Murray (Hardwick and Murray, 1995), and in that report some of the basic 
characteristics of this protein were defined: MAD1 is predicted to encode a coiled-coil 
protein, using the algorithm of Lupas et al. (Lupas et al., 1991), with a globular domain at the 
carboxy-terminal. It contains a putative bi-partite nuclear localization signal, many potential 
phosphorylation sites and an unusual stretch rich in asparagine residues. Using the deletion 
mutant mad1∆.1, it was shown that the MAD1 gene encodes a component of the spindle 
assembly checkpoint, as mad1∆.1 cells are unable to delay the cell cycle in the presence of 
benomyl  (a MT depolymerizing drug).  
Using polyclonal antibodies raised against a GST construct containing the amino-
terminal half of Mad1, it was shown that this is an 85 kD protein, whose abundance remains 
constant along the cell cycle and is not affected by benomyl-induced mitotic arrest. Mad1 was 
found to form discrete patches in the nucleus in a fixation sensitive manner, as greater than 5 
min of formaldehyde fixation dramatically reduced Mad1 staining and further fixation 
completely abolished it. However, Mad1 was found not to co-localize either with Rap1p (a 
telomere protein), or with nuclear pore antigens.  
On gel filtration, Mad1 behaved as a very large protein, but it sedimented relatively 
slowly through sucrose gradients, and this was  unaffected by the presence of 1M NaCl. 
Similar behavior has been reported for other coiled-coil proteins, such as myosin and kinesin 
(Hackney et al., 1992; Hirano and Mitchison, 1994). It was therefore proposed that Mad1 has 
a large Stoke’s radius and that it may be rod shaped, consistent with the elongated structure of 
many coiled-coil proteins. 
During a normal cell cycle, only a minor variation in the gel electrophoretic mobility 
of Mad1 could be detected, but when cells were arrested in mitosis by benomyl treatment, a 
significant fraction of the protein showed a decrease in  electrophoretic mobility. This shift 
was abolished upon phosphatase treatment, and recovered in the presence of phosphatase 
inhibitors, suggesting that it is due to phosphorylation of Mad1. However, it was shown that 
phosphate incorporation into Mad1 occurs to equal extents in exponentially growing, 
benomyl-arrested and α-factor-arrested cells, suggesting that Mad1 is phosphorylated 
throughout the cell cycle. Looking at the phosphorylation of the amino-terminal half of Mad1 
expressed in the mad1∆.1 strain, it was shown that even when phosphate incorporation was as 
efficient as into the wild-type protein, neither this mutant nor the original mad1 alleles shifted 
upon benomyl treatment. According to this, the authors proposed that Mad1 could be the 
target of two types of phosphorylation: constitutive, that appears to occur throughout the cell 
cycle and both on functional and non-functional forms of Mad1, and regulated 
phosphorylation that is dependent on activation of the spindle assembly checkpoint and 
occurs only on functional Mad1. Further studies using mutant strains, showed that Mad1 
hyperphosphorylation was dramatically reduced in mad2-1 and absent in bub1∆ and 
bub3∆, indicating that these genes are all important for Mad1 modification. However, Mad1 
is still able to incorporate phosphate in the bub1∆  strain, showing that Bub1 is not 
responsible for the addition of all the phosphate groups to Mad1. 
Later on it was shown that Mad1 was not hyperphosphorylated in mps1 mutant cells, 
which failed to arrest at restrictive temperature, even when cells were treated with nocodazole 
(Hardwick et al., 1996). Furthermore, it was shown that active GST-Mps1p purified from 
yeast directly phosphorylates the amino-terminal third of Mad1 expressed and purified from 
E.coli, and this in vitro phosphorylation led to reduced mobility of Mad1. However, it was not 
determined whether this modification of Mad1 is required for the activation of the checkpoint. 
In cells overexpressing Mps1p, Bub1 and Bub3 are not necessary for Mad1 modification, 
whereas in cells with wild-type amounts of Mps1p, both of them are necessary. This showed 
that Mps1p may be a physiologically important Mad1 kinase whose activity is required to 
detect a wide variety of spindle defects. 
However while it is possible that hyperphosphorylated forms of Mad1 may be a good 
indicator of spindle damage, Mad1 hyperphosphorylation is not always correlated with 
mitotic delay (Farr and Hoyt, 1998). Farr and Hoyt showed that mitotic delay can be induced 
in cells by BUB1-5 (a mutant probably with altered kinase activity) overexpression without 
resulting in detectable Mad1 hyperphosphorylation. The opposite situation was also  
observed. Mad1 can be hyperphosphorylated in cells that are not delayed in mitosis (i.e., in 
bub1∆ cells in which MPS1 is overexpressed, Hardwick et al., 1996). According to the 
authors, all of this may indicate that hyperphosphorylated Mad1 is not an intermediate in 
spindle damage signal transduction. Thus, the role of Mad1 hyperphosphorylation in 
checkpoint activation in yeast is not clear. 
Two recent papers (Brady and Hardwick, 2000; Chen et al., 1999) have shown that the 
spindle checkpoint depends on the complex formation of Mad1-Mad2 and Mad1-Bub1-Bub3. 
In the first paper it was shown that Mad2 immunoprecipitates contained Mad1. To analyze 
this complex, whole yeast cell extracts were analyzed by gel filtration, showing that there 
were two pools of Mad2, one that co-fractionated with Mad1, whereas the other pool was 
running at the size expected for monomeric Mad2. All of the Mad1 co-fractionated with 
Mad2. The Mad1-Mad2 interaction was shown to be constant throughout the cell cycle, and 
the phosphorylation of Mad1 that is observed in mitosis (upon nocodazole checkpoint 
activation) did not seem to affect the Mad2 interaction. This Mad1-Mad2 complex was shown 
to be resistant to stringent conditions (5M NaCl, 1M urea), indicating that Mad1 and Mad2 
form a tight complex in yeast cells. Furthermore, Mad1 hyperphosphorylation was not 
observed in mad2 mutants unable to bind Mad1, suggesting that Mad2, by binding to Mad1, 
may facilitate Mad1 phosphorylation. 
Brady and Hardwick showed that Mad1 is associated with Bub1 and Bub3 in a 
regulated manner (Brady and Hardwick, 2000). This complex was formed 40 minutes after 
release from an α-factor arrest and was then maintained. This complex was also observed 
during a normal cell cycle, the first biochemical evidence that the budding yeast spindle 
checkpoint is activated every cell cycle. Whereas in nocodazole arrested cells high levels of 
Mad1-Bub1-Bub3 can be detected, in a cdc26∆ arrest (in which the APC/C is inactive and 
spindle microtubules are still attached to kinetochores) very little was found. It was shown 
that Mad2, Bub3 and Mps1p were necessary for the formation of a stable Mad1-Bub1 
complex, and similarly, Mad2, Bub1 and Mps1p were required for the Mad1-Bub3 
association. Surprisingly, very little of Mad2 was associated with the Mad1-Bub1-Bub3 
complex. Using a kinase-dead version of Bub1, it was shown that Bub1 kinase activity is not 
absolutely required for its complex formation with Mad1. 
Mad1 homologues 
 
 Homologues of Mad1 have been found in several species (see figure 6). Comparison 
of the amino-acid sequences reveals that there is little homology (see table 5), and the little 
that there is lies towards the carboxy-terminus.  
In C.elegans, mdf-1 (C50F4.1, gi|14530364|) was proposed as a Mad1 homologue 
(Kitagawa and Rose, 1999). This gene was found as a two-hybrid interactor of mdf-2, a gene 
that can functionally replace yeast MAD2. The mdf-1 gene product has a predicted coiled-coil 
domain but did not rescue the benomyl-sensitive phenotype of the budding yeast mad1 
deletion strain. There is a second protein in C.elegans (F59A2.6, gi|7504717|), which can be 
obtained in a BLAST X 2.1.3 search using dmMad1 (AF123262) as query, (E Value: 2e-06). 
F59A2.6 is also a coiled-coil protein, and using CLUSTAL W (1.81), this protein obtains a 
score of 13 when compared with scMad1, whereas mdf-1 gets only a score of 9. However, 
when the comparison is made using only the last 250-300 residues (the part of the protein 
which shows higher homology), F59A2.6 obtains a score of 10, whereas mdf-1 gets 15, 
suggesting that mdf-1 is a better candidate. 
 
Table 5: alignment results obtained with CLUSTAL W (1.81) at EMBL outstation 
 1 2 3 4 5 6 7 
Gi 14530364 7491648 6321352 4530484 4583429 4580769 4416457 
Species Ce Sp Sc Dm Xl Mm Hs 
1 Ce  11 9 14 13 16 12 
2 Sp   20 16 20 21 21 
3 Sc    12 14 14 12 
4 Dm     19 22 20 
5 Xl      59 61 
6 Mm       80 
 
xMad1: the Xenopus laevis homologue 
 
Mad1 in Xenopus laevis was isolated as a xMad2 interacting protein by 
immunoprecipitation followed by mass spectrometry (Chen et al., 1998). It is an 85kD protein 
predicted to form a long coiled-coil similar to the budding yeast protein. Antibodies raised 
against the full-length protein recognized an 84kD band in Xenopus extracts, and an 86kD 
band in HeLa extracts. The protein level is not regulated during the cell cycle and it binds 
tightly to xMad2. Furthermore, and differently to scMad1, no upshift of xMad1 was detected 
in mitosis. It was shown that anti-xMad1 interfered with the spindle checkpoint, because 
when a Xenopus egg extract was preincubated with this antibody, it failed to establish mitotic 
arrest in the presence of a high concentration of sperm nuclei and nocodazole. This effect was 
not observed when the antibody was preincubated with recombinant xMad1. The antibody 
still abolished the checkpoint function when added to egg extracts after the checkpoint was 
first activated. These results show that, like xMad2, xMad1 is critical both for establishing 
and maintaining the spindle checkpoint. 
Both xMad1 and xMad2 were shown to localize to the nuclear envelope and the 
nucleus during interphase in XTC cells by immunofluorescence. At prophase, xMad1 
dissociated from the nuclear envelope before all xMad2 did, and a fraction of both xMad1 and 
xMad2 localized to kinetochores, being released at metaphase. In cells arrested with 
nocodazole, both xMad1 and xMad2 persisted at kinetochores. When anti-xMad1 was added 
into frog extracts, which were allowed to assemble metaphase chromosomes, the isolated 
chromosomes did not show any staining neither for xMad1 nor for xMad2, and these extracts 
failed to establish mitotic arrest in the presence of a high concentration of sperm nuclei and 
nocodazole. However, if anti-xMad2 was added to the extracts, chromosomes showed 
staining for both proteins, although these extracts were similarly not able to activate the 
spindle checkpoint. Even when xMad1 and xMad2 were first allowed to bind to kinetochores, 
the addition of anti-xMad1 displaced both proteins from these sites. These results indicate that 
xMad1 is essential for kinetochore localization of xMad2 and that binding of xMad1 and 
xMad2 to kinetochores is not sufficient to activate the checkpoint.  
The major role of xMad1 seems to be to recruit xMad2 to unattached kinetochores. 
This was tested by immunodepletion of xMad1 from extracts, which removed >95% of the 
protein. In these conditions, the extracts were unable to activate the checkpoint in the 
presence of nocodazole and high concentration of sperm nuclei, even when 60% of xMad2 
was present in these extracts. However, addition of excess recombinant xMad2 could still 
trigger mitotic arrest in xMad1-depleted extracts. This indicates that the effect of excess 
xMad2 is independent of xMad1, suggesting that xMad1 recruits xMad2 to the kinetochore, 
but is not involved in signaling downstream of xMad2. 
Recently Sharp-Baker and Chen showed by immunodepleting frog extracts using 
specific antibodies, that xBub1 is required for kinetochore localization of xMad1, xMad2, 
xBub3 and xCENP-E (Sharp-Baker and Chen, 2001). This function seems to be independent 
of the xBub1 kinase activity, as addition of a kinase-dead mutant of xBub1 (K872R) into 
extracts immunodepleted with anti-xBub1 restored the kinetochore localization of the above-
mentioned proteins. Furthermore, whereas the depleted extracts were not able to arrest in the 
presence of nocodazole, the checkpoint activity was also restored by the addition of either the 
wild type or the kinase inactive form of xBub1, suggesting that the kinase activity of xBub1 is 
not required for checkpoint activation. Interestingly, the authors also detected a reduction in 
the xCENP-E staining at the kinetochores in xMad1-depleted extracts.  
Mad1 in humans: hMad1 
 
 The human homologue of Mad1 was first identified in a two-hybrid screen as an 
interactor of Tax, a 40 kD phosphoprotein encoded by HTLV-I (human T cell leukemia virus 
type I), the etiological agent for adult T cell leukemia (Jin et al., 1998). For this reason, it was 
first named TXBP181 (Tax Binding Protein 181). TXBP181 has similar coiled-coil domains 
as scMad1 using the COILS algorithm (Lupas et al., 1991) and shares 21% amino-acid 
identity with scMad1. Furthermore, it was shown to homodimerize and to bind to hMad2 in 
the two-hybrid system. Using the same method, Jin and colleagues mapped an hMad2-
interactive domain between aminoacids 465 and 584 of TXBP181. 
 However, probably due to a sequencing error (see also Campbell et al., 2001), there is 
one base lost in the 3’ half of the TXBP181 gene (between positions 2162 and 2163), which 
leads to a frameshift in the carboxy-terminal half of the protein. This change generates a full-
length protein of 803 amino-acids, instead of 718. For antibody generation, a carboxy-
terminal fragment was produced in bacteria, and the fragment chosen laid in fact after the 
frameshift indicated before, leading to an amino-acid sequence completely unrelated to the 
sequence of hMad1. This antibody recognized a protein with a very low mobility in gel 
(somewhere in the middle between 97.4 kD and 220 kD) and by immunofuorescence it 
detected an antigen at the centrosome from prometaphase to metaphase. 
 hMad1 was cloned (GB: AF123318) by an independent group (Seeley et al., 1999), 
the product of which was predicted to be 718 amino-acid long. In this report, using in vitro 
translation products followed by immunoprecipitation, hMad1 was shown to bind hBub1 and 
hMad2, and two independent complexes were proposed: hMad1/hMad2 and 
hBub1/hBub3/hMad1. It was also shown that hMad1 is phosphorylated by hBub1 in the 
presence of hBub3, by incorporation of 33-P in a band with a gel mobility precisely matching 
that expected of hMad1 (no upshift was detected). This band was absent when hMad1 was 
omitted from translations, identifying this band as the hMad1 gene product. 
 Campbell et al. (2001) raised antibodies against a carboxy-terminal peptide of the 
correct hMad1, reporting that it recognizes an 83 kD human protein, which is in agreement 
with the previously reported data for scMad1 and xMad1.  The amount of protein was found 
to be the same in S-phase and mitotic cells, suggesting that the protein levels of hMad1 do not 
fluctuate between S-phase and mitosis. On normal exposure times, the authors did not detect 
any upshift of hMad1 upon nocodazole arrest in HeLa cells. However, on longer exposure 
times a higher molecular weight band was detected, yet this band failed to collapse upon 
treatment by lambda phosphatase. Therefore it is unclear that the modification is due to 
phosphorylation, consistent with xMad1 data. By immunofluorescence, this antibody detected 
hMad1 in punctate dots at the nuclear periphery (no evidence was found for labeling of 
chromosomes at interphase), and at kinetochores from prometaphase until metaphase, when 
chromosomes become aligned. They also detected hMad1 in discrete speckles along spindle 
microtubules. Upon nocodazole treatment, all the kinetochores showed strong hMad1 
labeling.  
It was also shown by immunoprecipitation of endogenous hMad1 that it can interact 
with hMad2 but not with p55CDC. This result was confirmed using transfected GST-hMad1, 
showing that this fusion protein can bind endogenous hMad2, yet no endogenous hMad1 was 
precipitated. This would argue against hMad1 dimerization unless the GST moiety prevented 
dimerization of the fusion protein with native hMad1. 
 Using antibodies against NPC (Nuclear Pore Complex) proteins, hMad1 was shown to 
co-localize by immunofluorescence with nuclear pores. Furthermore, using nuclear envelope 
preparations from rat livers and human HL60 cells, hMad1 was shown to be recovered in the 
fraction that is highly enriched in nuclear envelopes. Extracting cells with 1% CHAPS (which 
permeabilizes both the cell membrane and the nuclear envelope) hMad1 pore labeling was 
detected, whereas when digitonin (which does not permeabilize the nuclear envelope) was 
used, no hMad1 NPC labeling was detected. In these conditions the antibodies cannot enter in 
the nucleus, which then indicates that hMad1 is likely to be located in the nucleoplasmic side 
of the NPC. Using immunoelectron microscopy, hMad1 was found at NPCs and clearly 
located inside the nucleus and not on the cytoplasmic side, in agreement with the digitonin 
results. When there was a view in which the nuclear envelope is parallel to the plane of 
section and the NPCs can be seen in face, hMad1 label was not detected at the circumference 
of the octameric pore structure itself, but appeared to coincide with the channel. When double 
immunofluorescent labeling was performed, hMad2 was found to co-localize with hMad1 at 
the NPCs, and hMad2 was also associated with nuclear envelope extracts from human HL60 
cells. 
 Upon GST-hMad1 overexpression in HeLa cells, the fusion protein localized to NPCs 
after six hours. When examined 24-36h after transfection, the fusion protein localized to 
vesicular structures present throughout the cell. The authors suggest that these structures were 
very reminiscent of annulate lamellae, an incompletely characterized organelle found in many 
types of cells consisting of membrane cisternae containing numerous structures that are 
morphologically and biochemically very similar to nuclear pore complexes (Kessel, 1992). 
Overexpression of a NPC protein was shown previously to induce formation of annulate 
lamellae (Imreh and Hallberg, 2000). When cells transfected with GST-hMad1 were stained 
with anti-Nup93 (a component of the NPC), it detected the vesicular structures in a punctated 
pattern, and a different punctate pattern can be detected on these structures with monoclonal 
antibody 414, which recognizes several known NPC proteins (Davis and Blobel, 1986). Also 
hMad2 was present in a punctate pattern on the fusion protein-induced structures. Therefore 
the authors concluded that overexpression of hMad1 is sufficient to induce formation of 
annulate lamellae containing other known NPC proteins. 
Role of hMad1 in the spindle checkpoint 
 
 Due to the existing data about the function of scMad1 and xMad1, and the fact that 
hMad1 was shown (by three independent groups) to interact with hMad2, it was tempting to 
speculate that hMad1 should play a role in the spindle checkpoint in humans. A recent report 
(Tsukasaki et al., 2001) has identified some mutations in prostate cancer cell lines in 
MAD1L1, either point mutations in conserved residues (some of them mapping in the 
putative hMad2 binding domain) or truncations of the protein. In the same report, it was 
shown that transfection of ∆649-hMad1 in HOS cells produced a reduction of the mitotic 
index upon nocodazole treatment as compared to overexpression of the wild type form of 
hMad1, indicating a dominant negative effect.  
For all the above reasons, further characterization of the function of hMad1 itself and 
the interaction hMad1/hMad2 could shed some light on the role of hMad1 in the spindle 
checkpoint. 
 
Results 
Sequence analysis for hMad1 
 
hMad1 was completely sequenced, and the sequence was shown to be identical to 
AF083811 (Homo sapiens mitotic checkpoint protein isoform MAD1a (MAD1) mRNA, 
complete cds). The resulting DNA and protein sequences were subjected to computer 
analysis :  
• http://www.up.univ-mrs.fr/~wabim/d_abim/compo-p.html 
• http://psort.nibb.ac.jp/form2.html 
• http://www.ch.embnet.org/software/COILS_form.html 
The protein had a predicted length of 718 aminoacids (aa), the estimated molecular weight 
was 83 kD, with a pI = 5,45. The computer analysis of the protein sequence predicted a 
bipartite nuclear localization signal (NLS) at aa 384 and the predicted localization was  
nuclear with 94,1% reliability. The PSORT program also identified a leucine zipper pattern at 
aa 501. The COILS program predicted a long coiled-coiled structure, from aa 48 up to aa 631 
(total: 517 residues). Sequence analysis of all the Mad1 homologues (Fig.7) showed an NLS 
signal in all the cases, and a similar coiled-coil structure, whereas the leucine-zipper motif 
was restricted to the vertebrate homologues. 
hMad1 in the cell cycle 
 
 Peptide antibodies were raised in rabbits against different regions of hMad1 (see Fig. 7 
and Material and Methods). Both sera (SD99041 rabbits 139 and 140) were tested in different 
ways and by immunoblot showed a band at around 85 kD in HeLa extracts (Fig.8A), as 
expected according to the computer predictions. No upshift was detected in cells arrested 
upon nocodazole treatment. Also, both sera were shown to be able to pull-down myc3-hMad1  
(Fig. 8B) produced by in vitro translation (IVT) in similar amounts to the one obtained using 
9E10 antibody (monoclonal anti-myc). None of these sera was able to detect any specific 
signal by immunofluorescence. The production of recombinant hMad1 in baculovirus was 
unsuccessful, as no band could be detected upon infection. 
 The serum from rabbit 139 was significantly stronger in immunoblotting,  therefore it 
was subjected to affinity purification using peptides EP991001 and EP991002 (Fig. 8C). 
The affinity-purified antibody EP991002 (Ab-2) was used for further characterization 
of hMad1 in immunofluorescence (Fig. 9). Similarly to hMad2, and according to the 
predictions, hMad1 is nuclear in interphase, showing stronger labeling in the nuclear 
envelope. Interestingly, in interphase hMad1 is accumulated in nuclear dots, in variable 
numbers from cell to cell (from none to 4-5). The nature of these dots is unknown, but similar 
dots were observed when GFP-hMad1 was ectopically expressed in HeLa cells, suggesting 
that these structures are indeed specific. Upon entry into mitosis, at prophase, hMad1 starts to 
relocalize to the centromeric region, as can be observed using anti-CENP-B. This localization 
is maintained along prometaphase, and is progressively lost as chromosomes congress in the 
metaphase plate, disappearing completely when all chromosomes are properly aligned. 
hMad1 is a component of the spindle checkpoint 
 
 In order to test the function of hMad1, RNA interference was performed using specific 
oligonucleotides against this gene. Depletion of the protein level for hMad1 was tested using 
the affinity purified antibody, both in immunoblot and in immunofluorescence. As expected, 
according to the results obtained previously in Xenopus (Chen et al., 1998), depletion of 
Mad1 produces lack of Mad2 at kinetochores in prometaphase (see Fig.10A). However, it 
does not have any effect on CENP-E localization at the same stage (Fig. 10B), indicating that 
CENP-E kinetochore localization is independent of Mad1. 
Next, to further investigate if hMad1 is a bona fide component of the spindle 
checkpoint necessary to establish an arrest when the conditions for chromosome alignment 
are compromised, we first depleted hMad1 using siRNA and after 42h we added nocodazole 
for 18h, to disrupt the microtubule network. Indeed, in the control (mock-treated cells), cells 
arrested  in a prometaphase-like state, which did not happen either in siRNA hMad1 treated 
cells or in siRNA hMad2 treated cells (Fig.11). 
hMad1 interacts with hMad2 through a region in the putative coiled-coil in the 
carboxy-terminal region of hMad1 
 
 We were then interested in verifying that hMad1 interacts with hMad2, and in finding 
the interaction domain in hMad1. Given the insolubility of hMad1 in bacteria and in human 
293/293T cells, and the lack of expression in the baculovirus construct prepared, we decided 
to work in vitro, using reticulocyte lysates to produce 35S labeled constructs. To do that, 
myc3-hMad1 constructs of different lengths were prepared, carrying both amino-terminal and 
carboxy-terminal deletions, and HA3-hMad2. All constructs were expressed in reticulocyte 
lysates, in the presence of 35S (Fig.12A: control), incubated for 30 min mixed in different 
combinations (Fig.12A: input) and subjected to immunoprecipitation using monoclonal anti-
myc antibody (9E10), which specifically pulls down myc3-hMad1 constructs, but not HA3-
Mad2 (Fig.12: data). After immunoblotting with anti-HA antibody (12C5), HA3-hMad2 was 
observed to interact only with the full length construct (wt) and with the largest carboxy-
terminal fragment of hMad1 (C1), which maps the interaction domain in the indicated region 
(Fig.13C). The experiment was repeated several times, and the results were consistent each 
time. 
To confirm this result using a different approach, additional fragments were prepared, 
two containing only internal domains of hMad1, one smaller amino-terminal fragment and 
one larger carboxy-terminal fragment. All the fragments were then cloned in a DBD vector 
for the two-hybrid system (Y2H), and tested against ACT-hMad2 (Fig.13A). Consistent with 
the results observed in the in vitro translation system (IVT), an interaction was detected only 
with the internal fragments and with the larger carboxy-terminal fragments of hMad1. 
Discussion 
 
According to our studies, hMad1 is a nuclear protein of 83kD which does not upshift 
in nocodazole arrested cells (see pag.45). However, the fact that no upshift can be detected 
does not rule out the possibility that Mad1 could be phosphorylated, as it is in yeast, and 
indeed there is evidence showing that hMad1 can be phosphorylated by hBub1 in the presence 
of hBub3 in vitro (Seeley et al., 1999). One interesting possibility is that Mad1 modification, 
such as phosphorylation by Mps1 or Bub1, could affect Mad1-Mad2 interaction, releasing 
both Mad1 and Mad2 of their stable association.  
Immunostaining using anti-hMad1 shows that this protein localizes to kinetochores 
during prophase-prometaphase, until all chromosomes are aligned at the metaphase plate, 
consistent with the localization of xMad1, xMad2 and hMad2 (Chen et al., 1998; Li and 
Benezra, 1996). Our results thus confirm the data from Campbell and colleagues (Campbell et 
al., 2001) but are in contradiction with other previously published results (Jin et al., 1998).  
The results of this study clearly show that hMad1 is a component of the spindle 
checkpoint, as depletion of hMad1 abolishes the mitotic arrest in the presence of nocodazole, 
consistent with previous results in yeast and Xenopus (Chen et al., 1998; Hardwick and 
Murray, 1995). Depletion of hMad1 also produces mislocalization of hMad2 during mitosis, 
as it was shown previously for xMad1-xMad2, indicating that hMad1 is required for hMad2 
localization at kinetochores. Interestingly, depletion of hMad2 produces also some effect on 
hMad1 kinetochore localization (data not shown), suggesting that Mad1-Mad2 is probably the 
functional species to be targeted to the kinetochore. However, CENP-E kinetochore 
localization seems to be independent of hMad1, as hMad1 depletion using siRNA did not 
affect CENP-E, whereas in Xenopus it has been reported that xMad1 depletion produces a 
reduction in xCENP-E signal at the kinetochores (Sharp-Baker and Chen, 2001). According to 
our data, Mad1 and CENP-E in humans are assembled independently to the kinetochores, 
suggesting that they might belong to independent pathways. The difference in behavior 
between hCENP-E and xCENP-E regarding Mad1 dependency could reflect an intrinsinc 
difference between the two homologs, as depletion of CENP-E in humans produces mitotic 
arrest (Yao et al., 2000) whereas depletion of CENP-E in Xenopus produces an abolishment 
of the spindle checkpoint (Abrieu et al., 2000).  
We also show that hMad1 interacts in vitro and in Y2H with hMad2, consistent with 
previous results (Campbell et al., 2001; Jin et al., 1998; Seeley et al., 1999).  Furthermore, we 
mapped the hMad2 interaction domain in hMad1 to a region between aa475-aa565, a 
specialized region in the predicted coiled-coil domain, which contains a leucine zipper motif. 
 
During the course of this work, two other  laboratories published new data confirming 
the results shown here and adding more information. First, Sironi and colleagues (Sironi et 
al., 2001) observed that both hMad2wt and hMad2R133A, a mutant that cannot oligomerize, 
can bind to hMad1486-719, which is consistent with our mapping results,  further narrowing the 
binding region to aa486-aa565. Furthermore, they observed that the Mad2-Cdc20 complex is 
not formed as an effect of competition by Cdc20111-154 on the Mad1-Mad2 interaction. Their 
biochemical studies show that Mad2 is oligomeric when bound to Mad1 in vitro, and that this 
oligomerization is required for the interaction of Mad2 with Cdc20.The monomeric mutant 
Mad2R133A cannot bind Cdc20 when engaged in a complex with Mad1. Overexpression of 
myc-Mad2∆C (a mutant form that cannot bind either Mad1 or Cdc20) in several mammalian 
cell lines, showed no enrichment on the kinetochores either in prophase or in metaphase, or 
when the spindle checkpoint was induced, whereas an enrichment was observed using myc-
Mad2R133A. This indicates that kinetochore localization of Mad2 is dependent on Mad1 or 
Cdc20 binding and is independent of Mad2 oligomerization. Their approach does not resolve 
if the required interaction for Mad2-kinetochore localization is through Mad1 or Cdc20, but 
given the results in Xenopus and our own results using siRNA hMad1, it seems reasonable to 
conclude that Mad1 binding is responsible for this specific localization. Finally, they observed 
that overexpression of Mad2 or microinjection of purified Mad2 proteins into cultured cells 
was not sufficient to induce the mitotic spindle checkpoint, whereas it was observed that high 
levels of recombinant Mad2 induce mitotic arrest in fission yeast and in Xenopus extracts 
(Chen et al., 1998; Fang et al., 1998; He et al., 1997). This mitotic arrest induction is 
independent of Mad1 and localization to the kinetochores. However, when Sironi and 
colleagues co-expressed Mad2 with Mad1, the spindle checkpoint was induced. The same 
effect was observed with Mad2R133A but not with Mad2∆C . These results indicate that the 
mitotic spindle checkpoint is dependent on both Mad1 and Mad2, and this conclusion is 
consistent with our results using siRNA followed by nocodazole addition. 
 
A second group (Luo et al., 2002) has confirmed using siRNA depletion of hMad1 
(oligonucleotides 391-413 of the Mad1 coding region), that hMad1 is indeed required for 
proper checkpoint signaling, and that hMad2 kinetochore localization is dependent on hMad1. 
However, they observed using this oligonucleotide that about 10% of the siRNA hMad1 cells 
appeared to contain kinetochores that were not properly aligned in prometaphase and 
metaphase, and they also observed lagging chromosomes in anaphase and telophase cells. In 
our experiments, this effect was not observed (see Fig.11B). Using deletion mutants and 
NMR, they mapped the regions within hMad1 and hCdc20 that were responsible for hMad2 
binding. They mapped the hMad2 binding region in hMad1 to residues 525-584, very close to 
our own result (aa486-aa565). Upon sequence alignment of Mad1 from different species, it 
was observed that the Mad2 binding domain of Mad1 contains a peptide motif (residues 540-
551) similar to the binding region in hCdc20p (residues 124-137: Cdc20P1). A peptide 
spanning residues 540-551 (Mad11) was indeed sufficient for hMad2 binding, and deletion of 
residues 541-549 or mutations of residues His544 and Met545 abolished the binding between 
hMad2 and the full-length hMad1. Taken together, all data point to the fact that this region is 
indeed responsible for hMad2 binding. 
Using phage display, Luo and colleagues (Luo et al., 2002) identified a class of Mad2 
binding peptides (MBPs) with a consensus motif. The sequence of the majority of the 
peptides (as MBP1) was found to be rather different from the sequence of hCdc20p and 
hMad1 binding motifs. However, they seem to contain a similar consensus found in the 
majority of the MBPs. Interestingly, they found in an in vitro APC ubiquitination assay that 
addition of MBP1 (but not a control peptide) blocked the ability of hMad2 to block APCCdc20 
in vitro. Given that hMad1 and hCdc20p contain similar hMad2 binding sites, they reasoned 
that is likely that they bind to similar sites on hMad2. To test whether the Mad1-Mad2 and the 
Cdc20-Mad2 were mutually exclusive, they added increasing concentrations of Mad1465-584 to 
the APC ubiquitination assay, and observed that high concentrations of Mad1465-584 reversed 
the inhibitory activity of Mad2 toward APCCdc20. These results indicate that Mad1 binding to 
Mad2 antagonizes the function of Mad2 by disrupting the Mad2-Cdc20 interaction. However, 
it should be noted that in vivo Mad2 is in excess over Mad1 (Chen et al., 1998), and Luo and 
colleagues (Luo et al., 2002) have found that both Cdc20 and Mad1 show relatively low 
affinities, and correspondingly slow aggregation of the complexes. This suggests that Mad1 is 
not likely competing for Mad2 binding in vivo, but that Mad1-Mad2 and Cdc20-Mad2 
complexes are indeed mutually exclusive. 
Interestingly, this group reports that overexpression of Mad2 arrested cells in mitosis, 
whereas cotransfection of Mad2 with GFP-MBP1 but not a control peptide abolished the 
arrest. Similar results were observed upon cotransfections using full length Mad1 or 
fragments containing the Mad2 binding motif, but not with constructs lacking this domain. 
This result is in agreement with previous results in fission yeast and Xenopus (Chen et al., 
1998; Fang et al., 1998; He et al., 1997), but not with the results obtained by Sironi and 
colleagues (Sironi et al., 2001). This discrepancy might be explained by different expression 
levels, as we could not observe any cell cycle arrest upon GFP-hMad2 or HA3-hMad2 
overexpression in HeLa cells either. 
Analysis of Mad2 NMR-spectra after addition of either Cdc20P1 or Mad11 showed a 
dramatic chemical shift as compared to free Mad2. As expected, the spectra of Mad2-
Cdc20P1 and Mad2-Mad11 were very similar, indicating that the two complexes posses 
similar structures. Comparison of the different structures indicated that Mad2 undergoes a 
large conformational change upon Mad1 or Cdc20 binding. 
The authors therefore suggest a model in which Mad2 is recruited to the unattached 
kinetochores via the Mad1-Mad2 interaction, which is indeed consistent with the results 
obtained in Xenopus (Chen et al., 1998) as well as with our own results. They then speculate 
that Mad1-bound Mad2 protein is transferred to Cdc20 by an unknown mechanism, allowing 
efficient formation of the inhibitory complex containing Mad2-Cdc20. Furthermore, they 
suggest that other checkpoint proteins weaken the interaction between Mad1 and Mad2, and 
allow faster turnover of Mad2 on Mad1, thus promoting the transfer of Mad2 from Mad1 to 
Cdc20. Two interesting candidates would be Mps1, which phosphorylates Mad1 upon 
checkpoint activation in yeast (Hardwick et al., 1996), and Bub1, which can phosphorylate 
hMad1 in vitro (Seeley et al., 1999), but other potential modifications should not be ruled out. 
According to the available data, Luo and colleagues (Luo et al., 2002) suggest that 
Mad1 could perform two functions: first to convert Mad2 to a form that is more compatible 
for Cdc20 binding and second to recruit Mad2 to the kinetochores. They point out that maybe 
the first function is not checkpoint regulated, as the Mad1-Mad2 interaction exists throughout 
the cell cycle (Chen et al., 1999), whereas the second could be regulated. However, we should 
note that unattached kinetochores are present not only upon checkpoint induction, but they 
occur every cell cycle, during prophase and prometaphase, exactly when these two proteins 
are found at kinetochores; therefore we propose that the targeting function of Mad1 could be 
also not checkpoint regulated. 
 
Another intriguing question about the potential role of Mad1 as a Mad2 “activator” is 
that Mad2 can induce a mitotic arrest in a Mad1 independent manner (Chen et al., 1998; Fang 
et al., 1998; He et al., 1997), suggesting that Mad2 can bind Cdc20 without previous binding 
to Mad1. One interesting possibility is that Mad2 is a dual function protein, needed to activate 
or inactivate both Cdc20 and Mad1 (and perhaps some other proteins sharing a similar motif). 
In other words, Mad2 could be a cofactor necessary for other proteins to modulate their 
activity. In the case of Cdc20, when it is bound to Mad2, is in an inhibited state, and cannot 
perform its activating function on the APC/C. About Mad1, one possible scenario is that 
Mad2 binding is keeping Mad1 in an inactive state (during most of the cell cycle) and upon 
microtubule attachment, some changes would release this interaction, allowing Mad1 to 
perform an unknown function: maybe to form a complex Bub1-Bub3-Mad1 (Brady and 
Hardwick, 2000; Seeley et al., 1999). 
Similarly, it is currently unknown why these proteins are localized at unattached 
kinetochores. The simplest explanation is that they are concentrated in this location in order to 
sense lack of attachment, and signal to terminate the cell cycle arrest when the attachment and 
tension are achieved. However, the molecular details of this mechanism need further studies 
to be completely understood. 
 
 
Part II: Search for novel  interacting partners of hMad1wt 
using  the yeast  two-hybrid system. 
Introduction 
 
 As outlined in the general introduction, the spindle assembly checkpoint is a 
surveillance mechanism that is able to delay the metaphase to anaphase transition in response 
to a variety of defects. However, the molecular mechanisms underlying this checkpoint are 
not fully understood. Summarizing the current literature, there are four mayor structures to 
take in consideration: 
 
• The spindle assembly checkpoint components themselves: how and when do they 
interact? How many different complexes are formed and in which order do they function? 
• The centromere-kinetochore and its components, intrinsic and transient. Intrinsic 
components should be considered as the scaffold on which the transient components are 
assembled. The complete protein network that provides the linkage between core 
kinetochore components and more transient ones has not been established yet in  any 
organism. 
• The spindle itself, consisting of microtubules, whose plus ends attach to kinetochores 
during mitosis, and associated proteins, such as motors and other regulatory proteins. 
Similarly, these proteins should be linked to the kinetochore components,  but the nature 
of these connections  is not currently well understood. 
• Both sister chromatids, held together through the cohesin complex, the “glue” that is the 
final target to be dissolved to allow the cell to enter anaphase. Here again, despite the 
interesting relationship between the kinetochore and cohesin, the molecular link between 
these complexes has not yet been defined. 
• Interactions amongst the spindle checkpoint components 
 
 Some distinct subcomplexes have been identified, yet the significance of most of them 
remains to be understood (see figure 3). In brief, the following interactions have been 
reported: 
 
• Mad1-Mad2 form a stable interaction all along the cell cycle in yeast and metazoans 
(Campbell et al., 2001; Chen et al., 1998; Chen et al., 1999; Jin et al., 1998a; Luo et al., 
2002; this study).  
• Mad2-Cdc20 form an inhibitory complex, keeping the APC/C inactive (Fang et al., 1998; 
Kallio et al., 1998; Kim et al., 1998; Li et al., 1997). 
• Bub3-BubR1-Mad2-Cdc20 (Hardwick et al., 2000; Hwang et al., 1998; Sudakin et al., 
2001) has been reported also to inhibit APC/C activity, independently of BubR1 kinase 
activity. Tang et al. (2001) identified a similar complex as Bub3-BubR1-Cdc20. 
• Bub3-BubR1-CENP-E (a kinesin-like protein) form a complex in HeLa cells, and BubR1 
seems to be required for mitotic arrest resulting from loss of CENP-E function (Chan et 
al., 1999). 
• Mad1-Bub1-Bub3 form a complex both in yeast and metazoans (Brady and Hardwick, 
2000; Seeley et al., 1999). In yeast this complex seems to be crucial for spindle 
checkpoint function. 
• Mps1 in Xenopus has been shown to be required for recruitment and retention of active 
CENP-E at kinetochores (Abrieu et al., 2001). It also seems to be necessary for 
recruitment of xMad1/xMad2 to the kinetochores. In yeast, Mps1 has been shown to 
phosphorylate scMad1 (Hardwick et al., 1996), but it  is not known whether this 
modification of scMad1 is required for spindle checkpoint activation. 
 
Interestingly, not all these components assemble simultaneously onto the kinetochores: for 
instance, hBub1 and hBubR1 bind sequentially to kinetochores (Jablonski et al., 1998). In this 
report, it was shown that in the human U2OS osteosarcoma cell line hBub1 first appeared at 
kinetochores during early prophase, before all the kinetochores were occupied by hBubR1 or 
CENP-F. CENP-F is a nuclear matrix protein that associates with the nascent kinetochore 
during late G2 and is proposed to participate in the early steps of kinetochore assembly (Liao 
et al., 1995).  Both hBub1 and hBubR1 differ from Mad1 and Mad2 in that they remain at 
kinetochores in low levels until anaphase. The same result has been observed for xBub1 
(Sharp-Baker and Chen, 2001). In this report it was shown that immunodepletion of xBub1 
abolishes the spindle checkpoint and the kinetochore binding of the checkpoint proteins 
xMad1, xBub1, xBub3 and CENP-E. It is interesting to note that the reintroduction of either 
wild-type or a kinase-dead mutant version of xBub1 restored the checkpoint function, as well 
as the kinetochore localization of these proteins. This would argue that Bub1 is a scaffold 
protein, essential for checkpoint function. 
However, how these subcomplexes interact and when exactly they function in mitosis, 
remains to be determined. 
The centromere-kinetochore: intrinsic and transient components 
 
 The centromere is the primary constriction of the mitotic chromosome, the origin from 
which the recombination distances are measured and the site of formation of the kinetochore, 
the proteinaceous structure at the chromosomal surface that binds spindle microtubules and 
regulates chromosome movement during mitosis. Although centromere functions are 
conserved, centromeres show high structural variation amongst species, but they can be 
divided into two broad classes: there are holocentric chromosomes (present in C.elegans, in 
many arthropods and in plants), where microtubules attach all along the chromatid, and 
chromosomes with localized centromeres, where microtubules attach to a specialized region. 
Two classes of localized centromeres can be defined: point centromeres (identified in 
S.cerevisiae, Schizosaccaromyces uvarum and Kluyveromyces lactii) and regional 
centromeres, present in S.pombe and in vertebrates (see Craig et al., 1999; Kitagawa and 
Hieter, 2001; Pluta et al., 1995 for review). 
Point centromeres 
 
 The point centromere in budding yeast is a 125-base-pair region containing three 
conserved elements: CDEI, CDEII and CDEIII. CDEI binds a protein called Cbf1, which 
mediates both transcriptional regulation and chromosome segregation. Neither CDEI nor Cbf1 
is essential for viability. CDEII is an A-T rich region that seems to serve as spacer between 
CDEI and CDEIII. The primary sequence is not conserved, but the length seems to be 
important for centromeric function. Genetic data suggest that there could be a physical 
interaction between CDEII and Cse4, a histone-H3 variant that associates with centromeric 
DNA in vivo.CDEIII is the only essential region, and it is the binding site for an essential 
protein complex, termed CBF3. Mutations within this region or in genes encoding the CBF3 
components abolish centromeric function and disrupt chromosome segregation. CBF3 is a 
complex which contains four main components: Ndc10 (Ctf14, Cbf2), Cep3 (Cbf3b), Ctf13 
and Skp1.The point centromere is packaged into a compact nuclease-resistant chromatin 
structure of about 250 bp that binds a single microtubule. Several findings suggest a model in 
which this structure maybe assembled around a modified nucleosome. This model predicts 
that CDEI and CDEIII might be juxtaposed in space. 
Regional centromeres 
 
 This class of centromeres encompasses kilobases of DNA, and includes both unique 
and repeated DNA elements (α-satellite DNA), whose organization can exhibit considerable 
polymorphisms amongst strains (as in S.pombe) or individuals (as in humans). Some data 
suggest that transcriptional suppression and centromeric function are mechanistically linked. 
In regional centromeres, bundles of microtubules bind to this region, and it is not clear 
if they are associated with specific DNA sequences, as in point centromeres, or if the regional 
centromere adopts a three-dimensional configuration that nucleates the assembly of a 
proteinaceous kinetochore. It also seems that centromere function may require not only a 
minimal set of sequences, but also the acquisition of specific epigenetic modifications by 
those sequences. The essentially identical composition of the mitotic kinetochore in 
neocentromeres (a fully functional centromere found on rearranged chromosome fragments 
that have separated from endogenous centromeres and contain no -satellite DNA) and 
normal centromeres, and the complete absence of a kinetochore from inactive centromeres, 
suggests that once the epigenetic mark is in place, kinetochores assemble during mitosis in an 
'all or nothing' coordinated cascade of protein interactions, regardless of the underlying DNA 
sequence. The presence of proteins such as PARP-1 and SUV39H in active centromeres 
suggests that post-translational modifications (such as poly-ADP riybosylation of possible 
substrates such as histones, or methylation of histone H3) could be important for centromeric 
function. Alternatively, histone H3 could be completely replaced by CENP-A at kinetochores 
(Warburton, 2001). 
It is worth noting that the sequence variability of centromeric DNA sequences 
amongst species is extraordinarily high. Only one centromeric sequence is known to be 
conserved between primates and rodents, and this is the binding site for CENP-B. However, 
mice lacking CENP-B protein apparently do not have significant problems with chromosome 
segregation. Nonetheless, de novo centromere formation has been observed only on -satelli e 
DNA that contains CENP-B binding sites, suggesting that CENP-B might facilitate or 
stabilize centromere formation. 
t
Kinetochore proteins in vertebrates 
 
Vertebrate kinetochores are trilaminar structures, which assemble onto the centromeric 
region, on both sister chromatids during G2/M. The kinetochore organization can be 
described in layers, from the inner centromere towards the outer centromere (see table 6).  
Intrinsic centromere components are those proteins that bind to the centromere 
throughout the cell cycle. They were first identified as autoantigens recognized by sera of 
certain patients with scleroderma spectrum disease. These sera are sometimes referred as 
CREST sera or ACA (anti-centromere antibodies). Five intrinsic centromere components have 
so far been identified: CENP-A (a histone-H3 related protein), CENP-B (a DNA-binding 
protein of the centromeric heterochromatin) and CENP-C (a DNA-binding protein of the 
inner kinetochore plate) were the first identified. Both CENP-A and CENP-C colocalize and 
are required for kinetochore assembly and for cytoplasmic dynein tethering to the 
kinetochores in the presence of microtubules. CENP-B function, however, remains obscure. 
CENP-G is unrelated to known proteins, and it seems to be associated with the CENP-B box 
(the binding site for CENP-B). However, CENP-G has been also localized in neocentromeres, 
which lack -satellite-DNA sequences. This would indicate that CENP-G may be an essential 
factor in centromeric function (Gimelli et al., 2000). CENP-H is the last intrinsic protein 
described (Fukagawa et al., 2001). It seems to be necessary for CENP-C localization, but not 
of CENP-A, to the centromere. According to the data available, centromere assembly in 
vertebrate cells proceeds in a hierarchical manner, in which the localization of CENP-A is an 
early event that occurs independently of CENP-C and CENP-H. 
 
Table 6: kinetochore structure in mammals (Craig, Earnshaw and Vagnarelli, 1999; Kitagawa and Hieter, 2001) 
 Centromeric  
heterochrom 
Inner plate Interzone Outer plate Fibrous 
corona 
Components α-Satellite 
DNA 
CENP-B 
INCENP 
Outermost 
DNA 
CENP-A 
CENP-C 
CENP-G 
3F3/2 
antigens 
CENP-F 
hBUBR1 
Hec1 
hNuf2 
Ch-TOG 
Clip-170 
CENP-E 
cytoplasmic- 
dynein 
Function Sister 
chromatid 
cohesion 
Structural 
support 
Kinetochore 
assembly 
Tension 
receptors? 
Microtubule 
binding 
Cell cycle 
signaling 
Microtubule 
binding 
Anaphase 
motors 
 
In addition to intrinsic proteins, kinetochores contain a number of other proteins, 
which associate with chromosomes only transiently during the cell cycle. CENP-F is a protein 
of the nuclear matrix synthesized in early G2, which relocalizes to the kinetochores in late G2 
(Liao et al., 1995). It seems to play a role in kinetochore assembly, and is rapidly degraded 
after mitosis, in an APC/CCdh1 dependent manner (Sorensen et al., 2000). Some of these 
transient kinetochore proteins belong to the chromosome passenger family (INCENP, 
AuroraB, survivin). They appear to use the centromere as an area through which they must 
transit prior to detaching from the chromosome and performing cytoskeletal functions 
elsewhere during the closing stages of mitosis.  
A different group of proteins are motors or microtubule-binding proteins, and in this 
category we find CENP-E, MCAK (two kinesins), the dynactin complex, CLIP-170 and 
EB1/APC (adenomatous polyposis coli). 
Finally, another group is comprised of proteins involved in cell cycle regulation, 
basically in the spindle assembly checkpoint: Mad1, Mad2, Bub1, Bub3, BubR1, Zw10, Rod 
and Cdc20. 
One particularly interesting kinetochore protein is Hec1 or HEC (highly expressed in 
cancer). This protein was first isolated through its interaction with the retinoblastoma protein 
(Rb) in the yeast two-hybrid system (Chen et al., 1997). Hec1 mRNA  was found to be 
abundantly expressed in rapidly dividing cancer cells, and Hec1 was expressed in actively 
dividing cells but not in terminally differentiated cells. By immunofluorescence, Hec1 was 
localized to the nucleus in interphase cells, and to the centromere during mitosis. However, 
the corresponding homologue in budding yeast (Ndc80p or Tid3p) was first isolated by 
MALDI mass spectrometric analysis of proteins associated with the spindle pole body (Wigge 
et al., 1998). Yet the mutant phenotype observed was similar to a temperature sensitive 
mutant of Ndc10p, a component of the yeast kinetochore. Recently, the kinetochore 
localization of Ndc80p in yeast has been confirmed by three independent groups (He et al., 
2001; Janke et al., 2001; Wigge and Kilmartin, 2001), indicating that Ndc80p is indeed 
similar to Hec1 in animal cells.  
 
Microtubules, motors and microtubule binding proteins during mitosis 
Molecular motors 
 
 During mitosis, microtubules form a specialized structure, the spindle. Some 
microtubules randomly hit the kinetochore, and are subsequently stabilized through this 
interaction. The kinetochore can recruit progressively more microtubules, and a kinetochore 
fiber (K-fiber) is formed, anchoring the chromosome to the centrosome. One chromosome has 
two sister kinetochores back to back, and that leads to chromosome bi-orientiation, in which 
one chromosome is connected to both spindle poles, through the K-fibers. Microtubules that 
are not attached to kinetochores interact either with chromosome arms or with microtubules 
emanating from the opposite pole. As a result of these interactions, chromosomes are 
subjected to opposing forces, and the combination of these forces produces chromosome 
movement between opposite poles, leading to congression at the metaphase plate (see Sharp 
et al., 2000; Brunet and Vernos, 2001 for review). Some of these forces are exerted on the 
chromosome arms (the polar ejection forces) and correlate with the efficiency of chromosome 
alignment and stabilization at the metaphase plate. Recently, a motor protein has been 
identified as a good candidate for generating the polar ejection force, Xkid (Antonio et al., 
2000; Funabiki and Murray, 2000). Although Xklp1 (in Xenopus) and Nod (in Drosophila) 
also colocalize with chromosome arms, they seem to function as “docking” motors that set 
and maintain microtubule-chromatin interactions, but do not generate movement. However, in 
a recent report (Levesque and Compton, 2001), the role of the chromokinesin Kid in 
chromosome movement in human somatic cells was tested using time-lapse video 
microscopy. According to the results of this study, Kid is required for generating the polar 
ejection force that pushes chromosomes away from the pole, but it was also shown that this 
force is not absolutely essential for chromosome congression.  
 A second way of force generation along the spindle is by motor-driven microtubule 
sliding: motors could crosslink and slide overlapping antiparallel microtubules within 
interpolar microtubule bundles to position spindle poles in relation to one another. Current 
evidence indicates that motors actually use two distinct forms of this “sliding filament 
mechanism” during mitosis: sliding adjacent microtubules in relation to each other and sliding 
astral microtubules in relation to the stationery cell cortex. Kinesins involved in this 
movement belong to the bimC family. Members of this kinesin subfamily form bipolar 
homotetramers, with two motor domains positioned at opposite ends of a central rod, 
indicating that they generate force along adjacent microtubules simultaneously. Functional 
inhibition of bipolar kinesins results in vivo in the formation of spindles with abnormally 
close poles (Blangy et al., 1995; Sawin et al., 1992; Sharp et al., 1999). 
 Most of the movements to which the chromosome is subjected are exerted through the 
K-fiber. That implies that kinetochores must establish and maintain stable attachments to 
dynamic microtubule plus ends that, prior to anaphase, alternatively depolymerize and 
polymerize, and during anaphase, depolymerize at both kinetochores. Therefore, amongst the 
kinetochore proteins some must function in microtubule attachment, in regulating microtubule 
dynamics and in generating movement. 
 Motors are the first candidates for generating the forces exerted at the kinetochores, 
and three motors are currently known to localize at kinetochores and have been studied for 
such functions: dynein, CENP-E and MCAK. 
 Dynein was the first motor found at the kinetochores, and it has been shown that it is 
responsible for the first poleward movement of chromosomes that occurs immediately after 
the first capture of microtubules by kinetochores (Rieder and Alexander, 1990). But  the role 
of this movement in chromosome congression is unclear. Dynein seems to be mainly active 
during anaphase,  when it is necessary for poleward movement of chromosomes (Sharp et al., 
2000). Interestingly, it has been shown that two spindle checkpoint proteins, Rod and Zw10, 
help to recruit dynein and dynactin to the kinetochore (Starr et al., 1998). The Dynein-Zw10-
Rod complex has been shown to move on the kinetochore fiber towards the spindle pole when 
chromosomes are subjected to tension (Scaerou et al., 1999; Williams et al., 1996), 
suggesting that dynein could play a role in the spindle checkpoint machinery. It has been also 
shown  that, in the absence of Rod and Zw10 the kinetochore localization and probably the 
function of other checkpoint proteins are not impaired (Mad2, BubR1), indicating that the 
dynein-Zw10-Rod could be part of an independent branch of the checkpoint machinery (Chan 
et al., 2000). However, in grasshopper spermatocytes it has been shown that dynein 
association with kinetochores depends on K-fiber attachment, and not tension (King et al., 
2000), indicating that the role of dynein on the checkpoint could be more complex than 
expected. 
 CENP-E is a kinesin that is required for chromosome alignment on the metaphase 
plate (Schaar et al., 1997; Wood et al., 1997). However, as it moves towards the plus end of 
the microtubules, it cannot be responsible for the poleward movement of chromosomes. 
Furthermore, its inhibition does not impair the movement of bioriented chromosomes before 
metaphase (Schaar et al., 1997). In vitro experiments suggest that CENP-E participates in the 
formation and stabilization of the K-fibers, and in the maintenance of the attachment of 
kinetochores to depolymerizing microtubule plus ends during poleward motion (Lombillo et 
al., 1995; Wood et al., 1997; Yao et al., 2000). CENP-E has also been shown to play a role in 
the spindle assembly checkpoint: antibodies microinjected against the non-motor domain of 
CENP-E inhibit metaphase transition (Yen et al., 1991). This arrest requires BubR1, with 
which CENP-E interacts directly (Chan et al., 1999). However, CENP-E is not required for 
kinetochore localization of BubR1 or Mad2  in somatic cells (Yao et al., 2000). In contrast, in 
Xenopus egg extracts CENP-E is required for Mad2 recruitment to the kinetochores (Abrieu et 
al., 2000). Interestingly, in Drosophila two isoforms of CENP-E have been found, meta and 
ana (Yucel et al., 2000) supporting the idea that maybe the embryonic form could be 
performing the functions of different motors in somatic cells. 
MCAK/Xkcm1 is another kinesin-related protein that does not function as a 
conventional motor. It seems to promote microtubule depolymerization (Desai et al., 1999; 
Walczak and Mitchison, 1996). This would suggest that MACK is involved in shortening of 
microtubule plus ends during poleward chromosome movement. Inhibition of MACK 
function does not impair congression, but chromosome segregation during anaphase (Maney 
et al., 1998), indicating that MCAK may be essential only during anaphase.  
Other microtubule-binding proteins 
 
Distinct from motors, there are other microtubule-binding proteins (MBPs) which 
have been found at the kinetochore during mitosis: CLIP-170 and EB1/APC. 
CLIP-170 is a protein that binds specifically to the plus ends of microtubules (Perez et 
al., 1999), localizing at the kinetochores during mitosis (Dujardin et al., 1998). It has been 
shown that CLIP-170 recruits dynactin to the microtubule plus ends (Valetti et al., 1999). and 
plays a role in the establishment of the metaphase plate (Dujardin et al., 1998). An  
overexpressed COOH-terminal domain of CLIP-170 localizes to the kinetochores and causes 
endogenous full-length CLIP-170 to be lost from the kinetochores, resulting in a delay in 
prometaphase. Overexpression of p50/dynamitin, one of the components of the dynactin 
complex, strongly reduced the amount of CLIP-170 at the kinetochores, suggesting that 
dynactin could be responsible of CLIP-170 targeting to the kinetochores.  
Human EB1 also interacts with the plus end of microtubules, and was initially cloned 
as a protein that interacts with the COOH terminus of APC (Su et al., 1995). Due to mutations 
in APC, this interaction is often disrupted in colon cancer. Since APC is detected on the 
kinetochores during mitosis, it has been proposed that the EB1-APC interaction connects 
microtubules to the kinetochores and regulates microtubule stability (Fodde et al., 2001; 
Kaplan et al., 2001). Indeed, it has been shown that EB1 promotes microtubule 
polymerization in vitro and in permeabilized cells, but only in the presence of the COOH-
terminal of APC (C-APC), which is the binding domain for EB1 (Nakamura et al., 2001). 
Furthermore, C-APC is able to promote microtubule polymerization when stably expressed in 
APC mutant cells, demonstrating the ability of C-APC to promote microtubule assembly in 
vivo. Interestingly, cells expressing mutant APC that lacks the C-terminal domain are prone 
to errors in chromosome segregation and develop aneuploidy (Fodde et al., 2001; Kaplan et 
al., 2001). Human EB1 can be coprecipitated with p150Glued, a member of the dynactin 
complex and it was found associated also with dynamitin (p50), another component of the 
complex, but not with dynein heavy chain (Berrueta et al., 1999). This association of EB1 
with the dynactin complex is independent of APC. It has also been shown that APC co-
immunoprecipitates with both Bub1 and Bub3 from lysates of mitotically arrested, but not 
asynchronous HeLa cells (Kaplan et al., 2001). Recombinant complexes containing Bub1-
Bub3 or BubR1-Bub3, and also Bub1 isolated from mitotic HeLa cells, are able to 
phosphorylate APC, and in vitro reactions using mutant forms of these kinases  with reduced 
activity were less effective in APC phosphorylation. However, cell lines with mutant APC (as 
HT29) still have an active spindle checkpoint, indicating that APC is not a component of this 
machinery. It has therefore been proposed that the phosphorylation of APC by Bub kinases is 
involved in regulating kinetochore-microtubule attachment. Interestingly, it has been shown 
that C-APC activity is abolished by phosphorylation, which also disrupts its ability to bind 
EB1 (Nakamura et al., 2001). 
Sister chromatids cohesion: are centromeres involved? 
 
 For a number of years, it was assumed that physical intertwining of centromeric DNA 
was responsible for holding sister chromatids together and that sister chromatids separation 
might be regulated through the activity of DNA topoisomerase II. Using data from genetic 
experiments, antibody microinjection and drug studies in vitro and in vivo, it seems clear that 
topoisomerase II is required for separation of sister chromatids. Furthermore, topoisomerase II 
has an important role in kinetochore assembly (see Craig et al., 1999 for review). However, 
studies in yeast with mutant forms of topoisomerase II showed that chromosomes tend not to 
break during anaphase, suggesting that physical intertwining is not the only mechanism 
holding sister chromatids together. 
 As it was discussed in the general introduction, recent studies identified a key role for 
SMC family proteins (the cohesin complex) and their regulators in this process. In 
vertebrates, the bulk of the cohesins are released early in prophase in an APC/C independent 
manner (Sumara et al., 2000), but it has been shown that a small amount of Scc1 remains at 
the kinetochores until metaphase (Losada et al., 2000). However, as it has been pointed by  
Kitagawa and Hieter (2001), “despite the interesting relationship between the kinetochore and 
cohesin, the molecular link between these complexes has not yet been defined”. 
 
Results 
Two-hybrid screen using hMad1wt as a bait 
 
 Aiming to define some of the unknown molecular components of the spindle 
checkpoint, we decided to use hMad1 to screen for interacting proteins using a yeast two-
hybrid approach. Out of 1,4x105 transformants, we obtained 39 different clones, which were 
sequenced. Homology searches using BLAST and ClustalW allowed us to identify 26 known 
proteins, 8 unknown proteins and 2 clones out of frame (3 did not grow and were lost). After 
computer analysis of these sequences, we defined 19 potential candidates. The results are 
summarized in Table 7. 
 As can be observed, both hMad2 and two independent fragments of hMad1 itself were 
obtained as interacting partners of hMad1 in our screen, suggesting that hMad1 could 
oligomerize in vivo. This result is consistent with a previous report using a similar bait (Jin et 
al., 1998).  
 
Table 7: A. Known proteins identified in the Two-hybrid screen using hMad1wt as a bait. B. unknown proteins 
identified in the same screen. 
  
No. Identification MW Localization Structure Comments C
Mi-01 hMad1 from 572 90 kD Nuclear 
Coiled-coil, 
leucine zipper, 
NLS 
 
Mi-06 
hBRCA1 assoc. 
prot.: BRAP 
67 kD Cytoplasmic  
May regulate 
nuclear 
localization 
Mi-09 
Hs p45 ATPase 
proteasome subunit 
45 kD 
Pred.: 
cytoplasmic 
Coiled-coil at 
N-term., 
leucine zipper 
 
Mi-10 
Hs HCAP or 
hSMC3 
142 kD 
Mitotic 
chromosomes 
SMC structure, 
coiled-coil, 
leucine zipper 
Involved in 
progression of 
metaphase 
Mi-18 Hs Prer protein 66 kD Nuclear dots NLS at C-term.  
Mi-20 hMad1 from 1487 90 kD Nuclear 
Coiled-coil, 
leucine zipper, 
NLS 
 
Mi-30 hMad2 24 kD 
Nuclear, 
kinetochores 
  
Mi-34 
Hs Hec1 (Highly 
Expressed in 
Cancer 1) 
74 kD 
Nuclear, 
centromeres 
Leucine heptad 
repeats, 2 
coiled-coils 
Involved in 
chromosome 
segregation, 
interacts with 
Rb, SMC, 
MSS1 and p45 
Mi-59 Hs CENP-F 74 kD 
Nuclear matrix,
kinetochores 
2 coiled-coils, 
9 leucine 
zippers, P-loop 
nucleotide 
binding 
Interacts with 
CENP-E 
(which 
interacts with 
BubR1) Table 7Alones Identities 
3 703/712 
1 560/561 
6 684/691 
2 660/663 
2 595/601 
1 649/665 
1 455/455 
1 443/445 
1 630/664 
No. Identification MW Localization Structure Comments Clones Identities 
Mi-68 
Hs Ki proteasome 
subunit 
400 kD 
Pred.: 
cytoplasmic 
  1 601/646 
Mi-88 
Hs Ubc9 (SUMO 
conjugating E) 
18 kD Pred.: nuclear  
3 independent 
clones fished 
5 606/616 
Mi-93 
Hs N-myc and 
STAT interactor 
35 kD Nuclear  
High 
expression in 
cancer cell 
lines 
3 547/559 
 
 
 Table 7B 
No. Identification Comments Clones Identities 
Mi-26 Hs PAC clone 
ESTprot: potential zinc finger, similar to replication 
factor 
1 462/464 
Mi-36 Hs KIAA0182 
ESTprot: potential NLS, novel repeat composed of 
alternating Arg and Pro 
5 398/399 
Mi-39 
Hs cDNA clone 
EUROIMAGE 
ESTprot: potential zinc finger, probable nuclear 9 153/154 
Mi-48 THC211630 ESTprot: potential NLS 1 232/232 
Mi-61 FLJ0586 No data 1 385/386 
Mi-74 
Hs cDNA 
FIJ22097 fis 
ESTprot: potential similarity to myosin 1 74 
Mi-77 Hs KIAA1328 
ESTprot: potential similarity to CLIP-170 and 
predicted nuclear 
1 639/660 
 
 
 In order to rule out a potential unspecific interaction due to the presence of coiled-coil 
motifs, all the potential interacting proteins were tested against DBD-hMad1wt, DBD-GM130 
(C-term: coiled-coil region, Barr et al., 1998) and an empty DBD vector (pGBDO).  A few 
proteins showed unspecific interaction with DBD-GM130, and therefore were excluded from 
further consideration. Results are summarized in Table 8. 
 
Table 8: potential hMad1 interacting (MI) clones identified in the Y2H screen. +(*): poor growth. 
 Mad1 pGBDO GM130 No. Identification Clones 
1 + - - Mi-01 hMad1 from 572 3 
 Mad1 pGBDO GM130 No. Identification Clones 
2 (+) - - Mi-06 hBRCA1 assoc. prot.: BRAP 1 
3 + - (+) Mi-09 
Hs p45 ATPase proteasome 
subunit 
6 
4 +(*) - - Mi-10 Hs HCAP or hSMC3 2 
5 + - - Mi-18 Hs Prer protein 2 
6 Bad growth - - Mi-20 hMad1 from 1487 1 
7 ++ - - Mi-30 hMad2 1 
8 + - - Mi-34 
Hs Hec1 (Highly Expressed in 
Cancer 1) 
1 
9 ++ - - Mi-59 Hs CENP-F 1 
10 + - (+) Mi-68 Hs Ki proteasome subunit 1 
11 (+) - - Mi-88 Hs Ubc9 (SUMO conjugating E) 5 
12 + - - Mi-93 Hs N-myc and STAT interactor 3 
13 (+) - - Mi-26 Hs PAC clone 1 
14 +(*) - - Mi-36 Hs KIAA0182 5 
15 + - - Mi-39 Hs cDNA clone EUROIMAGE 9 
16 + - - Mi-48 THC211630 1 
17 ++ - ++ Mi-61 FLJ0586 1 
18 ++ - - Mi-74 Hs cDNA FIJ22097 fis 1 
19 + - - Mi-77 Hs KIAA1328 1 
20 - - +++ control GRASP (Nterm) ---- 
 
Interestingly, some other kinetochore proteins were also identified, mostly Hec1 (or 
HEC in some reports), Smc3 and CENP-F, as well as Ubc9.  
Mapping the interaction domain in hMad1 
 
 In order to identify the regions in hMad1 necessary for binding to the above proteins, 
we performed two-hybrid interaction assays using the same set of constructs used to map the 
interaction with hMad2. As can be observed in the scheme (Fig.15), none of the proteins 
tested map to the same region as Mad2, indicating that Mad2 interaction could occur 
simultaneously with the other potential interactions. 
The region in hMad1 (residues 202 to 379) that interacts with Hec1 is close to the NLS 
(nuclear localization signal). Smc3 shows similar results than Hec1, but CENP-F only 
interacts with the hMad1 construct lacking a small carboxy-terminal fragment (∆C) 
suggesting that interaction might occur through several regions. 
Hec1 is a kinetochore protein 
 
 One of the potentially most interesting candidates for a hMad1 interacting protein was 
Hec1, whose homologue in yeast, Ndc80, has been implicated in microtubule attachment and 
is part of a complex that has been shown to be important for kinetochore clustering and 
checkpoint function (He et al., 2001; Janke et al., 2001; Wigge and Kilmartin, 2001). 
 We thus prepared antibodies in rabbits, using different Hec1 constructs, either the wild 
type (rabbits wt1, wt2), a carboxy-terminal fragment (rabbits c1, c2) or an internal fragment 
(rabbits k1, k2). All  sera were tested by immunoblot on HeLa extracts (from nocodazole 
arrested cells) and on recombinant MBP-Hec1 (Fig.  16A). All antibodies showed similar 
capacity to pull-down HA3-Hec1 after in vitro translation (IVT) in reticulocyte lysates, 
whereas no signal was detected when HA3-Bub1 was used (Fig.16B). 
 One of these antibodies (wt2) appeared to be very specific by immunoblot. When 
tested by immunofluorescence on HeLa cells, the signal was also very  specific. We used this 
antibody to characterize Hec1 localization throughout the cell cycle (Fig.17). As can be 
observed in these figures, using CENP-B as counterstaining, Hec1 stays on the kinetochores 
from prophase until telophase. This indicates that microtubule attachment does not affect 
kinetochore localization of Hec1, whereas hMad1 is released when kinetochores are properly 
attached to microtubules (see Fig.9 for comparison). That means that Hec1 and hMad1 only 
colocalize during prophase-prometaphase, after which hMad1 is released from this location at 
the same time as hMad2. 
BA 
Depletion of Hec1 produces hMad1 release from kinetochores during mitosis 
 
 To test the potential interaction Mad1-Hec1 in vivo, we used gene silencing by small 
interfering RNA (siRNA) duplexes (Elbashir et al., 2001). Prior to performing these 
experiments, we tested in mock-treated cells that checkpoint proteins were properly localized 
during mitosis (Fig.18).  
To deplete Hec1 levels, HeLa S3 cells were transfected with a 21-nucleotide duplex 
homologous to a region of the Hec1 sequence, and 42h later, cells were fixed and processed 
for immunofluorescence. Transfection efficiency in these experiments was about 90%. 
Silencing of the gene was confirmed after 42h treatment with the Hec1 siRNA duplex (by 
immunofluorescence, Fig. 19B and also by immunoblot, see Fig.22C), whereas no reduction 
in Hec1 levels were observed in control cultures stained with anti-Hec1 antibody (fig. 19A). 
When Hec1-depleted cells were analyzed using an anti-hMad1 antibody, no signal at 
the kinetochores in mitotic cells could be observed (Fig. 19C), whereas this staining was 
normal in control cells (see also Fig.18). Simultaneously, we used anti-CENP-B as a marker 
for kinetochores  which still localizes at kinetochores upon Hec1-p depletion. 
To examine whether the localization of Hec1 is dependent on Mad1, we also tested the 
effect of Mad1 depletion by siRNA. As expected, Mad1 depletion produced loss of Mad2. 
However it did not affect the localization of Hec1 at kinetochores (Fig.20), which places Hec1 
upstream of Mad1-Mad2 in this context.  
Hec1 depletion affects specifically Mad1-Mad2 kinetochore localization 
 
Next we asked if the observed effect was specific for Mad1 or more general, and 
therefore we tested cells treated with the Hec1 siRNA duplex for the localization at mitosis of 
different kinetochore proteins. Specifically we tested the following kinetochore proteins: 
• Mad2, the binding partner of Mad1. 
• Bub1, a kinase that has been found in a complex formed by Mad1-Bub1-Bub3 (Brady and 
Hardwick, 2000; Seeley et al., 1999).  
• CENP-F is a component of the nuclear matrix and it has been shown to interact with 
CENP-E (Chan et al., 1998).  
• CENP-E has been shown to play a role in the spindle checkpoint, as anti-CENP-E 
microinjection inhibits metaphase transition in a BubR1 dependent manner (Chan et al., 
1999; Yen et al., 1991), a protein with which CENP-E directly interacts.  
Hec1-depleted cells showed no detectable Mad2 signal at kinetochores (Fig. 21A). Bub1 
also appeared to be depleted (Fig. 21B), although some remaining labeling could be observed 
on some kinetochores. Most of the kinetochores were positive for CENP-F (Fig. 21C), 
indicating that CENP-F localization at mitosis is independent of Hec1. Interestingly, CENP-E 
localization on kinetochores was not altered in these cells (Fig. 21D). According to these 
results, Hec1 seems to affect the kinetochore localization of Mad1 and Mad2, and to a lesser 
extent Bub1, but not CENP-E or CENP-F. 
We also tested dynactin and EB1 localization in siRNAi-Hec1 treated cells (data not 
shown), and observed that both proteins are still able to localize to spindles and kinetochores, 
indicating that these microtubule binding proteins do not depend on Hec1 to properly localize. 
This suggests that either they can bind directly to kinetochores or that microtubules are still 
attached to kinetochores, and therefore dynactin and EB1 (which bind to microtubule-plus 
ends) are brought to this localization via microtubules. 
Hec1 is required to silence the spindle checkpoint 
Cells treated with Hec1 siRNA show mitotic arrest 
 
Strikingly, in cells treated with the Hec1 siRNA duplex a high percentage of 
prometaphase-like cells was observed (Fig. 22B), with condensed chromosomes and a fully 
assembled spindle, compared to control cells at the same time point (Fig. 22A). This result 
indicates that Hec1 depletion leads to mitotic arrest. Hec1 levels were also tested by 
immunoblotting (Fig. 22C), confirming that the levels of Hec1 were not affected in control 
cells, but strongly reduced within 42h of treatment with the Hec1 siRNA duplex.  
We then quantified the number of cells with condensed chromosomes in both cases, at 
24h and 42h after treatment (Fig. 22D). In cells with Hec1 depleted levels, an increase in the 
mitotic index was already observed at 24h (about 15%), which reached 40% after 42h 
treatment.  
It should be noted that in a normal cell cycle CENP-F is degraded after mitosis in a 
APC/CCdh1 dependent manner (Sorensen et al., 2000). Yet these cells show CENP-F labeling 
on the kinetochores (Fig. 21C), which indicates that the APC/C is inactive, suggesting that in 
Hec1 depleted cells the spindle checkpoint is ON.  
We noted that in cells treated with Hec1 siRNA duplex, 88.3% of the mitotic cells 
observed were in a prometaphase-like stage, as compared to 42% in control cells, suggesting 
that chromosome congression is impaired when Hec1 levels are low. Ndc80 (the homologue 
of Hec1 in yeast) has been implicated in microtubule attachment (He et al., 2001), and 
therefore we wondered if microtubule attachment to kinetochores in Hec1 depleted cells was 
abolished.  We thus performed calcium treatment, which is known to destabilize non-attached 
microtubules (Kapoor et al., 2000). However, upon calcium treatment microtubules were still 
organized in spindles, albeit somewhat abnormal ones (data not shown), indicating that 
microtubule attachment is not completely lost in Hec1 siRNA cells, but rather altered, 
consistent with the failure in chromosome congression.  
The observed mitotic arrest is checkpoint dependent 
 
We then asked if we could abolish the observed mitotic arrest by simultaneous 
depletion of Hec1 and Mad2 and this was indeed the case (Fig. 23A,B, C). We prepared 
extracts from these cells and processed them for immunoblotting (Fig. 23D): Hec1 levels 
were unaffected in control cells, and reduced in cells treated either with Hec1 siRNA duplex 
or with both Hec1 and Mad2 siRNA duplexes. However, Mad2 levels were unaffected in 
control cells or in cells treated with Hec1 siRNA duplex, but reduced in cells treated with both 
Hec1 and Mad2 siRNA duplexes. When quantified (Fig. 23E), we observed that the number 
of cells with condensed chromosomes was strongly reduced in cells treated with both 
duplexes, as compared to cells treated with Hec1 siRNA duplex only. We also performed a 
similar experiment using simultaneously Hec1 and BubR1 siRNA duplexes, and the number 
of cells with condensed chromosomes was also strongly reduced (Fig. 23F). These results 
strongly suggest that the observed arrest is spindle checkpoint dependent. 
As a control, we used laminA oligonucleotides (a kind gift of F.Barr). Transfection of 
laminA alone did not have any effect on cell cycle progression, as opposed to Hec1. As 
indicated before, transfection of Hec1+Mad2 siRNA completely abolished the mitotic arrest. 
Yet when we transfected Hec1+lamin A, cells arrested in mitosis at a similar level to that 
observed for Hec1 alone  
Interestingly, siRNA Hec1 cells arrest in a prometaphase-like state, and therefore the 
checkpoint is active, but no Mad2 is detectable at the kinetochores. This surprising finding is 
in striking contrast with the current model of checkpoint activation, which postulates that 
Mad2 needs to be activated at unattached kinetochores to be able to bind Cdc20. Considering 
the short half-life of the Mad1/Mad2 complex at the kinetochore (Howell et al, 2000), it is 
conceivable that undetectably low levels of kinetochore-associated Mad1/Mad2 complexes 
are sufficient for checkpoint signaling. Alternatively, it is possible that a factor whose 
association with kinetochores does not depend on Hec1 is able to communicate with 
diffusible Mad2 complexes to signal checkpoint activation.  
CENP-E siRNA produces also a mitotic arrest, but does not affect Mad1-Mad2 
kinetochore localization 
 
 The results observed for Hec1 depletion could be explained if Hec1 was implicated in 
microtubule attachment and checkpoint signaling. Data from Ndc80, the yeast homologue of 
Hec1, strongly supports this possibility (He et al., 2001). However, in vertebrate cells a very 
similar role that has been assigned to CENP-E (Yao et al., 2000). Therefore we decided to 
deplete CENP-E by siRNA. 
In CENP-E siRNA treated cells, all Hec1 (Fig.25B), Mad1 (Fig.25C) and Mad2 
(Fig.25D) showed normal kinetochore localization, which was lost for Mad1 and Mad2 when 
chromosomes aligned at the metaphase plate. We also co-stained CENP-E depleted cells with 
anti-CENP-E and anti-Mad2 (data not shown), confirming that Mad2 localization on 
kinetochores does not depend on CENP-E. It is interesting to note that the mitotic figures 
observed in CENP-E siRNA cells were different to the ones observed in Hec1 siRNA cells. 
Whereas loss of Hec1 produces a majority of cells in a prometaphase-like state, loss of 
CENP-E produces many cells in which most of the chromosomes are able to reach the 
metaphase plate, yet some chromosomes are near the spindle poles. This is consistent with the 
fact that CENP-E depletion by antibody microinjection produces a large percentage of cells 
with a robust metaphase plate (McEwen et al., 2001). 
 As observed for Hec1, CENP-E depletion also produces an increase of the mitotic 
index, although less pronounced (Fig.26). This arrest is also checkpoint dependent, as it can 
be abolished upon double siRNA, using either Mad2 or BubR1 together with CENP-E 
depletion.  
In CENP-E siRNA treated cells, all Hec1 (Fig.25B), Mad1 (Fig.25C) and Mad2 
(Fig.25D) showed normal kinetochore localization, which was lost for Mad1 and Mad2 when 
chromosomes aligned at the metaphase plate. We also co-stained CENP-E depleted cells with 
anti-CENP-E and anti-Mad2 (data not shown), confirming that Mad2 localization on 
kinetochores does not depend on CENP-E. It is interesting to note that the mitotic figures 
observed in CENP-E siRNA cells were different to the ones observed in Hec1 siRNA cells. 
Whereas loss of Hec1 produces a majority of cells in a prometaphase-like state, loss of 
CENP-E produces many cells in which most of the chromosomes are able to reach the 
metaphase plate, yet some chromosomes are near the spindle poles. This is consistent with the 
fact that CENP-E depletion by antibody microinjection produces a large percentage of cells 
with a robust metaphase plate (McEwen et al., 2001). 
 As observed for Hec1, CENP-E depletion also produces an increase of the mitotic 
index, although less pronounced (Fig.26). This arrest is also checkpoint dependent, as it can 
be abolished upon double siRNA, using either Mad2 or BubR1 together with CENP-E 
depletion.  
Consistent with our result in this study, it was reported that unattached kinetochores in 
CENP-E depleted cells retain high levels of Mad2. A second report (McEwen et al., 2001) 
indicated that CENP-E is a kinesin-like protein that when depleted from mammalian 
kinetochores leads to mitotic arrest with a mixture of aligned and unaligned chromosomes. In 
that study, immunofluorescence, video, and electron microscopy was used to demonstrate that 
depletion of CENP-E from kinetochores via antibody microinjection reduces kinetochore 
microtubule binding by 23% at aligned chromosomes, and severely reduces microtubule 
binding at unaligned chromosomes.  
On the contrary, there was a study in Xenopus (Abrieu et al., 2000) which showed that 
when CENP-E function is disrupted by immunodepletion or antibody addition, extracts fail to 
arrest in response to spindle damage. Mitotic arrest can be restored by addition of high levels 
of soluble Mad2, demonstrating that the absence of CENP-E eliminates kinetochore-
dependent signaling but not the downstream steps in checkpoint signal transduction. 
Hec1 in cancer: checkpoint disruption? 
 
It was previously reported (Chen et al., 1997) that MS751 is a cervical carcinoma cell 
line showing high levels of Hec1 mRNA expression. However, when we tested the protein 
level of Hec1, we observed that the full-length protein was expressed at about the same level 
of expression than in HeLa cells (which, to our knowledge, does not have high levels of 
Hec1). Nonetheless, it was observed that in this cell line, a second band (around 45kD: 
fig.27E) appeared. Whether or not this band corresponds to a fragment of Hec1, which could 
explain the observations described below, was not further tested. 
 
 Interestingly, when tested by immunofluorescence, the MS751 cell line showed 
normal Hec1 labeling during mitosis, but no kinetochore localization either for Mad1 or 
Mad2, and Bub1 localization was severely disrupted (Fig.27A-D). We do not know for certain 
whether or not the defect in the localization of Mad1, Mad2 and Bub1 is due to the presence 
of this putative fragment of Hec1, because some other mutations could also be involved 
(although it should be noted that overexpression of GFP-Hec1 in HeLa cells produced a 
similar effect, data not shown).  
Independently of the reason behind the observed defect, it was interesting to test if 
MS751 cells were able to activate the spindle checkpoint in the absence of Mad2 at 
kinetochores. Therefore we asked if this cell line had a normal checkpoint response, and  in 
agreement with our results in HeLa cells treated with Hec1 siRNA, MS751 cells showed a 
mitotic arrest upon nocodazole treatment comparable to the response observed in other cancer 
cell lines (Fig.28A). HT29 and LoVo36 are colon cancer cell lines showing chromosome 
instability (CIN) and a robust spindle checkpoint (Tighe et al., 2001), consistent with the 
results shown here. However, when time points were taken every 6h after nocodazole 
addition, it was observed that MS751 cells underwent mitotic arrest with normal kinetics, but 
they showed a sustained arrest even after 42h (Fig.28B). Interestingly, this effect was similar 
in another cancer cell line (LNCaP), which has a mutation in hMad1 (Tsukasaki et al., 2001). 
Then we tested if this effect was dependent on the absence of microtubules, but taxol 
treatment showed a comparable effect (Fig.28C), indicating that the sustained arrest observed 
in MS751 cells is independent on the presence of microtubules. 
Consistent with the data obtained upon depletion of Hec1 siRNA, the results obtained 
in MS751 cells support the idea that steady-state levels of Mad2 at kinetochores are not 
required to establish a spindle-checkpoint dependent arrest. Either a transient and non-
detectable association of Mad2 with kinetochores is sufficient to produce the proposed Mad2 
activation, or alternatively Mad2 does not need to be activated at the kinetochores. Another 
intriguing observation is that MS751 (as well as LNCaP) cells are not able to release the 
mitotic arrest once the spindle checkpoint is activated via nocodazole or taxol addition, 
suggesting that perhaps Mad1-Mad2 localization at kinetochores is required to inactivate the 
spindle checkpoint. 
Discussion 
Survey of candidate proteins interacting with hMad1 
In order to find new interactions relevant to understand the molecular mechanisms 
underlying the spindle checkpoint, we have used a two-hybrid screen approach, using Mad1 
as a bait. Several potentially interesting candidates were identified. Among them, Hec1, 
CENP-F and Smc3 all localize at or near the kinetochores, and for this reason they seem to be 
particularly interesting. However CENP-F localization was not affected when hMad1 was 
depleted by siRNA, and siRNA for CENP-F or Smc3 did not show either a noticeable 
phenotype or Mad1 mislocalization (data not shown). Therefore, our subsequent studies 
focused on Hec1 (see below). 
Ubc9 is also an interesting candidate that could conceivably function on the 
kinetochores. In yeast, SUMO (SMT3) as well as Ulp2 (SMT4: SUMO C-terminal 
hydrolase/isopeptidase) were both originally identified as high-copy suppressors of a mutant 
in the centromere protein Mif2, and yeast Ubc9 interacts in two-hybrid screens with Cbf3p, a 
subunit of the centromere DNA-binding core complex CBF3 (see Melchior, 2000 for review). 
A putative role for SUMO in chromosome segregation is further supported by studies in 
fission yeast. In contrast to S. cerevisiae, Schizosaccharomyces pombe does not absolutely 
require SUMOylation for viability. Neither pmt3 (the gene for SUMO) nor rad31 (S. pombe 
Aos1), nor hus5 (the gene for S. pombe Ubc9) are truly essential. However, disruption of any 
of these three genes leads to high levels of abortive mitosis and loss of minichromosomes, 
defects that would be consistent with a role of these genes in chromosome segregation. 
Furthermore, it has been recently reported that SUMO-1 conjugation targets RanGAP1 to 
kinetochores and mitotic spindles in a microtubule-dependent manner (Joseph et al., 2002). It 
should also be noted that several of the verified SUMO targets (e.g. PML, I B , p53, and 
HIPK2) were initially linked to the SUMOylation pathway through identification of Ubc9 
and/or SUMO1 as binding partners in yeast two-hybrid interaction screens (Melchior, 2000). 
Using Aos1/Uba2, Ubc9, RanBP2 and SUMO-1/SUMO-2 (kindly provided by F.Melchior) in 
reticulocyte lysates, I could not observe any modification on Mad1, whereas RanGAP1 was 
readily modified (data not shown). However, RanGAP1 is one of the best substrates for 
SUMOylation, and modification of other substrates has been shown to be much less efficient 
or dependent on the presence of an E3 ligase (Pichler et al., 2002), indicating that SUMO 
modification of Mad1 might still occur, and this could perhaps be further tested in different 
conditions.  
Hec1, an attractive interacting partner of hMad1 
 
Most of our work on potential novel partners of hMad1 was focused on Hec1, the 
human homologue of yeast Ndc80. We show that Hec1 binding to Mad1 can occur 
simultaneously to Mad1-Mad2 binding, as they interact through different domains in Mad1 
using the two-hybrid system. Hec1 has been shown to be overexpressed in cancer, and it was 
proposed to be involved in chromosome segregation, as antibody microinjection produced 
high numbers of aberrant mitosis (Chen et al., 1997). The yeast homologue, Ndc80, is a 
component of a complex together with Nuf2, Spc24 and Spc25. This complex has been 
implicated in microtubule attachment to kinetochores  (He et al., 2001) and mutant forms of 
Spc24 showed a mitotic checkpoint defect when microtubules were depolymerized with 
nocodazole, indicating that Spc24p has a function in checkpoint control (Janke et al., 2001).  
Here we show that upon depletion of Hec1 using siRNA, Mad1 as well as Mad2 and 
partially Bub1 were not localized at kinetochores of misaligned chromosomes. Yet core 
kinetochore structure was not affected, as other proteins tested (CENP-B, CENP-E, CENP-F, 
dynactin, EB1) were still properly localized. Upon Mad1 depletion using siRNA we observe 
loss of Mad2 but not of Hec1 at kinetochores (Fig.19), which places Hec1 upstream of Mad1-
Mad2.  
Interestingly, Hec1 depletion produced a mitotic arrest in a prometaphase-like stage, 
with all chromosomes unable to align at the metaphase plate. We show that this arrest is 
checkpoint-dependent, as double siRNA Hec1+Mad2 or Hec1+BubR1 but not Hec1+LaminA 
abolished the observed mitotic arrest. This result indicates that Hec1 is required for 
checkpoint silencing, as cells lacking Hec1 are not able to inactivate the checkpoint-induced 
arrest. Consistent with previous data in mammalian cells (Yao et al., 2000, McEwen et al., 
2001), we observe that depletion of CENP-E using siRNA also produces a checkpoint-
dependent arrest. Yet CENP-E depletion does not disturb kinetochore localization of Mad1-
Mad2, which are still present at kinetochores of misaligned chromosomes.  
Taken together, our results suggest that Hec1 is indeed involved in spindle checkpoint 
function via Mad1-Mad2 and that Hec1 and CENP-E are part of parallel pathways involved in 
checkpoint inactivation.  
Hec1 is necessary for kinetochore targeting of Mad1-Mad2 
 
 Our siRNA experiments show clearly that depletion of Hec1 produces mislocalization 
of Mad1 and Mad2 from kinetochores during mitosis, suggesting that Hec1 is required for 
targeting these checkpoint proteins to kinetochores. However, Mad1 depletion using siRNA 
produces loss of Mad2 at kinetochores but not of Hec1 (see Fig.19), which places Hec1 
upstream of Mad1-Mad2. According to current data in yeast, Ndc80 is involved in 
microtubule attachment to kinetochores, as mutant forms of this protein show chromosomes 
completely detached from the spindle (Wigge and Kilmartin, 2001, He et al., 2001). This 
suggests the interesting possibility that Hec1 is a bridging molecule (Fig.29), connecting 
microtubule attachment to kinetochores with checkpoint signaling. 
In mammals, a very similar role has been proposed for CENP-E, a kinesin involved in 
chromosome attachment (Yao et al., 2000, McEwen et al., 2001). Interestingly, CENP-E 
depletion does not affect Mad1-Mad2 localization, whereas it interacts with BubR1. Our data 
suggest that there are two independent complexes for checkpoint signaling, which is 
consistent with previous models (McEwen et al., 2001). One possibility is that both pathways 
are able to detect distinct events, as has been recently suggested  (Skoufias et al., 2001 
Biggins and Murray, 2001). Alternatively, they might belong to redundant mechanisms 
converging on and inhibiting APC/CCdc20, which subsequently produces anaphase entry delay, 
to increase security in this crucial process. 
Hec1 depletion induces mitotic arrest and failure in chromosome congression 
 
In yeast, Ndc80 (the homologue of Hec1) is part of a complex involving Spc24, Spc25 
and Nuf2 (Janke et al., 2001). It is interesting to note that Ndc80 mutants (which show no 
microtubule attachment) do not produce any arrest, whereas in nuf2-61, a mutant which 
produces metastable attachments, a metaphase arrest is observed (He et al., 2001). The 
authors explain this observation proposing that in the complete absence of kinetochore-
microtubule attachment, no checkpoint signal is generated, whereas metastable attachments 
do signal the checkpoint. This interpretation is consistent with the results observed in CENP-
E depleted cells (McEwen et al., 2001), as discussed below, and it is also consistent with the 
fact that mutations that completely abolish kinetochore function in yeast destroy the spindle 
checkpoint (Gardner et al., 2001).  
Hec1 depletion produces a mitotic arrest in a prometaphase-like situation, with 
chromosomes unable to congress at the metaphase plate despite the presence of a fully 
assembled spindle. Although we did not study microtubule attachment via electron 
microscopy in Hec1 depleted cells, our results upon calcium treatment and investigating 
dynactin/EB1 localization suggest that microtubule attachment is not lost, yet chromosome 
congression is severely impaired, leading to mitotic arrest.  
This discrepancy might be explained by taking in consideration some differences 
between budding yeast and vertebrate kinetochores. In budding yeast, kinetochores are 
attached to a single MT. However, although sister kinetochores in yeast do not become 
aligned on the spindle equator prior to anaphase, they exhibit motile behavior largely similar 
to that of vertebrate kinetochores. In vertebrates, the MT-binding capacity of sister 
kinetochores is similar and related to their diameter, which, although it can vary between 
chromosomes of a genome, correlates only weakly with chromosome size. In most organisms, 
kinetochores range between 0.1–0.5 µm in diameter and bind 10–45 MTs (Rieder and 
Salmon, 1998). This difference in microtubule number could represent an adaptation to 
increase the security and thus reduce the risk of losing chromosome attachment and the 
consequent effect of chromosome misegregation. Concomitantly, evolution could have 
introduced redundant mechanisms for microtubule attachment, reducing in this way the 
possibility that attachment is lost due to mutation in one single protein. Indeed, our data 
suggest that there are at least two parallel pathways involved in microtubule attachment and 
checkpoint signaling, one comprised by Hec1/Mad1/Mad2, and a second involving CENP-
F/CENP-E/BubR1. Interestingly, neither CENP-F nor CENP-E has homologues in budding 
yeast, and BubR1 is strikingly different from its counterpart, Mad3, which shows no kinase 
domain.  
Taking these differences into account, it seems clear that in budding yeast it would be 
easier to find a situation of “all or nothing”: either the microtubule is bound to the kinetochore 
or not, but a metastable situation is more difficult to generate. In this scenario, if in yeast the 
Ndc80 complex is the main player establishing the connection microtubule-kinetochore, 
mutations in any of its components will completely disrupt the interaction. However in 
vertebrates, disruption of the connection established through Hec1 would not affect the one 
maintained through CENP-E, and perhaps through others, so that the connection would still 
exist, although somehow perturbed or weakened. Indeed, this is what is observed when 
CENP-E is depleted via antibody microinjection: kinetochore microtubule binding is reduced 
by 23% at aligned chromosomes, and more severely at unaligned chromosomes (McEwen et 
al., 2001). Consistent with this idea, the authors in this report proposed that redundant 
mechanisms enable kinetochore microtubule binding and checkpoint monitoring in the 
absence of CENP-E at kinetochores. 
 
Cells can arrest in mitosis with unaligned chromosomes and no detectable levels 
of Mad1-Mad2 at kinetochores 
 
It is interesting to note that in Hec1 depleted cells, mitotic arrest occurs even when 
most (if not all) Mad1 and Mad2 are not localized to kinetochores of unaligned chromosomes. 
This is challenging the current models (Shah and Cleveland, 2000), as most of them propose 
that Mad2 is activated (denoted as Mad2*) by associating with unattached kinetochores. 
According to the current models, the subsequent release of Mad2* would provide the 
diffusible signal (a reporter of unattached kinetochores) that directly interacts with the cell 
cycle proteolytic machinery to prevent the onset of anaphase. Yet there is some evidence 
indicating that Mad2 can produce a mitotic arrest without activation at the kinetochores. First,  
it was observed that high levels of recombinant Mad2 induce mitotic arrest in fission yeast 
and in Xenopus extracts (Chen et al., 1998, Fang et al., 1998; He et al., 1997) and this mitotic 
arrest induction is independent of Mad1 and localization to the kinetochores. And more 
recently, Sudakin and colleagues (Sudakin et al., 2001) (see fig.30 for a summary of the 
proposed model) have shown that the inhibitory complex (consisting of hBubR1, hBub3, 
Cdc20, and Mad2) is not generated from kinetochores, as it is also present and active in 
interphase cells. However, all these data reported information obtained upon overexpression 
of Mad2 or under in vitro conditions. 
Our results provide the first in vivo data supporting the idea that Mad2 does not need 
to be activated via Mad1 and kinetochore binding to be able to interact with and inhibit 
Cdc20. Furthermore, the physiological relevance of Mad2 as APC/CCdc20 inhibitor was 
recently under question, given to the fact that Mad2 is much less efficient than BubR1 in vitro 
(Tang et al., 2001). However, we have clearly shown that, even when Mad2 is not detected on 
the kinetochores in Hec1 depleted cells, simultaneous depletion of Mad2 abolishes the mitotic 
arrest, indicating that Mad2 is indeed active and inhibiting APC/CCdc20 function in vivo.  
Our data suggest that there should be a diffusible signal, capable of transducing the 
ready-to-go signal generated when all chromosomes are aligned and release the inhibitory 
interaction Mad2/BubR1-APC/CCdc20, and this signal does not seem to be Mad2. In cells 
depleted of Hec1, this activity could be CENP-E/BubR1. However, Hec1+CENP-E siRNA 
cells still show a mitotic arrest (data not shown), indicating that either the remaining levels of 
CENP-E are enough for checkpoint signaling or that other unknown factors are involved. 
Although the identity of such molecule is currently unknown, our data suggest that its 
association with kinetochores should be independent of the presence of Hec1. Intriguingly, 
some traffic of checkpoint proteins has been described through the k-fibers towards the 
centrosome (Basto et al., 2000 Wojcik et al., 2001 Howell et al., 2000 Howell et al., 2001), 
and it has been proposed that this traffic could be implicated in checkpoint inactivation. One 
interesting possibility is that the centrosome could behave like a central station, receiving 
some signal from misaligned chromosomes. Upon alignment, kinetochores lose some of the 
checkpoint components and stop signaling. When all of them are aligned, no signal is 
generated from the kinetochores, and in this scenario an unknown component would be 
released from the centrosome (see also Fig.5). This would be responsible to release the 
inhibitory interaction upon APC/CCdc20, triggering anaphase onset through sister chromatid 
separation. This model would also account for the known fact that only one misaligned 
chromosome is able to maintain the mitotic arrest, although the mechanism of checkpoint 
silencing remains currently unknown. Alternatively, the diffusible signal could be directly 
generated by the kinetochores of misaligned chromosomes, but in this scenario the role of the 
traffic along k-fibers remains to be explained. 
Another intriguing question that obviously arises from our results concerns the 
function of Mad1-Mad2 localization at the kinetochores of misaligned chromosomes. 
Correlated with the absence of Hec1, Mad1-Mad2 at the kinetochores could be necessary for 
checkpoint silencing. However, they are necessary but clearly not sufficient, as upon 
nocodazole or taxol treatment these proteins are localized at kinetochores yet there is a mitotic 
arrest. One interesting possibility is that, independently to its function as Cdc20 inhibitor 
(although probably in a similar fashion, Luo et al., 2002), Mad2 is a cofactor required to 
maintain Mad1 unable to bind to other proteins. Most likely, Mad1-Mad2 bind to 
kinetochores to be able to interact with some other proteins relevant for checkpoint function, 
such as the Mad1-Bub1-Bub3 complex (Seeley et al., 1999, Brady and Hardwick, 2000). Yet 
it has been shown that all Mad1 is bound to Mad2 (Chen et al., 1999), and Mad1 binding to 
other complexes would implicate its previous release from Mad2. Upon certain conditions, 
Mad1-Mad2 interaction might be released (perhaps through Mad1 modification, such as 
phosphorylation (Hardwick et al., 1996 Seeley et al., 1999)), rendering Mad1 free to 
participate in other complexes. 
 
In conclusion, our data suggest that Hec1 in humans is necessary to target Mad1-Mad2 
at the kinetochores during mitosis and is required for chromosome congression and 
checkpoint silencing. Furthermore, we provide in vivo data suggesting that Mad2 activation at 
kinetochores is not required to establish a mitotic arrest, suggesting the presence of a 
diffusible factor independent of Hec1 for kinetochore association, and therefore challenging 
the current models for checkpoint induction. Although it is clear that more molecules would 
be implicated in microtubule attachment to kinetochores and checkpoint signaling, our data 
have important implications, pointing to the existence of redundant molecular mechanisms for 
signaling, identifying novel interactions and suggesting potential new mechanisms leading to 
checkpoint inactivation. 
Hec1 in cancer 
 
 It has been proposed that Hec1 could be overexpressed in some cancers (Chen et al., 
1997), using mRNA levels to check for this alteration. However, in one such cancer cell line 
(MS751) we could not detect a noticeable increase of Hec1 at the protein level, although a 
second, smaller band could be detected using specific anti-Hec1 antibodies. It remains to be 
proven that this band is indeed a fragment of Hec1, as our data suggest. 
 Interestingly, this cell line shows mislocalization of Mad1, Mad2 and partially Bub1 at 
kinetochores, a very similar phenotype to the one observed upon Hec1 depletion, indicating 
that this fragment could have a dominant-negative effect (we also detected a similar effect 
upon GFP-Hec1 overexpression, data not shown). Consistent also with our Hec1-depletion 
data, MS751 cells show an intact spindle checkpoint upon nocodazole or taxol treatment, 
supporting the idea that checkpoint activation can happen without detectable levels of Mad1-
Mad2 at kinetochores. However, MS751 cells are still arrested 42h after nocodazole 
treatment, whereas most of the other cell lines release after 24-30h. This suggests that MS751 
cells have a defect that impairs their ability to inactivate the spindle checkpoint. Whether or 
not this defect is related to the absence of Mad1-Mad2 at the kinetochores remains to be 
investigated. 
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Appendix: List of constructs 
name tag gene insert species vector comment 
SM004    Bgl II site  pBS SK from pBS RN3P Kpn I-
Hind III.  
SM089      pDNR3s Clontech fragment BspMI-SpeI 
religated 
SM090      pDNR2s Clontech fragment BspMI-SacI 
religated 
SM091      pDNR1s Clontech fragment BspMI-SacI 
religated 
SM027 6His Bub1 D946A; complete cds human pUNI10*p1206 E.coli expression 
SM029 6His Bub1 D946A; complete cds human pUNI10*p1213 Baculovirus expression
SM151 ACT Bub1 D946A; complete cds human pUNI10*1231 from SM011 
SM153 DBD Bub1 D946A; complete cds human pUNI10*1232 from SM011 
SM030 FLAG Bub1 D946A; complete cds human pUNI10*p1207 E.coli expression 
SM026 GST Bub1 D946A; complete cds human pUNI10*p1205 E.coli expression 
SM028 GST Bub1 D946A; complete cds human pUNI10*p1212 Baculovirus expression
SM037 Myc3 Bub1 D946A; complete cds human pUNI10*p1226 Mammalian expression
SM025  Bub1 D946A; complete cds human pBS SK fragment Kpn I-Bgl ll 
(D946A). Not 
completely sequenced 
SM031  Bub1 D946A; complete cds human pUNI10*p1208 Baculovirus expression
SM178  Bub1 M to K human pDNR1s from SM175, correct 
first mutation 
SM179  Bub1 M to K + R to Q human pDNR1s from SM176, correct 
second mutation 
SM180  Bub1 M to K + R to Q + G to 
D 
human pDNR1s from SM177, correct 
third mutation: wild 
type 
SM020 6His Bub1 wt; complete cds human pUNI10*p1206 E.coli expression 
SM022 6His Bub1 wt; complete cds human pUNI10*p1213 Baculovirus expression
SM150 ACT Bub1 wt; complete cds human pUNI10*1231 from SM008 
SM152 DBD Bub1 wt; complete cds human pUNI10*1232 from SM008 
SM023 GFP Bub1 wt; complete cds human pBI gift from Vogelstein 
lab; cloned Not I-Sal I 
SM019 GST Bub1 wt; complete cds human pUNI10*p1205 E.coli expression 
SM021 GST Bub1 wt; complete cds human pUNI10*p1212 Baculovirus expression
SM036 Myc3 Bub1 wt; complete cds human pUNI10*p1226 Mammalian expression
SM001  Bub1 wt; complete cds human pBS SK cloned Not I-Sal I 
name tag gene insert species vector comment 
SM006  Bub1 wt; complete cds human pBS SK Nde I  site at ATG; 
BamHI-EcoRV 
fragment 
SM008  Bub1 wt; complete cds human pUNI10 Nde I  site at ATG 
SM012  Bub1 wt; complete cds human pBS SK Nde I site at ATG 
SM053  Bub1 wt; complete cds human pBS SK +NdeI site before 
kinase dom. (from 
SM012) 
SM175  Bub1 wt; complete cds human pDNR1s from SM012, cloned 
NdeI-SalI/SmaI 
SM062 6His Bub1 wt; incomplete cds human pUNI10*p1206 kinase domain (from 
SM056) 
SM061 GST Bub1 wt; incomplete cds human pUNI10*p1205 kinase domain (from 
SM056) 
SM074 HA3 Bub1 wt; incomplete cds human pUNI10*p1225 kinase domain (from 
SM056) 
SM069 Myc3 Bub1 wt; incomplete cds human pUNI10*p1226 kinase domain (from 
SM056) 
SM005  Bub1 wt; incomplete cds human pBS SK fragment Kpn I-Bgl ll 
(D946) 
SM056  Bub1 wt; incomplete cds human pUNI10 kinase domain (from 
SM053) 
SM003  Bub1  D946A; complete cds human pBS SK cloned Not I-Sal I 
SM011  Bub1  D946A; complete cds human pUNI10 Nde I site at ATG 
SM162 ACT Bub3 wt; complete cds human pUNI10*1231 from SM075 
SM163 DBD Bub3 wt; complete cds human pUNI10*1232 from SM075 
SM076 HA3 Bub3 wt; complete cds human pUNI10*p1225 from SM075 
SM065  Bub3 wt; complete cds human pBS SK (-) clone AA308669 (EST 
ATCC) 
SM067  Bub3 wt; complete cds human pBS SK (-) NdeI at ATG. Cloned 
EcoRI - XhoI 
SM075  Bub3 wt; complete cds human pUNI10 NdeI at ATG. Cloned 
NdeI - SacI 
SM024 GFP BubR1 wt; incomplete cds human pWSgfp gift from T. Yen lab; 
cloned BamH I-Sal I; 
C-term deletion 
SM002  BubR1 wt; incomplete cds human pBS SK C' term deletion 
SM120 ACT CENP-F wt; incomplete cds human pACT Mi-59: aa2778-3210 
(C-term) 
SM094 DBD CENP-F wt; incomplete cds human pDNR3s*pGBKT7 aa 2778-3210 (Cterm); 
DBD+T7+myc 
SM173 EGFP CENP-F wt; incomplete cds human pDNR3s * pLP- from SM086 
name tag gene insert species vector comment 
EGFPC1 
SM086  CENP-F wt; incomplete cds human pDNR3s aa 2778-3210 (Cterm) 
SM077 myc-GFP CLIP-170 wt; complete cds human pCB6 from R.Stalder 
(T.E.Kreis) 
SM054  DNA-J wt E.coli pET 11d from Hartl group 
SM055  DNA-K wt E.coli pET 11d from Hartl group 
SM124 ACT EUROIMAGE 
clone 
wt; incomplete cds human pACT Mi-39: bp184-1200 
(lacks N) 
SM126 ACT FIJ22097 fis wt; incomplete cds human pACT Mi-74: up to bp1469 
(central region) 
SM119 ACT HEC wt; complete cds human pACT Mi-34: 642aa (full 
length) 
SM092 DBD HEC wt; complete cds human pDNR3s*pGBKT7 DBD+T7+myc 
SM171 EGFP HEC wt; complete cds human pDNR3s * pLP-
EGFPC1 
from SM084 
SM182 GST HEC wt; complete cds human pVH127*p1205 from SM135 
SM139 HA3 HEC wt; complete cds human pUNI(VH127)*p1225 Mi-34: 642aa (full 
length) 
SM183 His6 HEC wt; complete cds human pVH127*p1206 from SM135 
SM194 MBP HEC wt; complete cds human pMAL-c2x from SM119 (PCR). 
Cloned XmnI/blunt-
HindIII. Not seq. 
Cytoplasmic expression 
(c2x) 
SM195 MBP HEC wt; complete cds human pMAL-p2x from SM119 
(PCR).Cloned 
XmnI/blunt-HindIII. 
Not seq. Periplasmic 
expression (p2x) 
SM084  HEC wt; complete cds human pDNR3s  
SM135  HEC wt; complete cds human pUNI(VH127) Mi-34: 642aa (full 
length) 
SM187 GST HEC wt; incomplete cds human pUNI10*p1205 from SM184 (N-HEC) 
SM188 GST HEC wt; incomplete cds human pUNI10*p1205 from SM185 (K-HEC) 
SM189 GST HEC wt; incomplete cds human pUNI10*p1205 from SM186 (C-HEC) 
SM190 His6 HEC wt; incomplete cds human pUNI10*p1206 from SM184 (N-HEC) 
SM191 His6 HEC wt; incomplete cds human pUNI10*p1206 from SM185 (K-HEC) 
SM192 His6 HEC wt; incomplete cds human pUNI10*p1206 from SM186 (C-HEC) 
SM184  HEC wt; incomplete cds human pUNI10 aa1-99 (N-HEC) 
SM185  HEC wt; incomplete cds human pUNI10 aa235-409 (Kilmartin 
fragment) 
SM186  HEC wt; incomplete cds human pUNi10 aa542-642 (C-HEC) 
name tag gene insert species vector comment 
SM123 ACT KIAA0182 wt; incomplete cds human pACT Mi-36: aa1058-1157 
(C-term) 
SM127 ACT KIAA1328 wt; incomplete cds human pACT Mi-77: aa3-556 (lacks 
start) 
SM145 DBD Mad1 K503R; complete cds human pDNR1s*pGBKT7 potential SUMOlation 
site abolished 
SM147 EGFP Mad1 K503R; complete cds human pDNR1s*pLP-EGFP-
C1 
potential SUMOlation 
site abolished 
SM143  Mad1 K503R; complete cds human pDNR1s potential SUMOlation 
site abolished 
SM146 DBD Mad1 L514K; complete cds human pDNR1s*pGBKT7 leucine zipper disrupted 
SM148 EGFP Mad1 L514K; complete cds human pDNR1s*pLP-EGFP-
C1 
leucine zipper disrupted 
SM144  Mad1 L514K; complete cds human pDNR1s leucine zipper disrupted 
SM165 DBD Mad1 RLK to AAA human pDNR1s * pGBKT7 from SM164 
SM164  Mad1 RLK to AAA human pDNR1s from SM099 
SM078 DBD Mad1 T635A+S653A+T708A; 
complete cds 
human pUNI10*p1232 3As in yeast 2-hybrid 
DBD 
SM112 DBD Mad1 T635A+S653A+T708A; 
complete cds 
human pDNR1s*pGBKT7 3As in yeast 2-hybrid 
DBD 
SM066 EGFP Mad1 T635A+S653A+T708A; 
complete cds 
human EGFP-C1 (T7) cloned BspEI (blunt 
NdeI) + BamHI 
SM134 EGFP Mad1 T635A+S653A+T708A; 
complete cds 
human pDNR1s*pLP-EGFP-
C1 
3As 
SM045 Myc3 Mad1 T635A+S653A+T708A; 
complete cds 
human pUNI10*p1226  
SM043  Mad1 T635A+S653A+T708A; 
complete cds 
human pBS SK mutations sequenced 
SM044  Mad1 T635A+S653A+T708A; 
complete cds 
human pUNI10 mutations sequenced 
SM105  Mad1 T635A+S653A+T708A; 
complete cds 
human pDNR1s 3As in yeast 2-hybrid 
DBD 
SM033 6His Mad1 wt; complete cds human pUNI10*p1206 E.coli expression 
SM035 6His Mad1 wt; complete cds human pUNI10*p1213 Baculovirus expression
SM106 DBD Mad1 wt; complete cds  pDNR1s*pGBKT7  
SM063 EGFP Mad1 wt; complete cds human EGFP-C1 (T7) cloned BspEI (blunt 
NdeI) + BamHI 
SM128 EGFP Mad1 wt; complete cds human pDNR1s*pLP-EGFP-
C1 
 
SM064 GAL4 BD Mad1 wt; complete cds human pGBDO-C3 cloned SmaI (NdeI 
blunt-BamHI blunt) 
SM193 GFP Mad1 wt; complete cds human pUNI10+GFP loxP- prepared by Peter 
name tag gene insert species vector comment 
Duncan 
SM032 GST Mad1 wt; complete cds human pUNI10*p1205 E.coli expression 
SM034 GST Mad1 wt; complete cds human pUNI10*p1212 Baculovirus expression
SM149 HA3 Mad1 wt; complete cds human pUNI10*p1225 from SM009 
SM038 Myc3 Mad1 wt; complete cds human pUNI10*p1226 Mammalian expression
SM007  Mad1 wt; complete cds human pBS SK Cloned BamH I-EcoR I 
from LA261. Corrected 
seq at the C-term 
(insertion): stop codon 
at TAG 
SM009  Mad1 wt; complete cds human pUNI10 Nde I site at ATG; 
BamHI site at TAA 
SM013  Mad1 wt; complete cds human pBS SK Nde I site at ATG 
SM014  Mad1 wt; complete cds human pBS SK Nde I site at ATG; 
BamHI site at TAA 
SM099  Mad1 wt; complete cds human pDNR1s  
SM174  Mad1 wt; complete cds drosophil
a 
pDNR1s cloned from cDNA 
SM176  Mad1 wt; complete cds drosophil
a 
pBS SK- cloned from cDNA, 
EcoRI-BamHI 
SM057 6His Mad1 wt; incomplete cds human pUNI10*p1206 C3-term (400 bp) from 
SM050 
SM058 6His Mad1 wt; incomplete cds human pUNI10*p1206 C2-term (700 bp) from 
SM051 
SM059 6His Mad1 wt; incomplete cds human pUNI10*p1206 C1-term (900 bp) from 
SM052 
SM060 6His Mad1 wt; incomplete cds human pUNI10*p1206 N-term (1,3 kb) from 
SM049 
SM113 ACT Mad1 wt; incomplete cds human pUNI10*p1231 N-term (1,3 kb) in 
yeast 2-hybrid ACT 
SM114 ACT Mad1 wt; incomplete cds human pACT Mi-1: aa108-718 (lacks 
N) 
SM117 ACT Mad1 wt; incomplete cds human pACT Mi-20: aa413-718 (C-
term) 
SM079 DBD Mad1 wt; incomplete cds human pUNI10*p1232 D687-718 in yeast 2-
hybrid DBD 
SM080 DBD Mad1 wt; incomplete cds human pUNI10*p1232 N-term (1,3 kb) in 
yeast 2-hybrid DBD 
SM081 DBD Mad1 wt; incomplete cds human pUNI10*p1232 C3-term (400 bp) in 
yeast 2-hybrid DBD 
SM082 DBD Mad1 wt; incomplete cds human pUNI10*p1232 C2-term (700 bp) in 
yeast 2-hybrid DBD 
name tag gene insert species vector comment 
SM083 DBD Mad1 wt; incomplete cds human pUNI10*p1232 C1-term (900 bp) in 
yeast 2-hybrid DBD 
SM107 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 N-term (1,3 kb) in 
yeast 2-hybrid DBD 
SM108 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 C1-term (900 bp) in 
yeast 2-hybrid DBD 
SM109 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 C2-term (700 bp) in 
yeast 2-hybrid DBD 
SM110 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 C3-term (400 bp) in 
yeast 2-hybrid DBD 
SM111 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 D687-718 in yeast 2-
hybrid DBD 
SM158 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 N2: aa1-202, 600 bp, 
25kD 
SM159 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 I2: aa379-565, 560 bp,  
24kD 
SM160 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 I1: aa475-565, 270 bp, 
11kD 
SM161 DBD Mad1 wt; incomplete cds human pDNR1s*pGBKT7 C0: aa379-718, 1kb, 
40kD 
SM129 EGFP Mad1 wt; incomplete cds human pDNR1s*pLP-EGFP-
C1 
N-term (1,3 kb) 
SM130 EGFP Mad1 wt; incomplete cds human pDNR1s*pLP-EGFP-
C1 
C1-term (900 bp) 
SM131 EGFP Mad1 wt; incomplete cds human pDNR1s*pLP-EGFP-
C1 
C2-term (700 bp) 
SM132 EGFP Mad1 wt; incomplete cds human pDNR1s*pLP-EGFP-
C1 
C3-term (400 bp) 
SM133 EGFP Mad1 wt; incomplete cds human pDNR1s*pLP-EGFP-
C1 
D687-718  
SM166 EGFP Mad1 wt; incomplete cds human pDNR1s * pLP-
EGFPC1 
from SM154 
SM167 EGFP Mad1 wt; incomplete cds human pDNR1s * pLP-
EGFPC1 
from SM155 
SM168 EGFP Mad1 wt; incomplete cds human pDNR1s * pLP-
EGFPC1 
from SM156 
SM169 EGFP Mad1 wt; incomplete cds human pDNR1s * pLP-
EGFPC1 
from SM157 
SM048 Myc3 Mad1 wt; incomplete cds human pUNI10*p1226 D687-718 mutation 
sequenced 
SM070 Myc3 Mad1 wt; incomplete cds human pUNI10*p1226 C3-term (400 bp) from 
SM050 
name tag gene insert species vector comment 
SM071 Myc3 Mad1 wt; incomplete cds human pUNI10*p1226 C2-term (700 bp) from 
SM051 
SM072 Myc3 Mad1 wt; incomplete cds human pUNI10*p1226 C1-term (900 bp) from 
SM052 
SM073 Myc3 Mad1 wt; incomplete cds human pUNI10*p1226 N-term (1,3 kb) from 
SM049 
SM039  Mad1 wt; incomplete cds human pBS SK fragment Bgl II - Sma I 
(from SM007) 
SM040  Mad1 wt; incomplete cds human pBS SK fragment Sma I - Eco 
RI (from SM007) 
SM041  Mad1 wt; incomplete cds human pBS SK fragment Bgl II - Sma I 
(from SM014) 
SM042  Mad1 wt; incomplete cds human pBS SK fragment Sma I - Eco 
RI (from SM014) 
SM046  Mad1 wt; incomplete cds human pBS SK D687-718 mutation 
sequenced 
SM047  Mad1 wt; incomplete cds human pUNI10 D687-718 mutation 
sequenced 
SM049  Mad1 wt; incomplete cds human pUNI10 N-term (1,3 kb) from 
SM014 
SM050  Mad1 wt; incomplete cds human pUNI10 C3-term (400 bp) from 
SM014 
SM051  Mad1 wt; incomplete cds human pUNI10 C2-term (700 bp) from 
SM014 
SM052  Mad1 wt; incomplete cds human pUNI10 C1-term (900 bp) from 
SM014 
SM100  Mad1 wt; incomplete cds human pDNR1s N-term (1,3 kb) 
SM101  Mad1 wt; incomplete cds human pDNR1s C1-term (900 bp) 
SM102  Mad1 wt; incomplete cds human pDNR1s C2-term (700 bp) 
SM103  Mad1 wt; incomplete cds human pDNR1s C3-term (400 bp) 
SM104  Mad1 wt; incomplete cds human pDNR1s D687-718 in yeast 2-
hybrid DBD 
SM154  Mad1 wt; incomplete cds human pDNR1s from SM014; N2: aa1-
202, 600 bp, 25kD 
SM155  Mad1 wt; incomplete cds human pDNR1s from SM014; I2: 
aa379-565, 560 bp,  
24kD 
SM156  Mad1 wt; incomplete cds human pDNR1s from SM014; I1: 
aa475-565, 270 bp, 
11kD 
SM157  Mad1 wt; incomplete cds human pDNR1s from SM014; C0: 
aa379-718, 1kb, 40kD 
name tag gene insert species vector comment 
SM016 6His Mad2 wt; complete cds human pUNI10*p1206 E.coli expression 
SM018 6His Mad2 wt; complete cds human pUNI10*p1213 Baculovirus expression
SM118 ACT Mad2 wt; complete cds human pACT Mi-30: 205aa (full 
length) 
SM098 DBD Mad2 wt; complete cds human pDNR1s*pGBKT7 DBD+T7+myc 
SM181 EGFP Mad2 wt; complete cds human pDNR1s * pLP-
EGFPC1 
from SM097 
SM015 GST Mad2 wt; complete cds human pUNI10*p1205 E.coli expression 
SM017 GST Mad2 wt; complete cds human pUNI10*p1212 Baculovirus expression
SM068 HA3 Mad2 wt; complete cds human pUNI10*p1225  
SM010  Mad2 wt; complete cds human pUNI10 Cloned from LA262; 
Nco I site at ATG 
SM097  Mad2 wt; complete cds human pDNR1s from LA262, EcoRI-
ApaI cloning 
SM177  Mad2 wt; complete cds drosophil
a 
pBS SK- cloned from cDNA, 
EcoRI 
SM121 ACT NMI (N-myc 
and Stat int) 
wt; complete cds human pACT Mi-93: 307aa (full 
length) 
SM116 ACT Prer wt; incomplete cds human pACT Mi-18: aa156-557 
(lacks N) 
SM170 myc6 Scc1 wt; complete cds human CS2 gift from Olaf 
Stemman (Kirschner) 
extension Cter 
SM115 ACT Smc3 wt; incomplete cds human pACT Mi-10: aa117-434 (1st 
coil) 
SM093 DBD Smc3 wt; incomplete cds human pDNR3s*pGBKT7 aa 117-434 (Nterm); 
DBD+T7+myc 
SM172 EGFP Smc3 wt; incomplete cds human pDNR3s * pLP-
EGFPC1 
from SM085 
SM085  Smc3 wt; incomplete cds human pDNR3s aa 117-434 (Nterm) 
SM125 ACT THC211630 wt; incomplete cds human pACT Mi-48: bp151-1246 
(central region) 
SM122 ACT Ubc9* wt; complete cds (?) human pACT Mi-88:158 aa (full 
length) 
SM095 DBD Ubc9* wt; complete cds (?) human pDNR3s*pGBKT7 DBD+T7+myc 
SM087  Ubc9* wt; complete cds (?) human pDNR3s  
 
Abbreviations list 
 
3-AT 3-amino triazol  
Ab antibody 
ACA Anti-centromere antibodies 
ACT Activation domain 
APC/C Anaphase promoting complex / cyclosome 
ATP Adenosine triphosphate 
BrdU Bromo-deoxyuridine 
BV baculovirus 
CDK Cyclin dependent kinases 
CmR Chloramphenicol resistance gene 
CMV cytomegalovirus 
DAPI 4,6 Diamidino-2-phenylindole (DNA staining) 
DBD DNA binding domain 
DMEM Dulbecco’s modified Eagle medium 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
ECL Enhanced chemiluminiscence 
EGFP Enhanced green fluorescent protein 
EST Expressed sequence tagged 
GFP Green fluorescent protein 
GST Glutathione-S tranferase 
HA3 3 x hemagglutinine 
His6 6 x histidine 
IgG Immunoglobulin G 
IP Immunoprecipitation 
IVT In vitro translation 
kD kilodalton 
k-fiber Kinetochore fiber 
LeuZi Leucine zipper 
MALDI Matrix assisted laser desorption ionization 
MBP Maltose binding protein 
MCC Mitotic checkpoint complex 
MEN Mitotic exit network 
MPF M-phase/maturation promoting factor 
mRNA messenger RNA 
MTs microtubules 
Myc3 3 x myc 
NEB Nuclear envelope breakdown 
NLS Nuclear localization signal 
NMR Nuclear magnetic resonance 
NPC Nuclear pore complex 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction 
PEG Polyethylene glycol 
PI preimmune 
PP2A Protein phosphatase 2A 
RNA Ribonucleic acid 
RNAi Ribonucleic acid interference 
RT Room temperature 
SacB Sucrose gene from B.subtilis 
SC Synthetic complete medium  
SDS-PAGE Sodium dodecyl sulfate – polyacrylamid gel electrophoresis 
siRNA Small interference ribonucleic acid 
SMC Structural maintenance of chromosomes 
Trp tryptophan 
Tyr tyrosine 
wt Wild type 
Y2H Yeast two-hybrid system 
 
 
Figures 
Figure. 1  
The mitosis-to-interphase transition in budding yeast, adapted from Amon (1999) and 
Gardner & Burke (2000) 
 
 
 
 
 
 
 
 
 
Figure. 2 
The spindle checkpoint. During prophase/prometaphase, the spindle checkpoint components 
are localized at the kinetochores (but it is unlikely that they form a unique complex). When 
the chromosomes become aligned at the metaphase plate, the checkpoint proteins are released, 
the APC/CCdc20 becomes active and sister chromatids cohesion is lost, producing anaphase 
onset, a highly synchronized event. 
 
 
 
 
 
 
 
 
 
 
Figure. 3  
The spindle checkpoint. In vertebrate cells, all the known components have been localized at 
the kinetochores, and some interactions amongst them have been identified. However, it is not 
clear which subcomplexes are formed and their precise timing and function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 4 
Spindle checkpoint activation, according to the data presented by Sudakin, Chan and Yen 
(2001). The MCC (mitotic checkpoint complex) is active during interphase, but only mitotic 
APC/C (activated by phosphorylation) is capable of binding. This would turn the checkpoint 
ON until the last chromosome is aligned at the metaphase plate, turning the checkpoint OFF 
and triggering sister chromatid separation and anaphase onset. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 5 
Potential role of the centrosomes in the spindle assembly checkpoint. Chromosomes 
unaligned might send inhibitory signals towards the centrosome through the kinetochore 
microtubules. The Dynactin-Zw10-Rod complex, however, has been detected at kinetochore 
fibers after the chromosomes are under tension (see text in discussion for further comments).  
 
 
 
 
 
 
 
 
 
 
Figure. 6  
Homologues of Mad1 in different species. They were aligned using CLUSTALW (1.81) at 
EMBL outstation. The resulting .dnd file was then processed using TreeView (1.6.1; 
http://taxonomy.zoology.gla.ac.uk/rod/rod.html). All the vertebrate homologues cluster 
together and the budding and fission yeast ones are also closely related.  
 
 
 
 
 
 
 
Figure. 7  
Sequence analysis of homologues of Mad1 in different species. The picture shows conserved 
residues or motifs, and variations found.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 8  
Peptide antibodies against hMad1. A: test of sera from rabbits 139 and 140 on HeLa extracts 
(both exponentially growing or nocodazole-arrested cells) and on Sf9 cell extracts. B: 
immunoprecipitation of myc3-hMad1 prepared by in vitro translation (IVT) by sera from 
rabbits 139 and 140, as compared to anti-myc (9E10) or pre-immune sera. C: affinity 
purification of serum from rabbit 139 on peptides EP991001 and EP991002. Upper panel, 
left: Coomassie staining of the different antibody fractions after elution; fractions 2,3,4,5 
showed more antibody and they were pooled together (AB Hc: antibody heavy chain). Upper 
panel, right: Coomassie staining of total bacterial extracts used to test the antibodies. Lower 
panel, left: immunoblot of the pooled antibodies on cell extracts, both exponentially growing 
and nocodazole arrested; SD99041: immunoblot of the crude serum before affinity 
purification. Lower panel, right: immunoblot of the pooled antibodies on bacterial extracts 
(shown in the upper panel); all antibodies were positive against 6His-Mad1 and negative 
against GST-Mad2. Arrows: Mad1 position. 
 
 
  
 
 
 
 
Figure. 9  
Cell cycle localization of hMad1 using antibody from rabbit 139 purified on peptide 
EP991002. In all cases kinetochore localization was labeled using anti-CENP-B antibody and 
DNA was labeled using DAPI (4,6 Diamidino-2-phenylindole).The overlay shows Mad1 in 
green, CENP-B in red and DAPI in blue.  Bar represents 10µm. 
 
 
Figure. 10 
RNA interference using hMad1 small oligonuclotides (siRNA hMad1). A: first panel, control 
experiment, using mock-treated HeLa S3 cells. Next panels show HeLa S3 cells treated with 
siRNA hMad1 for 42h and tested for Mad1 (second panel) or Mad2 (third panel). Kinetochore 
localization was labeled using anti-CENP-B antibody and DNA was labeled using DAPI. B: 
immunoblot of cell extracts, either mock-treated (control) or treated with siRNA hMad1. 
Anti-α-tubulin was used as a marker for protein loading. C: Upper panel, control experiment, 
using mock-treated HeLa S3 cells. Lower panel shows HeLa S3 cells treated with siRNA 
hMad1 and tested for Mad1, CENP-E and DAPI. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 11 
Nocodazole treatment of cells treated by RNA interference using hMad1 small 
oligonucleotides (siRNA hMad1) or hMad2 small oligonucleotides (siRNA hMad2). A: 
quantification of cells showing condensed chromosomes using DAPI staining, after siRNA 
treatment followed by nocodazole addition. In all cases, three independent fields were 
counted, with 100 cells each. B: DAPI figures without nocodazole addition (upper panel) or 
after 18h nocodazole treatment (lower panel). Observe the fragmented nuclei that can be seen 
in siRNA hMad2 treatment without nocodazole or in siRNA hMad1 treatment after 
nocodazole addition. 
 
 
 
Figure. 12  
Mapping the interaction domain in hMad1 for hMad2. Upper panels: in vitro translation (IVT) 
products of myc3-hMad1 and HA3-hMad2 were prepared (35S control), mixed and incubated 
for 30min at 30°C to allow interaction to occur (35S input) and then subjected to 
immunoprecipitation using anti-myc antibody (35S data). Middle panel, right: The amount of 
antibody used was confirmed to be equal in every case (see the Ponceau staining of the IgG 
heavy chain). Lower panel: to verify the presence of hMad2, samples were processed by 
immunoblotting using anti-HA antibody; left, immunoblot from the input; right, immunoblot 
from the immunoprecipitation experiment (data); red arrow, Mad2, blue arrow, IgG light 
chain. Experiments were repeated several times and averaged (graph showing the hMad2 35S 
signal in the immunoprecipitation samples). 3As: mutant T635A+S653A+T708A. 
 
 
 
 
 
 
 
Figure. 13  
A: results in the yeast  two-Hybrid (Y2H) system using DBD-hMad1 constructs and ACT-
hMad2. All interactions were first tested on non-selective medium (minus leucine, 
tryptophan: -LW) to check that growth was correct, and same colonies were then tested on 
selective medium (minus leucine, tryptophan, adenine, histidine: -LWAH). B: control 
experiment in the Y2H using DBD-hMad1 constructs against an empty pACT vector, to 
discard potential transactivation effects. Same colonies were tested on non-selective and 
selective medium. C: scheme displaying the structure of the different hMad1 constructs tested 
against hMad2, both in IVT and in the Y2H. 
 
 
Figure. 14  
Model for the interaction between microtubule plus ends, MBPs and the kinetochore (in 
yellow).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 15  
Mapping the interaction domain in hMad1 for some of the Y2H candidates. A: example of 
yeast growth both on non-selective (-LW) and selective (-LWAH) plates, for the DBD-
hMad1/ACT-Hec1 interaction. B: scheme showing the observed results for the different 
constructs tested. 
 
 
 
 
 
 
 
 
Figure. 16 
Characterization of anti-hHec1 antibodies. Antibody wt2 (*) shows a clear unique signal on 
nocodazole extracts at about 80kD, the expected size for endogenous Hec1. Arrows: Hec1 
position. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 17 
Hec1 in the cell cycle. This protein shows kinetochore localization in all stages of mitosis, 
from prophase until telophase. Same localization was observed using GFP-Hec1 and using 
anti-mHec1 (kindly provided by J.Kilmartin). Overlay shows Hec1 in green, CENP-B in red 
and DAPI in blue. Bar, 10µm. 
 
Figure. 18  
Control experiment in mock-treated HeLa S3 cells. Cells were triple labeled with anti-Hec1 
(row A), anti-hMad1 (row B), anti-xMad2 (row C) or anti-hBub1 (row D) plus anti-CENP-B 
and DAPI. The overlay shows anti-CENP-B in red, DAPI in blue and the third protein in 
green. Bar represents 10 µm. 
 
 
 
 
 
 
 
 
Figure. 19  
Depletion of Hec1 levels by siRNA in HeLa cells produces disruption of kinetochore 
localization of Mad1 at mitosis. Row A: control (mock treated) cells triple labeled with anti-
Hec1, anti-CENP-B and DAPI. Rows B, C: HeLa cells treated with Hec1 siRNA duplex and 
triple labeled with anti-CENP-B, DAPI and anti-Hec1 (row B) or anti-hMad1 (row C). Bar 
represents 10 µm. 
 
 
 
 
 
 
Figure. 20  
Depletion of Mad1 by siRNA in HeLa cells does not affect kinetochore localization of Hec1 
at mitosis. Rows A, B: HeLa cells treated with Hec1 siRNA duplex and triple labeled with 
anti-CENP-B, DAPI and anti-hMad1 (row A) or anti-Hec1 (row B). Bar represents 10 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 21 
Cells treated with Hec1 siRNA duplex show reduced levels of checkpoint proteins on 
kinetochores, whereas structural components are still able to assemble. Rows A, B, C, D: 
HeLa cells treated with Hec1 siRNA duplex and triple labeled with anti-CENP-B, DAPI and 
anti-xMad2 (row A), anti-hBub1 (row C), anti-CENP-F (row D) or anti-CENP-E (row D). Bar 
represents 10 µm. 
 
 
Figure. 22  
HeLa cells with reduced levels of Hec1 show a prometaphase-like arrest, with condensed 
chromosomes and a fully assembled spindle. (A-B) Cells stained with DAPI (blue) and α-
tubulin (red) after 42h mock-treatment (A) or Hec1 siRNA duplex treatment (B). (C) 
Immunoblot from cell extracts after mock-treatment or Hec1 siRNA duplex treatment, and 
tested using anti-Hec1  and anti-α-tubulin. (D) Histogram showing the mitotic index of HeLa 
cells after 24 and 42h mock-treatment or Hec1 siRNA duplex treatment. The results were 
obtained by counting cells in three separated fields with at least 100 cells and averaged. Bar 
represents 20 µm. 
 
 
 
 
 
Figure. 23  
The mitotic arrest induced by low Hec1 levels is checkpoint dependent. (A-C) Upper panels: 
Cells stained with DAPI (blue) and α-tubulin (red) after 42h mock-treatment (A), Hec1 
siRNA duplex treatment (B) or Hec1+Mad2 siRNA duplexes treatment (C). Lower panels: 
same cells showing only DAPI staining. (D) Immunoblots of cell extracts after mock-
treatment, Hec1 siRNA duplex treatment or Hec1+Mad2 siRNA duplex treatment, tested 
using anti-Hec1 or anti-hMad2 and anti-α-tubulin. (E) Histogram showing the mitotic index 
of HeLa cells after 42h Hec1 siRNA duplex or Hec1+Mad2 siRNA duplex treatment. (F) 
Histogram showing the mitotic index of HeLa cells after 42h Hec1 siRNA duplex or 
Hec1+BubR1 siRNA duplex treatment. The results were obtained by counting cells in three 
separated fields with at least 100 cells and averaged (E, F). Bar represents 20 µm. 
 
Figure. 24 
Double siRNA Hec1+laminA does not abolish the mitotic arrest. Histogram showing the 
mitotic index of HeLa cells after 42h LaminA, Hec1, Hec1+Mad2 or Hec1+BubR1 siRNA 
duplex treatment. The results were obtained by counting cells in three separated fields with at 
least 100 cells and averaged. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 25 
CENP-E siRNA produces mitotic arrest but not Mad1-Mad2  or Hec1 mislocalization. Cells 
treated with CENP-E siRNA duplex show normal levels of checkpoint proteins on misaligned 
kinetochores (arrows), whereas kinetochores of chromosomes properly aligned on the 
metaphase plate show no signal either for Mad1 or Mad2. Row A: control HeLa cells (mock 
treated) and triple labeled with anti-Hec1, anti-CENP-E and DAPI. Rows B, C, D: HeLa cells 
treated with CENP-E siRNA duplex and triple labeled with anti-Hec1, anti-CENP-E and 
DAPI (row B) or anti-hMad1 (row C), anti-xMad2 (row D) plus anti-CENP-B and DAPI. 
Overlay shows Hec1/Mad1/Mad2 in green, CENP-E/CENP-B in red and DAPI in blue. Bar 
represents 10 µm. 
 
Figure. 26 
The mitotic arrest induced by CENP-E siRNA is checkpoint dependent. Histogram showing 
the mitotic index of HeLa cells after 42h mock-treatment, Hec1, CENP-E, CENP-E+BubR1 
or CENP-E+Mad2 siRNA duplex treatment. The results were obtained by counting cells in 
three separated fields with at least 100 cells and averaged. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 27 
MS751 shows mislocalization of checkpoint proteins during mitosis. Rows A, B, C, D: 
MS751 cells triple labeled with anti-CENP-B, anti-Hec1 (row A), anti-hBub1 (row B), anti-
hMad1 (row C) or anti-xMad2 (row D), and DAPI. Overlay shows Hec1/Bub1/Mad1/Mad2 in 
green, CENP-B in red and DAPI in blue. E: Immunoblot of HeLa (1) or MS751 (2) extracts 
with anti-Hec1 and anti-α-tubulin antibody. 
 
 
 
 
Figure. 28 
MS751 has a spindle checkpoint response similar to other cancer cell lines, but it has 
problems to release the arrest. A: mitotic index of different cancer cell lines after 18h 
nocodazole treatment. B: mitotic index of same cancer cell lines taken every 6h after 
nocodazole addition. C: comparison of mitotic index at 18h and 36h after nocodazole or taxol 
addition for three different cancer cell lines. The results were obtained by counting cells in 
three separated fields with at least 100 cells and averaged. 
 
 
 
 
 
 
 
 
 
Figure. 29  
Proposed model indicating Hec1 localization and interactions at kinetochores. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 30  
Model summarizing checkpoint activation and release, modified from Sudakin et al., 2001. 
Every cell cycle, upon entry into mitosis, the APC/C would become competent (perhaps 
through phosphorylation) to bind the inhibitory complex, and therefore the spindle checkpoint 
would become activated. When the last chromosome reaches the metaphase plate, a diffusible 
signal is released either directly from the kinetochores or via the centrosome. This diffusible 
factor would be able to communicate with the inhibitory complex, releasing it and rendering 
the APC/C active, triggering anaphase onset by promoting specific protein degradation. 
 
 
 
 
 
